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INTRODUCTION 
The role of aging in myocardial depression was investi-
gated. It was hypothesized that some component of blood 
plasma from aged dogs may depress myocardial contractility 
in young dogs. The experiments in this study were designed 
to investigate Myocardial Depressant Factor (MDF) as an 
aging factor. Previously, MDF has been implicated to have 
an important role in shock. 
Many of the changes which occur in the blood and body 
during the aging process may be correlated with common 
ele.ments in the mechanism of shock. The primary element 
present in both shock and aging is the pancreatic origin of 
MDF (shock) and human pancreatic polypeptide (hpp) (age). 
Other components. are: lysosomes, hydrolase activity, 
tissue hypoxia, mitochondrial changes, enzyme changes, 
neutrophilia, protein globulin changes, inhibitory protein 
and lipid factors·, less efficient homeostasis, organ hypo-
perfusion, serum copper levels, the role of cysteine, and 
parameters in muscle mechanics which are similarly affected 
in age and shock. 
Most. researchers accept the presence of a myocardial 
depressant factor during shock. The controversy pertains to· 
t.he isolation arid characterization of the factor. Therefo.re, 
to initiate this study, the evidence that MDF is a peptide 
2 
which can be induced with experimental shock was first 
established. The search for MDF in the plasma of aged dogs 
was conducted with gel filtration chromatography. Semi-
purified fractions of canine plasma from both young and 
aged dogs were tested with isolated young canine papillary 
muscle. 
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LITERATURE REVIEW 
Myocardial Depressant Factor in 
' Shock - a Controversy 
The etiology of irreversible circulatory shock is contro.,-
versiai. Two well-known researchers, Allan Lefer and 
Stephen Wangensteen, debate over the existence of a myo-
cardial depressant factor (MDF) which has been implicated to 
have an important .role in shock. The controversy stems from 
the uncertainty _of the-chemical nature of MDF. Some in-
vestigators question the peptidic nature of MDF, claiming 
it is just a s_alti others question the origin, formation, 
transport, and precise actions. Some of the difficulties 
in the_characterization of MDF are apparent from the in-
consistent reports on the molecular charge, elution volume 
from chromatographic columns, and the reaction rate of MDF 
in in vitro studies. 
Characterization of MDF 
MDF was first isolated from feline shock pl.asma by 
·Brand and Lefer· (1966). Since. then, MDF has been isolated 
from many species (man, cat, dog·, guinea pig, baboon) in a 
variety of shock states (endotoxic, cardi0genic, he111orrhagic · 
and burn shock, pancreati tis., and in splartchnic, bowel, and 
pancreatic ischemia). MDF has been reported to be present 
in shock plasma at concentrations of o.s-1.0 nmole/ml 
4 
(Greene et al., 19771 Yamada and Pettit, 1977), 10 nmoles/ml 
(Lefer, 1970), and in the picomolar range (Goldfarb and 
Weber, 1977b). 
MDF has been characterized as a biologically active 
octapeptide or nonapeptide (Lovett et al., 1971). The fol-
lowing amino acids were found in MDF: alanine, aspartic 
acid, glycine, glutamic acid, iso-leucine, leucine, serine, 
threonine, and valine (Okuda and Fukui, 1974). An active 
myocardial depressant component of shock plasma, which was 
isolated by Bio-gel filtration chromatography as peak D, 
was further fractionated into nine components by cation 
exchange chromatography. The fifth component consisted of 
free L-isoleucine and L-leucine in a ratio of 1:4 and had 
high cardiodepressant activity which was comparable to 
the original shock plasma peak D {Goldfarb et al., 1978). 
Since L-isoleucine was co-purified with L-leucine, each 
amino acid was tested individually on the papillary muscle 
bioassay system. Free L-leucine caused a dose-related 
depressioni free L-isoleucine slightly stimulated the muscle, 
The amino acid composition of the MDF fraction from 
high voltage paper electrophoresis consisted of glutamic 
acid, glycine, serine, and an unidentified acidic amino 
acid (Greene et al., _1977). 
Twenty common amino acids were assayed for inotropic 
activity at concentrations of 1 and 10 mM. At 1 mM, none of 
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the twenty amino acids exerted any significant negative 
inotropic activity. Leucine, glycine and valine were re-
ported to increase the contractile force by 3-4%. Cysteine, 
histidine and tryptophan each decreased contractile force 
by 10-20% at a 10 mM concentration (Greene et al., 1977). 
MDF has been reported to be. a charged substance capable 
of being bound to mixed cation-anion exchange resins. 
While MDF has been described to contain either a positive 
or a negative electric charge or both (Brand et al., 1969), 
most researchers have claimed MDF to be anionic. 
MDF contains no sulfur-linked amino acids, and may 
even be a glycopeptide, since an unidentified carbohydrate 
substance was found in the Dowex-50 active peak o1 (a 
further purified Bio-gel peak D) (Lefer, 1970). 
MDF was found in the fourth peak (peak D) of a gel fil-
tration chromatogram in an elution volume of 80-100 ml 
(Lefer and Inge, 1973). A molecular weight range of 500-
1000 was thus assigned to MDF; some researchers reported MDF 
to be between 500-700 daltons, while others claimed it has a 
molecular weight between 800-1000 daltons. There is dis-
agreement on the elution volume for MDF. Lefer 
originally found peak D at the 155 ml elution volume, later 
reported it at 120 ml, and presently recovers it at 80-100 
ml. Yamada and Pettit (1977) found the elution volume of 
MDF to be between 85-105 ml. Wangensteen et al~ (1973a) iso-
lated their peak D at 120-150 ml. Goldfarb and Weber (1977b) 
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claimed MDF was contained in the peak eluted at 122-150 
ml. According to Okuda and Fukui (1974), the elution volume 
for peak D was 135-154 ml. The elution volume for peak 
D approximated from one of Lefer and Martin's (1970a) 
original column elution patterns was actually 131-169 ml 
with a peak height at 156 ml. 
MDF was heat stable at SOC for 30 minutes at neutral 
pH, water soluble, insoluble in methylene chloride, 
dialyzable, and rtinhydrin positive. 
Peptide or salt? 
The primary biological action of MDF is its negative 
inotropic effect on the isolated papillary muscle, isolated 
perfused heart, and in the intact animal. This negative 
inotropic effect follows a dose-response curve. 
Wangensteen attributed this depressant activity to salt. 
He claimed that this MDF was just an artifact of isolation 
and assay procedure, namely, excess sodium chloride (NaCl) 
rather than a peptide. The myocardial depressant activity 
could be correlated only with changes in Na+ concentration 
and, to a lesser degree, calcium ion (Ca++) concentration. 
According to Wangensteen et al. (1973a), 200 mEq/l of 
Na+ caused 40% depression, 350 mEq/l caused 80% depression. 
and 500 mEq/l caused 100% depression. Thus, an increase in 
the sodium ion concentration depressed papillary muscle in a 
linear fashion (Goldfarb and Weber, 1977b). Wangensteen et al. 
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(1973a) also claimed that peak D and NaCl were eluted from 
the col~mn at the same elution volume, 120 ml. 
When paper high voltage electrophoresis and thin layer 
chromatography were performed, all bands causing depression 
of papillary muscle activity were in positions identical 
to the NaCl bands. Ca],culated elution-to-void volume ratios 
for peak D and for salts were 2.44-2.99 and 2.5 or greater,· 
respectively (Wangensteen et al., 1973a). According to 
Wangensteen, a peptide with .a molecular weight of 800-1000 
should appear near the elution volume of 63 ml with a 
Ve/V
0 
ratio of 1.4. 'However, this is assuming that there 
is no adsorption to the Bio-gel P-2. Certain charged 
organic substances are adsorbed to the Bio-gel and are eluted 
at higher volumes than predicted (Wangensteen et ai·., .1973a). 
Lefer and Glenn (1973) insisted that MDF was not an 
inorganic salt nor an artifact of column ·chromatography; 
peak D contained only 10-20 mEq/l NaCl above that of Krebs-
Henselei t solution. In fact, proper elution of gel fil-
·tration columns yielded sodium concentrations of 120-150 
mEq/liter (Lefer and Inge, 1973). Only when 'total sodium 
approached .520 mEq/l·, a ·fourfold concentration of plasma 
sodium, did the salt effect approximate the negative inc•' 
tropic. ·effect of MDF (Lefer and Inge, 1973). It is there-
fore highly'unlikely that salt could have interfered with 
the assay of MDF in column eluates. Lefer and several others 
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have effectively desalted the MDF peak by column chromatog-
raphy. MDF was eluted prior to the salt peak which showed 
up at 115-150 ml (Lefer and Inge, 1973) and at a later 
volume in Goldfarb and Weber's (1977b) study. 
If the negative inotropic action of MDF could be attribu-
ted to NaCl, the NaCl concentration would have to be far in 
excess of that occurring during the shock state. Secondly, 
one could easily distinguish a MDF effect from that of a 
high salt concentration effect by looking for any changes in 
base line tension. MDF depresses developed tension by 
decreasing active tension wi.thout a change in resting 
tension. High salt concentrations depress developed tension 
by decreasing active tension and markedly increasing resting 
(base line) tension (Greene et al., 1977). This large in-
crease in base line tension serves to distinguish a MDF 
activity response from that of a high salt concentration 
response. Another distinguishing factor is thetime to 
elicit a response. -The reaction rate of sodium was dif-
ferent from that of MDF; the sodium effect being instan-
taneous. (Okuda and Fukui, 1974), whereas the MDF effect 
would take anywhere from 2-30 minutes. 
Further evidence that MDF is a peptide has been ques-
tioned. Pronase, a nonspecific proteolytic enzyme isolated 
from Streptomyces gri·seus, will inactivate peptides by the 
cleavage of peptide bonds to form single amino acids when 
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incubated at SSC for four hours. Lefer (1970) reported 
almost total inactivation of MDF. Wangensteen et al. (1973a) 
incubated their shock plasma peak D for six hours at 37C 
followed by one-half hour at S6C to inactivate the enzyme. 
The depressant activity was not eliminated, thus suggesting 
that peak D was not a peptide. Wangensteen eliminated the . 
positive inotropic activity of angiotension II, an octa-
peptide, by the same procedure. Wangensteen dialyzed the 
enzyme, protease VI, free of calcium prior to use since it 
was supplied in 30% calcium acetate. Lefer did not report 
the presence of calcium with his enzyme. However, if 
Lefer's pronase was supplied with an excess of calcium as a 
stabilizing agent, calcium would antagonize any depressant 
activity. ·Perhaps Lefer's report that pronase incubation 
caused a loss of depressant activity, and therefore the 
depressant substance was a peptide is an incorrect inference. 
The loss of depressant activity could simply be due to masking 
by the calcium present with the pronase. 
Lefer questioned the techniques of Wangensteen and 
claimed Wangensteen's results were all based on the use of 
an incorrect peak, the salt peak, as opposed to the peptide 
peak that Lefer isolated. 
Wangensteen et al. (1973a) even went so far as to claim 
that plasma depressant activities in normal control animals 
and human volunteers were as high or higher than plasma 
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activities from those dying in shock. 
Goldfarb and Weber (1977b) investigated the problem 
using different techniques. They obtained a salt-free 
peptide peak which they purified to obtain one cardio-
depressant active peak. They believed MDF to. be a single 
peptide rather than a mixture of different active compounds 
(Goldfarb and Weber, 1977a; Okuda and Fukui, 1974). 
It is of interest that no other known peptide with 
negative inotropic action has been found in mammals. 
Eledoisin, an endecapeptide which has been isolated from 
the sal;!.vary gland of the mollusk, is the only known peptide 
in the entire animal kingdom which will depress the myo-
C(lrdium. A 10-5 Molar concentration of eledoisin has de-
c~eased the developed tension of papillary muscle in a 10 ml 
muscle bath by 55.% (Lefer and Inge, 1973). 
Thus, if MDF is indeed a peptide wi.th negative ino-
tropic action, it will be the first one to be isolated from 
the vertebrates. 
Origin of MDF 
There is evidence to claim that the ischemic pancreas 
is the origin of MDF. A marked decrease in the splanchnic 
blood flow has been reported in various types of shock. 
·Other shock factors which appeared to originate in the 
splanchnic region were: endotoxin, hemochromogen, RDS 
(reticuloendothelial depressant substance) from the intestine, 
11 
Fukuda' s factor from the liver, Clowes' factor and Thal •·s 
factor from the splanchnic region. 
Pancreatectomy, which was performed prior to the in-
duction of hemorrhagic shock or splanchnic vessel occlusion 
(SVO), prevented·MDF activity in the plasma. Incubated 
homogenates .of pancreas without the presence of plasma or 
any other tissue constituents produced large amounts of MDF, 
whereas incubated homogenates of liver, spleen, or intes-
tine failed to produce MDF. 
Chromatographic patterns from homogenates of various 
.visceral organs (pam;:reas, liver, spleen, small intestine, 
heart) were compared with plasma from animals in shock. 
Every_ peak from only the pancreatic elution profile W9-S 
much higher than the corresponding peaks from plasma. ·The 
decrease in papillary muscle contraction was much more 
severe with MDF from the pancreas peak than with MDF from 
the plasma peak. Peak D from the liver was higher than peak 
D from the heart. Peak. D from the spleen was higher than 
peak D from the small intestine. A possible explanation 
for slightly increased peaks in liver and spleen was 
.that the reticuloendothelial system in these two organs per.,. 
111itted accumulation of MDF in shock animals. 
The fractional distribution of cardiac output for 
several principa-1 organs (heart, brain, gastrointestinal 
tract, kidneys, skin, muscle, spleen, pancreas) was determined 
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during hypotension. The most pronounced reduction in blood 
flow was found in the spleen and pancreas (Okada et al., 
1977). This is perhaps another indication that the pancreas 
is the source of MDF formation. 
A review of the conflicting reports on whether MDF 
is formed in the oligemic phase or postoligemic phase 
of shock, splanchnic vessel occlusion-no release shock or 
splanchnic vessel occlusion-release shock, early shock or 
late shock will further support our reasoning for the 
ischemic-pancreatic origin of MDF. 
Early shock plasma decreased developed tension by 26%, 
and late shock plasma decreased developed tension by 43% 
(Lefer, 1970). Splanchnic arterial occlusion (SAO) with 
release of the occlusive clamps results in high MDF activi-
ties in both the plasma and pancreas. Splanchnic arterial 
occlusion-no release is characterized by a low plasma MDF 
activity with a very high pancreatic MDF level. This indi-
cates that MDF was produced but not released into the plasma. 
MDF transport is dependent to a large degree on the splanchnic 
circulation. This is also evidence that MDF is continuously 
produced during the entire SAO shock process, since a high 
residual pancreatic MDF activity was found both in non-
released and released SAO shock cats. 
Some researchers have shown MDF to accumulate in the 
oligemic phase before reinfusion of the shed blood, in 
13 
contrast to the majority of studies demonstrating high plasma 
MDF activities only in the postoligemic period after rein-
fusion (Wangensteen et al., 1970; Glenn and Lefer, 1970). 
In those studies where MDF appeared in the plasma 
during the occlusive period of splanchnic ischemia shock, 
MDF was transported from the splanchnic bed to the systemic 
circulation via collateral circulation. In these studies, 
only the superior mesenteric artery was occluded allowing 
the celiac axis and inferior mesenteric artery to be the 
primary collaterals. This explains the discrepancy in the 
literature concer ning the presence of MDF during the occlusive 
period and postrelease of the occlusion. To reiterate, MDF 
is formed in the ischemic splanchnic region, the pancreas 
in particular, during the occlusive period, and probably 
enters the circulation in large quantities only after re-
lease of the occlusion. 
Occlusion of just the vessels supplying the pancreas 
(superior and inferior pancreaticoduodenal arteries) for 
two hours resulted in high MDF activity comparable to that 
seen with splanchnic vessel occlusion or hemorrhagic shock. 
Induced-pancreatitis caused plasma MDF activity to reach 
shock levels. These studies thus point to the ischemic and/ 
or inflamed pancreas as the origin of MDF. 
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Formation of MDF 
A generalized scheme for the formation of MDF in the 
pancreatic acinar cell will introduce the various components 
and their interactions in shock. 
Hypoxia is the primary trigger mechanism for MDF 
formation. This hypoxia acts on the zymogen granule; tryp-
sinogen, kallikreininogen and prophospholipase A are acti-
vated. Activation and release of trypsin, which requires 
calcium ions, serves to initiate proteolysis. Trypsin 
activates phospholipase A... Tryps~n may also partially 
hydrolyze free protein which·makes it available to 
lysosomal cathepsins. The hypoxia acts on the lysosome 
causing membrane disruption. Lysosomal proteases such as 
cathepsins, peptidases, glucuronidases, acid phosphatases 
are released. The phospholipase A lyses subcellular mem-. 
branes to release compartmentalized protein. The lysosomal 
proteases then hydrolyze these compartmentalized protein 
substances to produce peptide fragments like MDF. 
This hypoxia can be induced experimentally by creating 
a hypotensive condition with splanchnic vessel occlusion, 
hemorrhagic shock, or cardiogenic shock. A significant 
decrease in cardiac output develops soon after superior 
mesenteric artery occlusion. An abrupt decline in mean 
arterial blood pressure occurs after release of the occlusive 
clamps in splanchnic arterial occlusion shock due to release 
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of both MDF and lysosomal enzymes. A fall in systemic 
arterial blood pressure will result in vasoconstriction of 
the splanchnic vascular bed. This is a homeostatic at-
tempt to shunt the blood to vital organs. However, this 
vasoconstriction will create pancreatic ischemia, acidosis', 
and lysosomal membrane disruption. Lysosomes play'an im-
portant role in the cellular changes leading to the ir-
reversibility of shock states. Lysosomes of the splanchnic 
region are more sensitive to ischemia than the lysosomes 
of other regions of the body, and the pancreatic lysosomes 
are much more sensitive to ischemia than those of the spleen 
or intestine. 
As a result of pancreatic hypoperfusion, the pancreatic 
acinar cells underwent severe autolytic changes. Peripheral 
margination and Clumping of chromatin material were evi-
dent in the nuclei of the acinar cells. The orderly 
arrangement of endoplasmic reticulum was lacking~ . Irregular 
dilat·ation of the smooth endoplasmic reticulum resulted in 
large vesicles. The zymogen granules were no.t , as dense. 
Advanced degenerative changes in mitochondria were an indi-
cation of the cessation of oxidative phosphorylation 
(Okuda and Fukui, 1974). The pancreatic lysosomes were 
vacuolated and enlarged which indicated fragility and a less 
stable membrane. The percent of lysosomal area occupied 
by autophagic vacuoles in splanchnic arterial occlusion 
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shock was 25% compared to 7.1% in sham SAO (Lefer and 
Barenholz, 1972). Autolysosomes were present in pancreatic 
cells undergoing cellular digestion. 
It is speculated that there is a two-component system· 
for MDF production: lysosomal proteases and enzymes of 
zymogen-granule origin. A cell fractionation scheme for 
pancreatic homogenates explained how two constituents, P2A 
and P2B, were derived from a particulate P2 component in an 
attempt to separate zymogen activity from that of the lyso-
some (Litvin et al., 1973). The sum of the constituent 
activities of P 2A and P2B for cathepsin D was very close 
to the activity in the parent P2 fraction. Neither P2A 
nor P2B produced significant amounts of MDF activity when 
incubated separately; when they were recombined, P2 (A+B)' the 
MDF activity equalled that of the parent fraction P2 • A 
two component system is thus implied. 
The unique role of the pancreas in the pathogenesis 
of circulatory shock is evident. Intracellular acidosis 
present from the pancreatic ischemia provides an optimal 
environment for active enzymes. Maximal MDF activity·in 
pancreatic homogenates was found at a pH of 5-6. 
Pancreatic trypsin activity increased fourfold and 
phospholipase A activity increased sevenfold in SAO shock. 
A decrease in the total pancreatic acid phosphatase specific 
activity suggests a release of hydrolases from the pancreas 
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into the plasma. The plasma enzyme activity for acid 
phosphatase was 594% of control at the termination of SAO 
shock (Lefer and Barenholz, 1972). Within fifteen minutes 
after splanchnic arte.rial occlusion, there was a signifi-
cant increase in S-glucuronidase and cathepsin activities. 
'Release of the occlusion created an additional rise in the 
plasma activities of these enzymes; this· was actually a 
washout of enzyme that had accumulated in the ischemic 
splanchnic bed during the occlusive period. 'Ihe rise in S-
glucuronidase activity peaked within thirty minutes after 
release of the clamps, but the cathepsin activity continued 
to increase throughout the entire postrelease period. Final 
enzyme activities were 3-4 times pre-SAO values (Glenn and 
Lefer, 1970; Leffler et al., 1973). 
Cathepsin_B and/or C seem(s) to be the most likely 
enzyme(s) responsible for MDF production (Litvin et al., 
1973). 
Pancreatic chymotrypsin activities did not increase 
in the plasma of SAO shock due to endogenous inhibitors of 
this protease. Amylase activity correlated with MDF activity; 
succinate neotetrazolium reductase activity did not (Litvin 
et al., 1973). A high plasma cathepsin activity was always 
closely c.orrelated with a high plasma MDF activity, whereas 
plasma S-glucuronidase activity did not correlate as well 
(Lovett et al., 1971). Cathepsins Band c, which require 
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thiol groups for action, are inhibited by parachloromercuri-
benzoate (PCMB), a sulfhydryl blocking protease inhibitor. 
PCMB-treatment has been shown to prevent MDF formation 
(Lefer, 1978). 
Plasma amino nitrogen activity, which represents the 
total end product of all proteolysis, increased 175% above 
the control value two hours after superior mesenteric artery 
occlusion and 920% after release of the occlusive clamps 
(Leffler et al., 1973). 
The increase in lysosomal protease activity in the plasma 
occurred before the plasma appearance of MDF (Glenn and Lefer, 
1970), which confirms the scheme for MDF formation. The in-
fusion of just lysosomal enzymes into healthy dogs has been 
shown to depress cardiac function. Thus, all the necessary 
ingredients for MDF production are present within the 
pancreas. 
There appears to be some ionic requirement for· the MDF-
producing reaction. Low MDF activities were found when 
pancreatic homogenates were prepared in distilled water 
rather than in Krebs-Henseleit solution, and incubated. 
Homogenates incubated in Krebs-Henseleit solution had the 
usual high MDF activities (Litvin et al., 1973). Phospho-
lipase A requires calcium ions for activity, which suggests 
that ions may serve as enzyme activators in MDF formation 
(Litvin et al., 1973). 
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MDF production has been shown to proceed at equal rates 
in an aerobic or anaerobic environment (Litvin et al., 1973). 
Mitochondria are therefore not essential for MDF production. 
Hypoxia, the trigger mechanism for MDF formation, therefore 
has an action which does not inhibit aerobic metabolism. 
This further confirms the scheme for MDF formation; pancreatic 
lysosomes and zymogen granules, which 'are extremely sensitive 
to a lowered P0 , release the enzymes necessary for MDF 2 
formation. 
Systemic hypotension is not a prerequisite for MDF 
formation; however, the pancreas must be rendered ischemic 
(Lefer and Martin, 1970b). An inverse relationship exists 
between superior mesenteric artery blood flow and MDF 
activity. There is some degree of specificity for the produc-
tion of MDF since femoral ischemia, which was produced by 
ligation of the common iliac arteries at the descending 
aorta, did not produce MDF. 
Transport of MDF 
Similar MDF activities were found in both arterial and 
venous blood (Brand et al., 1969) indicating that MDF was 
present throughout the blood st~eam. 
In 1943, it was reported that thoracic duct lymph from 
dogs in traumatic shock contained toxic substances (Lefer, 
1973; Lefer, 1978). A transient spikelike increase in 
l:irmph flow was shown to occur immediate·ly upon initiation. 
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of hemorrhage (Glenn and Lefer, 1970). 
Many proteins including enzymes are known to be trans-
ported via lymph. It would be difficult for large molecular 
weight enzymes (lysosomal enzymes: molecular weight = 
25,000-200,000) to cross capillary membranes. Indeed, a 
significant lymphatic transport of lysosomal enzymes in 
hemorrhagic shock has been shown (Glenn and Lefer, 1970). 
An experiment was conducted with cats in which the 
thoracic lymph duct was cannulated during shock to divert 
the lymph. A threefold increase in postoligemic survival 
time was found. In the lymph, MDF activity was high, and 
plasma cathepsinlike and 13-glucuronidase activity were in-
creased three- to fourfold. In the plasma, MDF activity 
was negligible and the lysosomal enzyme activity was low 
(Lefer, 1970) . 
MDF thus appears to be in part transported to the 
systemic circulation via the lymphatics, which may indicate 
that it is bound to a larger molecule sometime during its 
formation. The splanchnic region almost solely provides the 
thoracic duct lymph in anesthetized cats (Lefer, 1970). 
The proteases, which are released into the extracellular 
fluid, are taken up by the lymphatic vessels and transported 
by the thoracic lymph duct to the systemic circulation. While 
in the lymph, these proteases may hydrolyze lymphatic 
proteins to make "preformed" MDF (Lefer, 1970). 
I 
I 
I 
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Thus,· the question exists whether MDF is transported 
to the systemic circulation via splanchnic collaterals or 
the lymphatic system. MDF is formed primarily in the plasma, 
since the volume of lymph is much smaller than the blood volume. 
However, part of the MDF may be formed in the lymph from 
lymphatic protein substrate. Additional MDF is formed once 
the lysosomal enzymes reach the systemic circulation. 
It may be concluded that cardiac depr_ession occurs as a 
consequence of a humoral factor (Gomez and Hamilton, 1964; 
Okada et al., 1977). 
In the hemodynamically protected canine heart, cardiac 
output, intraventricular, proximal aortic and coronary 
artery pressures, coronary blood flow, and venous return were 
maintained at preshock levels, whereas the rest of the body 
was in shock. Any change in cardiac function would there-
fore occur only as the composition of the blood changed which 
was returning from the shocked body to perfuse the coronary 
arteries. Bradycardia was observed and attributed to the 
shock-induced metabolic acidosis. Acidosis depresses heart 
contractility by interfering with normal ionic cycles (Rogel 
and Hilewitz, 1978). The. bradycardia was prevented by 
normalizing the acidic pH with sodium bicarbonate. The 
force of contraction of the heart decreased in shock, but 
this decline could not be prevented by pH adjustment. If 
the blood from the dog in shock was exchanged with the blood 
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of a normal healthy dog, the recipient's heart rate de-
creased and myocardial tension fell just as it had in the 
shock dog prior to the exchange. Thus, all of the responses 
to shock occur in control animals if their blood is ex-
changed with the blood of animals in prolonged shock. 
Biological action of MDF 
MDF seems to play a role in the pathogenesis of circu-
latory shock by exerting its effects in a positive feedback 
fashion. This humeral substance depresses the heart and 
further aggravates the splanchnic ischemia which results 
in the production of additional MDF to continue the cycle. 
MDF has reticuloendothelial depressing properties which im-
pair phagocytosis in fixed macrophages (Lefer and Blattberg, 
1968). 
Thus, with the reticuloendothelial system malfunctioning, 
a reduced liver blood flow, a depletion of plasma opsonins, 
and a depressed kidney with oliguria, the animal has fe~ 
pathways which will remove MDF from the circulatory system. 
Consequently, MDF accumulates in the plasma. 
MDF-induced depression in developed tension is com-
pletely reversible. This was shown in the papillary muscle 
bioassay system by simply washing out the muscle chamber 
with fresh Krebs-Henseleit solution (Lefer and Blattberg, 
1968; Harden and Garrett, 1973). The contractility of 
muscles returned to the base line level (Okuda and Fukui, 
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1974). 
When the external calcium concentration was increased 
in the papillar¥ muscle system from 2.54 mM to 6.5 mM, the 
negative inotropic effect of MDF was also completely re-
versed. When the test medium containing MDF with the high 
6.5 mM calcium concentration was replaced with Krebs-Henseleit 
solution, there was at first a rapid decline in contractility 
to the level of previous depression elicited by the MDF. 
This was followed by a gradual increase in contractility to, 
the base line level. A concentration gradient of MDF was 
created across the cell membrane of the papillary muscle 
by washing out the external medium in the muscle chamber .• 
The co~tractile force o~ the papillary muscle recovered 
after washout of the MDF sample with fresh Krebs-Henseleit 
solution; this indicated that MDF acted intracellularly and 
diffused out of the myocardial cells according to its con-
centration gradient (Okuda and Fukui, 1974). Repeated wash-
out of the MDF sample with fresh b·uffer increased the dif-
fusic;m rate and recovery of contractility of the muscle to 
base line level (Okuda and Fukui, 1974). 
MDF exerts several other biological actions. A 35% 
increase in coronary flow by a coronary vasodilation may 
possibly be due to an increase in myocardial metabolic 
activity which is brought about· by the factor. MDF decreas'ed 
co~tractile force 83%, and caused cardiac arrest followed by 
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arrhythmias .(premature ventricular contractions and A-V 
conduction block) in an isolated perfused cat heart with 
constant heart rate, coronary perfusion pressure and resting 
cardiac tension. MDF has been postulated to play a primary 
role in the development of heart failure during circulatory 
shock by having a direct depressant effect on the myo-
cardium. 
In a study by Harden and Garrett (1973), the reversible 
nature of MDF may make it unreasonable to assume that this 
peptide per se could produce irreversible heart failure 
during circulatory shock. However, an elevated plasma level 
of metabolic end products and substances which are released 
during shock may potentiate the cardiotoxic action of the 
peptide in vivo. 
MDF has a hypotensive effect. MDF exerts a selective 
vasoconstrictor effect on splanchnic vascular strips, and 
it depresses contractility of isolated intestinal strips. 
There is an inverse relationship between plasma MDF activity 
and survival time during shock. 
There seems to be a discrepancy in the reaction rate 
of MD.F. A fast acting MDF has been reported to exert 
maximal depressant action within fifteen to twenty minutes. 
A slower acting MDF required thirty minutes or longer to 
cause maximal depression (Okuda and Fukui, 1974). MDF has 
also been reported to decrease cardiac contractility by 83% 
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within one to two minutes (Glenn and Lefer, 1970; Harden and 
Garrett, 1973). 
The mechanism of the myocardial depressant effect is 
hypothesized. The negative inotropic effect is a decrease 
in developed tension rather than in the time to peak 
tension or in the resting tension. MDF does not interfere 
with the electrophysiological properties of isolated papillary 
muscles. There is no alteration of the magnitude of the 
transmembrane resting or action potential of the muscle 
cells. This was determined by the use of intracellular 
microelectrodes. However, a slight but statistically signi·fi-
cant decrease in the time to peak tension was demonstrated 
in a study using three-hour shock plasma. Control plasma 
and two-hour shock plasma had no effect on time to peak 
tension (Lundgren et al., 1976). 
This leads us to conclude that the mechanism of the 
negative inotropic effect is possibly an interference with 
the process of excitation-contraction coupling or a direct 
depression of contractile proteins. The mechanism of MDF 
action may involve binding of calcium in the sarcoplasm,· 
sarcoplasmic reticulum, or at contractile components. This 
is speculated since MDF depression was reversed by an incre-
ment of 4 rnM/L of calcium. 
It has been deduced that the negative inotropic effect 
is due to a reduction in active state intensity of the myo-
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cardial contractile element (Lefer, 1970; Williams et al., 
1969). The contrac.tile element of the myocardium is the 
active factor which is capable of both shortening and 
tension development. Changes in peak active state intensity 
reflect changes in the shortening properties of the con-
tractile element. Changes in peak active state duration 
indicate changes in the time allotted to the contractile 
I 
element to produce tension. Thus, the change in peak de-
veloped tension by MDF could possibly be brought about by 
changes in either peak active state intensity or peak active 
state duration. Since there is no real change in time to 
peak tension, the negative inotropic action of MDF must 
therefore be associated with changes in peak active state 
intensity of the contractile element. 
Blocking MDF ·fo.rmation 
Pretreatment of animals with high concentrations of 
glucocorticoids, protease inhibitors, local anesthetics, a-
adrenergic blockers, prostaglandins, sulfhydryl containing 
compounds, or surgical interventions such as pancreatectomy, 
diversion of thoracic duct lymph,.hemodialysis, pancreatic 
duct ligation will prevent the accumulation of MDF in the 
plasma. 
Glucocorticoids are the most beneficial, since they 
stabilize the lysosomal membrane to prevent the release of 
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those lysosomal enzymes which act in concert with the zymo-
genic enzymes to form MDF. This was also shown by adrenalec-
tomizing cats to deplete their endogenous glucocorticoids 
and increase the fragility of pancreatic lysosomes. In 
fact, the free pancreatic S-glucuronidase activity in 
adrenalectomized cats was comparable to that found in SAO 
shock cats (Glenn and Lefer, 1970). Methylprednisolone, 
a synthetic glucocorticoid, prevented changes in lysosomal 
hydrolase activity and ultrastructure, mucosa! lesions, 
MDF activity, and prolonged survival time fourfold. 
Zymogenic protease inhibitors such.as aprotinin in-
hi~it the action of proteases (pancreatic trypsin, chymo-
trypsin, phospholipase A) when they are released from the 
zymogen granule. Therefore, the proteases can no longer 
cleave the protein substrate to form peptide fragments. 
The MDF level in shock plasma is significantly lowered and 
survival time is prolonged. 
Local anesthetics such as lidocaine cause celiac 
~angliqnic blockade. This partially prevents splanchnic 
ischemia by maintaining normal splanchnic blood flow to 
prevent an increase in plasma lysosomal enzymes and MDF 
(Glenn and Lefer, 1970; Lefer, 1970). Alpha adrenergic 
blocking agents, such as phenoxybenzamine, maintained 
splanchnic blood flow during shock (Lovett et al., 1971). 
Products formed by the prostaglandin synthetase system 
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either directly stabilize lysosomal membranes to prevent 
MDF formation or preserve liver phagocytic cell integrity 
so cathepsins and MDF may be cleared from the circulation. 
Prostaglandins increase four- to fivefold in the circulating 
blood in a variety of shock states (Flynn and Lefer, 1977). 
Arachidonic acid, a twenty carbon fatty acid, is the primary 
substrate for the production of prostaglandins. Significant 
increases in circulating plasma prostaglandins PGE2 and 
PGF2a were demonstrated in dogs in hemorrhagic shock after 
the administration of arachidonic acid. This in turn 
prevented the plasma accumulation of cathepsin D and MDF 
while mean arterial blood pressure was maintained. 
Prostacyclin (PGI 2 ), a prostaglandin formed in blood 
vessel walls, is an anti-ischemic agent. It was five to 
ten times more potent than PGE1 in preventing lysosomal 
hydrolase release (Lefer and Ogletree, 1978). PGI 2 , a 
vasodilator, reduced total peripheral resistance and coronary 
vascular resistance, and inhibited platelet aggregation and 
thromboxane A2 formation. 
Sulfhydryl containing compounds, such as glutathione 
and cysteine, also stabilize cellular and lysosomal mem-
branes to decrease plasma cathepsin D and MDF activities. 
An angiotensin converting enzyme inhibitor was also found 
to have protective action in hemorrhagic shock. Circulating 
lysosomal hydrolase activity, total plasma proteolysis, and 
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MDF formation were much less in converting enzyme inhibitor-
treated shock than in ~ntreated shock (Trachte and Lefer, 
1978) • 
Dopamine (3,4-dihyqroxyphenylethylamine), a unique 
splanchnic dilator, was found to have only transient 
beneficial effects on mean arterial blood pressure, renal 
arterial flow and superior mesenteric arterial flow. MDF 
formation was only delayed. At high concentrations of 
dopamine, B-glucuronidase release was reduced, but not 
cathepsin D (Galvin and Lefer, 1978a). This may imply that 
cathepsins do play a significant role in MDF formation. 
The ability to block MDF formation at specific sites 
is an indication that our hypothesis that lysosomal and 
zymogenic proteases are the two major components in the 
mechanism for MDF production is valid. 
The se arate identit of MDF in li ht of other 
cardioin J. itory factors 
Pancreatic MDF and plasma MDF are el.uted at essentially 
the same elution volume. Canine MDF also appears at the 
same el.ution volume as feline MDF, suggesting some uni-
versality among species. MDF produced during splanchnic 
vessel occlusion is identical to the MDF produced during 
hemorrhagic shock. In fact, of all the known shock factors, 
only MDF and endotoxin have been identified in the plasma 
of human patients in many forms of shock (Lefer, 1973). 
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several cardiodepressant factors have been proposed to 
occur in circulatory shock. We do not know if they are 
identical, exist as a family of related substances, or are 
totally unrelated. The similarities among these factors 
may help to elucidate the identity of MDF. 
There are basica·lly fourteen factors, none of which 
can be precisely characterized: PTLF (passively transferable 
lethal factor-Nagler-McConn's factor), Goldfarb-Weber's 
factor, Okuda-Hosono's factor, Okada-Kosugi's factor, Rogel-
David's factor, McArdle-Ledingham's factor, Clowe's factor, 
Thal's factor, Fukuda's factor, hemochromogen, endotoxin, 
lysosomal hydrolases, RDS (reticuloendothelial depressant 
substance-Blattberg-Levy's factor), Haglund-Lundgren's 
factor. 
PTLF is a negative inotropic peptide with a molecular 
weight greater than 10,000. It occurs in rat and man 
during hemorrhagic and cardiogenic shock. It originates. 
in the blood cells, and its appearance is prevented by the 
administration of glucocorticoids (Le fer,· 1978) • 
Goldfarb-Weber's factor is a negative inotropic factor 
with a molecular weight between 250-1000-. It possibly occurs 
in splanchnic ischemia in the dog, originating in the 
pancreas (Lefer, 1978). 
Okuda-Hosono's factor is a·negative inotropic factor· 
of 1000 daltons which originates in the canine pancreas 
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during cardiogenic shock. The administration of gluco-
corticoids prevents its formation (Lefer, 1978). 
Okada-Kosugi's factor is a negative inotropic factor 
and a reticuloendothelial depressant with·a molecular weight 
between 700~1000. It originates in the canine pancreas 
·during hemorrhagic and endotoxic shock. Protease inhibitors 
prevent its formation (Lefer, 1978; Okada et al., 1977). 
Rogel-David's factor is a negative inotropic factor of 
unknown molecular weight which occurs in the canine splanchnic 
region during hemorrhagic shock. Protease inhibitors pre-
vent its formation (Lefer, 1978; David and Rogel, 1976). 
McArdle-Ledingham's factor is a negative inotropic 
factor with a molecular weight of 500-700 which occurs in 
the dog during hemorrhagic shock. The origin of this factor 
is unknown (Lefer, 1978). 
Clowe's factor is possibly a peptide of 1000-3000 
daltons which originates in the canine splanchnic region 
during septic shock. Its activity is free of endotoxin; 
it increases pulmonary vascular resistance, induces focal 
alveolar collapse and right heart failure. Its formation is 
prevented by glucocorticoids, and aprotinin is partially 
effective (Lefer, 1973). 
Thal's factor has an unknown molecular weight and origi~ 
nates in the canine ischemic splanchnic region during SAO 
shock. It induces lesions in the lung and stimulates vascular 
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smooth muscle. Thal's factor may not be a single factor 
(Lefer, 1973). 
Fukuda's factor is probably of large molecular weight, 
water soluble and heat labile. It originates in the canine 
ischemic splanchnic region, the liver, during hemorrhagic 
and endotoxic shock. It causes hypotension and its forma-
tion is prevented by glucocorticoids (Lefer, 1973). 
Hemochromogen has a large molecular weight of 68,000 
and is nondialyzable. It is found in blood absorbed by 
damaged -intestinal mucosa during SAO shock, hemorrhagic 
shock, and acute pancreatitis in the dog. This hemoglobin 
derivative causes hypotension, but does not depress the myo-
cardium (Lefer, 1973). 
Endotoxin is a lipopolysaccharide of molecular weight 
200,000-2,ooo,ooo, is nondialyzable, originates in the ischemic 
intestine, but does not depress the myocardium (Lefer, 1973). 
Lysosomal hydrolases have a molecular weight between 
25, 000-200, 000, are heat labile and nondialyz_able. They 
sensitize the heart to other toxic factors (Lefer, 1973). 
Hemochromogen, endotoxin, and lysosomal enzymes appear 
to act indirectly by releasing other agents which act as 
toxic factors. Since these factors have high molecular 
weights, they may be degraded further to produce a toxic 
factor. No endotoxin was found in hepatic portal ve~ous 
blood of SAO shock animals. 
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RDS has a molecular weight of nearly 700, is a peptide-
sugar with a negative inotropic effect, impairs phagocytosis, 
originates in the splanchnic region (intestine) during 
hemorrhagic shock and splanchnic ischemia in the rat, cat, 
and dog. Although RDS and MDF share some properties (both 
are reticuloendothelial depressants, dialyzab1e, small 
molecules, heat stable, show linear dose-response relation-
ships) they can be distinguished from each other. RDS is 
methylene chloride soluble and MDF is not. RDS does not 
show distinct absorbance in ultraviolet light. In RDS 
there is an unidentified amino acid which does not appear to 
be acidic, whereas in MDF, an unidentified amino acid which 
is acidic has been reported. Neither MDF nor RDS can be 
endotoxin, since endotoxin is not dialyzable, nor does it 
have a negative inotropic effect on isolated papillary 
muscles (Lefer, 1978; Blattberg and Levy, 1966). 
Haglund-Lundgren's factor is a negative inotropic 
factor with an unknown molecular weight. It possibly occurs 
in feline splanchnic ischemia originating in the intestine. 
Its formation is prevented by glucocorticoids (Lefer, 1978). 
Thus, most of these factors appear to be small peptides; 
most originate in the splanchnic region and exert a negative 
inotropic effect. 
An acute burn serum inhibitor (ABS!), isolated from 
thermally injured patients, depressed developed tension 
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and decreased the rate of rise of tension of rat and human 
heart papillary muscles (Hakim, 1975). This was reversed 
by digitoxin, a cardiac glycoside. Digitoxin attaches to 
++ + + and activates a glycoside specific receptor, Mg , Na , K 
activated transport ATPase, in or on the plasma membrane 
of cardiac muscle. It was therefore suggested that ABSI 
may have depressed this ATPase. 
The presence of a myocardial depressing substance in 
dogs subjected to 50% third-degree burns .was described. 
This factor was suggested to have a higher molecular weight 
than MDF and may be clinically significant only in burns 
above 80% (Lefer and Glenn, 19731 Wangensteen et al., 1973a). 
The presence of an intestinal factor in irreversible 
shock has been debated. According to Lundgren, MDF is not 
involved in the intestinal shock model; the intestinal 
venous blood contained a depressant even though the pancreas 
had been removed (Lundgren et al., 1976). Haglund also 
tried to convince us that the shock factor is an intestinal. 
factor and not MDF. Williams demonstrated that experimental 
cardiac depression could be prevented by an intestinal 
extirpation (Haglund, 1973). However, in another report, 
surgical removal of the small intestine did not improve 
survival in dogs subjected to hemorrhagic shock, whereas 
chronic ligation of the pancreatic ducts did increase 
survival. This implies the intestine is not the primary 
.I 
I 
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source of the toxic material in shock. 
In 1957, Lillehei suggested the existence of an intesti-
nal factor in irreversible hemorrhagic shock and correlated 
this factor with mucosa! lesions (Haglund, 1973). A causal 
relationship between these mucosa! lesions and irreversibility 
in shock was suggested. Mucosa! lesions have been reported 
in both man and experimental animals dying in various types 
of shock. The pathogenesis of these lesions is debated also. 
A marked intestinal congestion, a net increase of 
regional blood volume, has been reported after hemorrhagic 
hypotension (Haglund, 1973). However, the pooling of blood 
in the intestinal capacitance vessels was not more than 1-2 
ml/100 g intestinal tissue. This small reduction, 1.5%, of 
the total blood volume could not explain the development 
of irreversible shock. 
Hypoxia is the key factor in the pathogenesis of the 
mucosa! lesions. A hypothesized countercurrent exchange 
mechanism between the central arterial vessel and the sub-
epi thelial network of capillaries of the villi can explain 
how hypoxia and mucosa! lesions develop without any change 
in villous blood flow (Haglund, 1973; Haglund and Lundgren, 
1978). An arterio-venous concentration difference is necessary 
for substances to diffuse from the central arterial vessel 
to the nearby subepithelial capillary network. 
In severe regional hypotension, mean transit time in 
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the villi is increased up to five times that of the control. 
The chances for extravascula.r shortcircuiting of oxygen in 
the villi are increased, and the villous tips become anoxic 
despite an almost unchanged volume. flow of blood. Thus, 
with a low pressure head, dilated villous blood vessels, 
and a reduced linear blood flow rate, villous lesions result. 
Destroyed villous cells will allow protein leakage. An in-
creased tissue colloid osmotic pressure and mean hydro-
static capillary pressure will upset the Starling equilibrium 
across the capillary wall. This explains the increased 
intestinal tissue fluid volume seen in late hypotension. 
The injured intestinal mucosal tissue possibly re-
leases products of .. tissue destruction such as enzymes, 
hormones, polypeptidelike substances forming cardiotoxic 
material (Haglund, 1973). This cardiotoxic material has 
been isolated and consists of two heat stable fractions; 
one is water soluble, 500-1000 daltons, and the other is 
lipid soluble with an unknown molecular weight (Haglund 
and Lundgren, 1978). A direct relationship has been shown 
between the degree of mucosal damage and cardiovascular 
·collapse. 
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The separate identity of MDF in light of other peptides 
and substances elevated during sho'ck 
Other peptides and substances which increased in the 
plasma of animals during shock were compared with MDF in 
attempt to elucidate its identity. 
It was suggested that MDF may represent an undescribed 
kinin, since MDF is of the same molecular weight as these 
vasoactive peptides and is released by proteases (Lovett 
et al., 1971). 
Naturally occurring peptides, such as angiotensin II, 
arginine vasopressin, and bradykinin, were considered, 
since they were significantly elevated in shock plasma, 
Angiotensin exerted a marked positive inotropic effect; 
vasopressin and bradykinin caused a very small positive 
inotropic effect. Vasopressin depressed the heart only in 
very high concentrations and only indirectly via coronary 
constriction. Angiotensin and vasopressin are vasoconstric-
tors which constrict the splanchnic, renal, and coronary 
vascular beds. Bradykinin, a vasodilator, increases 
capillary permeability and damages the microcirculation. 
Thus, MDF could not be any one of these three vasoactive 
peptides, but it is not difficult to see how they might 
potentiate the action of MDF. Angiotensin, vasopressin, 
and bradykinin are released early in the course of shock, 
and are to a large extent metabolized or cleared prior to 
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the late stages of shock. MDF appears more slowly in the 
plasma and gradually accumulates during shock. The clearance 
of MDF is then impaired. 
Several synthetic bradykinin and kallidin derivatives 
were studied, but none significantly altered developed tension 
·.of papillary muscles (Lefer arid Inge, 1973). Serotonin, a 
potent intestinal vasodilator, which is released by the 
intestine after periods of local or hemorrhagic hypotension, 
was also considered (Haglund, 1973). 
It has been concluded that these vasoactive substances 
along with norepinephrine, acetylcholine, histamine, 
ferritin, and lactic acid do not appear to be primary toxic 
factors. The release of these neurohumors is more likely a 
compensatory response to maintain mean arterial blood 
pressure or blood flow in shock. 
MDF activity was further determined not to be due· to 
the presence of nucleotides or nucleosides (Brand et al., 
1969). Charcoal, a highly efficient binding agent for 
nucleotides, failed to remove MDF activity from shock plasma. 
ultrafiltrate. Inosine a11d hypoxanthine levels increased 
in the coronary sinus blood after.hypoxia, but neither of 
the~e compounds depressed myocardial contractility (Brand 
et al., 1969). 
Several. other nitrogenous compounds which increased in 
the plasma of animals during shock have low.molecular weights, 
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are water soluble, and have charged groups (properties simi-. 
lar to MDF), but they are not myocardial depressants. 
Uric acid, urea, creatine, creatinine, and kynurenic acid 
were some of these nitrogenous compounds (Brand et al., 
1969). 
It is interesting to note that MDF was associated with 
a spectrophotofluorometric peak with maximum excitation and 
emission wavelengths of 330 and 428 mµ, respectively (Brand 
et al., 1969). The reduced form of nicotinamide adenine 
dinucleotide (NADH) and kynurenic acid (a normal metabolite 
of tryptophan) are the only obvious metabolites which have 
excitation and emission characteristics similar to this 
peak and are elevated in shock plasma. The presence of NADH 
in this peak may be discounted since t.he sample was pre-
treated with charcoal in this study. 
Plasma cations exert a profound effect on myocardial 
contractility. Most cations, however, are well-regulated 
and their plasma concentrations change only slightly in 
circulatory shock. The plasma concentration of sodium 
decreased slightly and calcium remained unchanged during 
shock (Lefer and Inge, 1973). A significantly higher K+ 
concentration was found in shock plasma, but this was not of 
sufficient magnitude to depress myocardial contractility 
(Lundgren et al., 1976). Intracellular K+ may have been 
released from damaged intestinal mucosa accounting for the 
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elevation in plasma. 
Thus, by studying peptides, compounds with an amino 
nitrogen, amino acids, ions, and other substances that 
markedly increase in plasma during shock, we can eliminate 
possibilities of what MDF might be; 
A plasma elution profile from a Bio-Gel P-2 gel fil-
tration chromatographic column usually has six peaks which 
are designated A through F. By comparing profiles from 
control and shock plasma, the effect of shock on the eleva-
tion of certain peptides may be seen. Since each elution 
volume corresponds to a molecular weight, the presence of 
known substances may be identified. 
Angiotensin and bradykinin were found in·peak c. 
Catecholamines and serotonin, if not inactivated by processing, 
appeared in peak F. None of the commonly occurring cardio-
active substances usually found in plasma were present in 
peak·D which was shown to contain MDF. 
Sequential changes in column elution patterns in 
hemorrhagic shock were studied; As shock progressed, peaks 
c and D increased while peak A, containing the largest 
molecular weight molecules decreased (Okada et al., 1974i 
Okada et al.,,1977). 
In one study, it was determined that peaks A, B, C 
had molecular weights greater than 1050, while peaks D, E, F 
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had molecular weights between 130 and 1050 (Lefer and Martin, 
1970a). Glycylglycine (130 daltons) and angiotensin (1050 
daltons) were used as molecular weight markers. 
The reported approximate molecular weights of peaks 
A through F were: peak A > 1600, peak B = 1300, peak C = 
1100, peak D = 800-1000, peak E = 500-700, peak F = 200-
300 (Lefer and Martin, 1970a). Peak A was characterized as 
consisting of large peptides and proteins. Peak B corresponded 
to unknown component(s); peak C contained a normal component 
of plasma; peak D contained MDF; peak E consisted of small 
peptides; and peak F contained very small peptides (Lefer 
and Martin, 1970a). 
However, there are discrepancies as to the number of peaks 
obtained, the elution volumes for the peaks, the ninhydrin 
result for one peak, and even which peak contained the myo-
cardial depressant activity. 
Okada et al. (1977) obtained seven distinct peaks 
instead of the six isolated by Lefer and Martin. Elution 
volumes for each of the peaks which were approximated from a 
chromatogram were: A 31-50 ml, B 56-81 ml, C 90-112.5 ml, 
D 131-168.5 ml, E 181-206 ml, F 225-244 ml with angiotensin at 
100-128 ml and glycylglycine at 237-268 ml. The flow rate 
was 9-12 ml/hr (Lefer and Martin, 1970a). 
In another study, peak A began at 90 ml; the flow rate 
was 10 ml/hr (Okuda and Fukui, 1974). Vitamin B12 (molecular 
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weight 1355) was eluted at approximately 84-113 ml and 
oxytocin (molecular weight 1007) was eluted at approximately 
126-131 ml. These values were calculated from a chromatogram 
(Okuda and Fukui, 1974). 
The discrepancy concerning the elution volume for peak 
D was discussed earlier in this review. 
All the peaks were described as ninhydrin positive 
except for peak B (Lefer and Martin, 1970a). However, 
according to Okuda and Fukui (1974), peak B was ninhydrin 
positive. 
Peak C in control plasma was reported to have slight 
myocardial depressant activity, while peak D in the shock 
animal had a marked myocardial. depressant effect which 
accounted for all of the activity of shock plasma. Harden 
and Garrett (1973) used the same ·chromatographic media, 
but their results differed. Peaks C and E were larger during 
shock; peak C showed appreciable depression. The flow 
rates of the columns were 9.6-13.8 ml/hr. 
A comparison of ultraviolet absorption spectra between 
normal and shock ultrafiltrates was made at wavelengths of 
220 nm to 320 nm. When optical density was plotted against 
wavelength, the curve for shock ultrafiltrates peaked at 
285 nm where the curve for normal ultrafiltrates remained 
low (Okada et al., 1977). This again indicates that there 
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is an increase in circulating peptides during shock, since 
protein is detected at absorption readings at 280 nm. 
Human Pancreatic Polypeptide 
and Age 
We have questioned the separate identity of MDF in 
light of othe.r proposed cardioinhibi tory factors, and 
peptides and substances which are elevated during shock. 
We can trace the cardiac depression which occurs late in the 
shock state back to splanchnic (pancreatic) hypoperfusion 
which occurs during early shock: Thus, the pancreas plays 
the key role in the ultimate myocardial depression. 
The pancreas is also the maj.or source of a polypeptide 
which can be extremely elevated in plasma during aging. 
A significant positive correlation of the basal plasma level 
of human pancreatic polypeptide (hPP) with age has been 
shown (Floyd et al., 1977; Taylor et al., 1978; Bloom 
et al., 1978). According to Tay.lor et al. (1978), there. is 
no obvious explanation for this relation. 
Human pancreatic polypeptide can be detected consistent-
ly in the plasma of healthy subjects. Pancreatic .Poly-
peptide has also been isolated from four additional species: 
avian, bovine, ovine, and porcine. This polypeptide has 
thirty-six amino acid residues with an average mole~ular 
weight of 4200 (Floyd et al., 1977). The four mammalian 
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polypeptides have nearly identical amino acid sequences. 
An amidated carboxyl-terminal residue (tyrosine amide) 
is present in pancreatic polypeptide from all five species. 
This is significant; amidated carboxyl-terminal residues 
appear only in polypeptide hormones which suggests that 
pancreatic polypeptide may have hormonal properties. Re-
moval of the amidated carboxyl-terininal residue markedly 
reduces some biological effects of bovine pancreatic poly-
peptide (bPP). According to Floyd et al. (1977), bPP may 
be a precursor molecule acted on by another enzyme system. 
The physiologic function of pancreatic polypeptide is 
unknown although a gastrointestinal function is suggested. 
Bovine pancreatic polypeptide when administered to dogs will 
inhibit the pancreatic enzyme secretion which is induced 
by cholecystokinin, and the pancreatic hydrelatic secretion 
which is regulated by secretin. The in vivo plasma half-
life of hPP is estimated to be about five minutes (Floyd 
et al., 1977). 
Human pancreatic polypeptide was undetectable in the 
plasma of pancreatectomized patients, thus confirming the 
pancreas as the origin of this polypeptide. Taylor et al. 
(1978) showed that portal blood contained 1080 pmol hPP/l 
compared with 176 pmol/l in.peripheral blood of a patient 
with Zollinger-Ellison Syndrome. 
'•. 
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The plasma concentration of hPP was also high in genetic 
and experimental diabetes, pancreatitis, and islet cell 
tumors. MDF activity was also elevated in pancreatitis. 
Comparison of Age 
and Shock 
There seem to be several similarities in the mechanisms 
of shock with that of the aging process. 
The deposition of lipofuscin pigment is one of the best 
characterized age changes in the myocardium. Lipofuscin, a 
yellow, green, brown pigment., accumulates intracellularly 
in myocardial cells, spleen, liver, adrenals, thyroid, 
pituitary, nerve cells, smooth, skeletal, and cardiac 
muscle (Andrew,· 1971; Finch and Hayflick, 1977). The possible 
origin, development, and significance of lipofuscin is 
under investigation. 
The origin of lipofuscin age pigment is unknown al-
though four possibilities have been suggested. The first 
possibility is that lipofuscin may represent the remains of 
lysosomes. The lipofuscin granules are sites of acid phos-
phatase activity. Acid phosphatase is a lysosbmal protease 
which increases 594% in SAO shock. Several other enzymes 
have been associated with lipofuscin: 13-glucuronidase, 
esterase, alkaline phosphatase, ATPase, succinic dehydro-
genaf;e (Finch and Hayflick,1977; Strehler, 1964). 13-
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glucuronidase is another lysosomal protease correlated with 
shock and MDF activity. Lipofuscin may occur as dense 
aggregates of very small granules or as organelles containing 
lucent vacuoles. Lysosomes enlarge and develop vacuoles 
during shock. In.creased numbers of lysosomes have been re-
ported in myocardial cells in aging rats (Finch and Hay-
flick, 1977). The proposed lysosomal origin of lipofuscin 
is favored. 
The second hypothesis is that lipofuscin may be a 
byproduct of mitochondrial breakdown. Nonfunctional mito-
chondria may undergo slow degradation in autophagic vacuoles. 
Areas of cytoplasm containing mitochondria may be acted on 
by lytic enzymes. Lipofuscin pigment bodies have been ob-
served to occur in regions of human cardiac muscle with 
many mitochondria (Strehler, 1964). Advanced degenerative 
changes occur in pancreatic mitochondria as a result of · 
pancreatic ischemia and other shock conditions which sug-
gests another correlation between shock and age. 
Thirdly, lipofuscin is also postulated to be formed by 
the cross-linking.of elements of the endoplasmic reticulum 
(Kohn, 1971). 
The fourth possibility is that lipofuscin granules 
represent secretory bodies which sequester harmful substances 
from the cytoplasm (Strehler, 1964). 
The linear relationship of accumulation of lipofuscin 
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w:i,.th age was indicated by Strehler in 1959 in man. In the 
human the rate of lipofuscin accumulation was 0.067% pig-
ment volume per myocardial volume per year. Pigment accumu-
lated in the canine myocardium at a rate 5.5 times faster 
(0.36% per year). There is a definite similarity between 
the rate of accumulation of lipofuscin pigment in the dog 
and man, since man has a life span which is approximately 
five times longer than the dog (Munnell and Getty, 1968; 
Andrew, 1971). This linear relationship was best seen 
beginning at 3.5 years of age in the dog. In a twelve 
year old dog, the pigment volume was 9.7% of the myocardial 
volume (Munnell and Getty, 1968). There is no adequate 
mechanism of removal of the accumulation of lipofuscin. 
Lipofuscin is a heterogeneous pigment which is composed 
of lipid, carbohydrate, lipoprotein, and protein. Several 
amino acids which have been identified in age pigment are: 
arginine, tryptophan, histidine, lysine, tyrosine, cysteine, 
cystine (Strehler, 1964; Finch·and Hayflick, 1977). Acidic 
groups with strong acid characteristics are present in 
lipofuscin. It is hypothesized that lipofuscin is a favored 
site of absorption of lytic enzymes. It should be noted 
that hydrolase activity is important in the mechanism of 
MDF formation. In addition to accumulating with age, lipo-
fuscin will appear with longstanding tissue hypoxia and 
vitamin E deficiency. It should be remembered that hypoxia 
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is the trigger mechanism for MDF formation. 
Oxidative polymerization of unsaturated lipids is the 
critical initiating reaction in lipofuscin formation. Vita-
min E, a biological antioxidant, inhibits lipid peroxida-
tion. Vitamin E deficiency and aging processes parallel 
each other (Finch and Hayflick, _1977). 
Lipofuscin may impair cell function by interfering 
with nerve transmission, cardiac contractility, or reactivity 
of smooth muscle cells in blood vessels. This could explain 
many of the debilities of age. At this time, we do not know 
what effect lipofuscin has on cells; we know only that it 
accumulates with age. 
With age, there is an alteration in the permeability 
of cellular and subcellular membranes in mitochondrial 
structure, and a reduction in their stability to harmful 
factors (Frolkis et al., 1973; Tate and Herbener, i976). 
The surface density of mitochondrial cristae per unit of 
cytoplasm, the volume density of mitochondria, and.the 
number of mitochondria per unit of cytoplasm decreased 
in the heart and liver as mice aged ·(Tate and Herbener, 
1976.). Advanced degenerative changes in mitochondria also 
occurred during shock (Okuda and Fukui, 1974). 
The expected enzyme changes which occurred during shock 
similarly occur with age. S-glucuronidase and cathepsin, 
hydrolytic enzymes, increase in arteries of humans with age 
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(Wilson, 1973). Cathepsin in the rat heart also increases 
with age. Cathepsin was postulated to play a key role in 
MDF formation. Monoamine oxidase, a myocardial and serum 
enzyme; pyrophosphatase, a hydrolytic enzyme in blood 
erythrocytes, peptidase in blood leucocytes; diamine oxi-
dase in the serum, and alkaline phosphatase in the serum 
increase with age in man (Finch and Hayflick, 1977; Wilson, 
1973). Dopamine-S-hydroxylase, an enzyme which is necessary 
for norepinephrine synthesis, increases. with age in man. 
Increased synthesis of norepinephrine, a vasoconstrictor, 
can be c.orrelated with reflex sympathetic stimulation during 
shock. 
Age-influenced alterations in blood cellular and pro-
tein components have been studied. Hematological changes 
occur with age in many mammalian species. 
The number of blood neutrophils increased with age in 
cattle, sheep, and rats (Riegle and Neller, 1966). Acute 
hemorrhage, coronary thrombosis, or almost any factor that 
.causes tissue destruction will cause neutrophilia. Neutro-
phils increase in number when degenerative substances are 
released into the blood from ne·crosing, ischemic heart 
muscle in coronary thrombosis. Thus, neutrophilia is 
associated with both shock and age. 
The total leucocyte numbers were decreased with in-
creasing age in cows (Riegle and Neller, 1966). Lymphopenia 
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also occurred with age. The decrease in leucocytes may 
indicate a depression in phagocytosis similar to reticule-
endothelial depression in shock. In the beagle, mean 
leucocyte values have been reported not to change with age 
(Andrew, 1971). Time trends, environmental effects of the 
calendar year, were eliminated to reveal hematological 
changes caused by aging per se in a study by Dougherty and 
Rosenblatt (1965). After correction factors were applied, 
it was concluded that the apparent downward trend of the 
leucocytes with age disappeared, and only the erythrocytes 
continued to show a downward trend with aging in the beagle. 
No change with age was found in total leucocyte numbers 
in sheep or goats, and an increase was observed in rats. 
Eosinophil numbers increased with age in sheep. Changes in 
blood leucocyte patterns are frequently used as an index 
of alterations in adrenocortical function (Riegle and Nellor, 
1966). Cortisol, a glucocorticoid secreted by the adrenal· 
cortex, decreases the number of lymphocytes and eosinophils 
in the blood (Guyton, 1976). Thus, an increase in total 
leucocytes and eosinophils might indicate insufficient 
production of cortisol. A lack of glucocorticoids would 
promote lysosomal membrane disruption characteristic of 
shock. Riegle and Neller (1966), however, do caution us that 
" 
there seems to be an inconsistent relationship of the hema-
tological patterns to adrenocortical hypo- or hyperfunction. 
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A decline in hemoglobin content, hematocrit, erythro-
cyte count, mean corpuscular volume, mean corpuscular 
hemoglobin, and mean corpuscular hemoglobin concentration 
occurred with increased age in mice (Ewing and Tauber, 1964). 
According to Finch and Hayflick (1977), there are no con-. 
sistent age-dependent changes in many hematological values 
from species to species. 
Statistically significan~ increases in total plasma 
protein with increasing age in cattle, sheep, goats, and 
rats have been shown (Riegle and Neller, 1966). The per-
centage of plasma albumin in rats, and plasma gamma globu-
lins in cows and goats increased with age (Riegle and Neller, 
1966). In man, globulins increased from 36.65% of the total 
protein at 10 years of age to 48.13% at 70 years of age 
(Finch and Hayflick, 1977). In aged rats, a 1-globulins and 
a 2-globulins increased by 22.4% and 26.8%, respectively 
(Frolkis et al., 1973). In shock, proteases act on these 
a 2-globulins to make peptides like MDF. 
According to Orgel's error theory of aging, an in-
creasing number of errors in protein synthesis occurs with 
age (Wilson, 1973). An age-dependent accumulation of 
aberrantly behaving protein molecules is possible (Finch and 
Hayflick, 1977). According to the autoimmunity theory of 
aging, abnormal serum globulins and autoantibodies are found 
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in increasing percentages of an aging population (Kohn, 
1971). 
Plasma or serum from aged animals inhibited cell pro-
liferation in tissue culture media. Both a protein and 
lipid fraction from the serum were inhibitory (Kohn, 1971). 
It is suggested that toxic factors are present in the blood 
from aged animals. It is not unlikely that a variety of in- · 
hibitory substances that are excreted or metabolized in the 
young accumulates in the blood of older animals due to less 
efficient homeostatic mechanisms. There is a decline with 
age in the function of the major organ systems (heart, lung, 
kidney, blood vessels) responsible for maintaining homeo-
stasis. In shock, the homeostatic balance is overwhelmed 
and MDF is produced. 
Age-related changes in the structure and function of 
the thyroid gland have been studied. The thyroxine-binding 
capacity of serum thyroxine-binding globulin, thyroxine-
binding prealbumin, and albumin is decreased with age, 
despite an increase in quantity of these proteins (Frolkis 
et al., 1973). This may indicate that the structure of 
the serum globulins is changing with age. 
There is an increase with age in the deiodination 
processes in heart, muscles, and liver. Frolkis et al. (1973) 
suggested that the increased deiodination capacity of the 
myocardium could help explain cardiovascular disorders in 
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clinical thyrotoxicosis of old people. A similarity between 
symptoms of hypothyroidism and aging was suggested. 
(Frolkis et al., 1973). Although thyroid hormone secretion 
decreases with increasing age, the rate of thyroxine (T4 ) 
disposal decreases, resulting in an unchanged circulating 
plasma level of T4 (Finch and Hayflick, 1977). Triiodo-
thyronine (T3 J, a more potent form of thyroid hormone, 
significantly decreased with age. The significance of 
this decrease remains to .be determined (Finch and Hayflick, 
1977). Kohn (1971) concluded that there is no characteristic 
endocrine gland failure, with respect to the hormones neces-
sary for life, which is associated with aging. 
With age, there is a decrease in perfusion of organs 
and in tissue permeability, .an impaired passage of materials 
between blood vessels and cells, and an increase in 
peripheral vascular resistance due to a progressive inter-
molecular cross-linking of collagen. Pancreatic hypo-
perfusion was also significant in shock and MDF production. 
Collagen is distributed in and around walls of all blood 
vessels and around cells; the passage of materials takes 
place through a collagen-containing matrix. Diffusion.of 
gases, nutrients, metabolites, hormones, and accumulated 
toxins is hindered by cross-linked structural proteins due to 
the vessel-connective tissue-cell relationship. 
It is suggested that cross-linking of collagen during 
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aging results, at least in part, from the oxidation of 
constituent tyrosine residues to reactive quinoid. struc-
tures capable of binding covalently to adjacent functional 
groups (LaBella and Paul, 1965) • Amine oxidase plays a 
role in the oxidative deamination of lysine resulting in 
cross-linking (Kohn, 1971; Finch and Hayflick, 1977). 
Amyloidosis is associated with aging (Finch and 
Hayflick, 1977). Amyloid is a hyaline eosinophilic material 
that is mostly in extracellular masses, causing atrophy of 
adjacent cells. It has different chemical· compositions wheri 
as~ociated with different diseases. It is suggested that 
some form of amyloid may be a normal component of connec-
tive tissue·. 
According to Finch and Hayflick (1977), calcium ion· 
concentrations in cardiac muscle of rats decreased as age 
increased. The increase in collagen content, fibrosis, age 
pigment, and other morphological_ changes associated with 
aging could mechanically interfere with the contractile 
process. 
Free radicals, highly reactive short-lived molecules. 
containing an unpaired electron, increase in the blood 
with age. Diamine oxidase, an enzyme which increases with 
age, may produce an excess of superoxide (•o;). Peroxide 
(H202 l and oxygen (02 ) are effective in maintaining 
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autooxidations initiated by active radicals. 
-
.Oz + H2o2 7 OH + ·OH + o2 
The hydroxyl-free radical (·OH) is produced ih the above 
Haber-Weis reaction (Finch and Hayflick, 1977) and plays a 
role in aging. 
Serum copper levels increase with age. Copper serves 
as an oxidation catalyst for free radical reactions. It is 
of interest that men with myocardial infarction have sig-
nificantly higher average serum copper levels (Harman, 
1965). A positive correlation of the serum level of copper 
with coronary artery disease was again shown in Harman and 
Piette's study in 1966. Ceruloplasmin, a component of the 
a 2-globulin fraction of serum, increases with age and is 
concerned with copper transport, complexing with about 
98% of the total serum copper in man (Wilkinson, 1976). 
The lipid peroxidation reaction initiating lipofuscin , 
formation is a free radical chain reaction. This reaction 
causes extensive damage to membrane structure, ATP and a-
tocopherol (Vitamin E) (Finch and Hayflick, 1977). The cross-
linking of collagen during aging also results from a free-
radical reaction. The most important intermolecular bond, 
initiated by a reaction of lysyl-oxidase, is catalyzed by 
copper ions. Oxidative alterations in chromosomal material, 
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arteriolocapillary fibrosis, and tissue injury are deleterious 
changes resulting from free radical reactions .• 
several substances capable of reacting rapidly with 
free radicals, such as 2-mercaptoethylamine and cysteine, 
have been found to significantly prolong the life span 
of mice (Harman, 1965). It should be remembered that cysteine 
significantly lowered plasma MDF and cathepsin D activity in 
shock animals. Perhaps free radicals play a role in shock 
in addition to aging. 
Beneficial effects were produced by free radical reac-
tion iphibitors, and according to Harman (1968) may be due 
to an inhibiting effect on the rate of amyloid formation. 
There is a decrease in serum antioxidants such as 
ascorbic acid and mercaptans with age (Harman, 1965). 
Ceruloplasmin is an oxidase and can oxidize ascorbic acid. 
The· decrease in serum levels of readily oxidized substances. 
with advancing age suggests an age-dependent rate of oxida-
tion. Serum mercaptan groups are attached mainly to globulin 
protein. The possibility exists that newly formed serum 
prote~n contains fewer mercaptan groups with increasing age. 
(Harman, 1960). 
A major site of formation of extracellular free radicals 
may be in plasma, since the concentration of molecular 
oxygen is relatively high, and catalysts for the reaction of 
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oxygen with lipids, proteins, ascorbic acid, epinephrine 
are present in small concentrations. 
Free radicals appear to be involved with many of the 
factors that increase in the blood and body with age: 
diamine oxidase; copper, ceruloplasmin, lipofuscin, cross-
linking of collagen, amyloids. 
Several investigators have reported age-dependent 
changes in human cardiac dynamics, such as decreased rates 
of pressure development, ejection and filling. Contraction 
rates decreased with increasing age in some papillary muscle. 
studies. 
Mechanical properties of muscles reflect the bio-
chemical activity of the contractile proteins within the 
muscle cells. Heller and Whitehorn (1972) showed that cardiac 
myosin S extracted from young animals had a significantly 
higher rate of ATPase activity than that from old animals. 
Myosin S ATPase activity is the energy-supplying event 
associated with contraction. 
The velocity and extent of shortening of the papillary 
muscle when lightly preloaded were shown to be significantly 
age-dependent. Preparations from young animals contracted 
faster and further. An age-dependent decrease in the 
velocity of shortening of the contractile element is im-
plied. It is suspected that the series-elastic element is 
stiffer in the older animal. There was a slight, but 
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insignificant increase in time to peak tension with age 
(Heller and Whitehorn, 1972). 
The cross-sectional area of the papillary muscle in-
creased significantly with age (Heller and Whitehorn, 1972). 
When the cross-sectional area increases, mechanical proper-
ties can be affected by a hypoxic core (less oxygenation 
of the inner core of the muscle). The slight decrease in 
active tension development with increasing age may be due to 
this hypoxic core effect (Heller and Whitehorn, 1972). 
According to Heller and Whitehorn (1972), the rate 
phenomena of the contracting muscle is most affected by 
aging, being regulated by the enzymatic activity of the 
contractile proteins (myosin-ATPase). 
Thus, the myocardial contractile properties altered 
with age were similarly affected in shock. Many of the 
changes occurring in the blood and body in the aging process 
can be traced to common elements in the shock picture. 
It is this interesting similarity between shock and 
age that I base my hypothesis. If there really is a shock-
induced MDF which I will first confirm, I will attempt to 
demonstrate its additional presence in the plasma of aged 
dogs, thus tying together the many similarities between 
shock and age. 
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Mechanics of Myocardial 
Contraction 
It was demonstrated in 1944 that the isolated papillary 
muscle could be used for mechanical studies of the myo-
cardium (Grimm and Wohlfart, 1974). The papillary muscle 
provides a sample of parallel fibers of cardiac muscle with~ 
out the geometric complexities of the heart. 
The papillary muscles are attached by chordae tendinae 
to the leaflets of the atrioventricular valves in vivo. The 
papillary muscles and the ventricular walls contract 
to pull the leaflets of the valves toward the ventricular 
chamber. This prevents the valves from being forced too 
far backward into the atrial chamber during ventricular 
contraction. If a chorda tendinea is ruptured or if a 
papillary muscle is paralyzed, the valve is forced backward, 
causing it to leak. A severe cardiac incapacity may result. 
In vitro, the isolated papillary muscle system can be 
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used as a bioassay for MDF. Alterations of the mechanical 
performance of the muscle which are induced by MDF can be 
demonstrated with force-velocity relations. 
Concepts, clarification of the parameters used in 
experimental procedures, and their relation to in vivo 
situations are presented. 
A model for muscle 
A three-component model devised for skeletal muscle, 
the Maxwell version of the Hill 1939 model, seems to be the 
most suitable mechanical model for rat papillary muscle 
(Minelli et al., 1975). The first component, the contractile 
element (CE), develops force and shortens when activated, . . 
and is extensible at rest. The primary components of the CE 
are myosin and actin filaments with their cross-bridges. 
The second component is the series elastic element (SE) which 
is composed of nonactivatable tissue. In series with the 
CE, the SE is passively stretched by shortening of the CE. 
The third component. is the parallel elastic element (PE) 
which is also nonactivatable tissue and is parallel to.both 
the CE and the SE. The PE maintains resting length of the 
freely extensible CE and ~upports the SE during resting 
tension. 
In brief, when the CE contracts and shortens, the SE 
is stretched. When the contractile force stretches the SE 
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to the point that its elastic tension equals and exceeds the 
load, the muscle shortens and lifts the load. Thus, the 
active state of the CE is transformed into external me-
chanical activity by stretching·~he SE. The active state 
represents a capacity of the CE to shorten and develop 
force. Maximal isometric tens'ion developed by the CE is 
the greatest tension that can be produced without appreciable 
shortening of the muscle (Parmley ·et al., 1972; Grood et al., 
1974) • 
Frank-Starling law 
The Frank-Starling law of the heart is an underlying 
concept in cardiac physiology which basically states that 
cardiac· output is a function of venous return. The heart 
has an intrinsic ability to adapt to changing volumes of in-
flowing blood. When additional·blood enters the heart 
chambers, cardiac muscle becomes stretched, which.alters the 
initial length o'f the cardiac muscle fibers. The stretche.d · 
inuscle will normally contract with increased force to pump · 
the extra' ·blood ·into the arteries. 
Preload ·curve 
The mechanism of the Frank-Starling law has been 
demonstrated ·in v'itro with the mechanics of isolated 
papillary muscle. The dependence of the force of.contraction 
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on initial muscle length (preload) has been depicted by the 
length-tension curve (preload curve). Preload has been 
defined as the amount of weight attached to a lever which 
establishes the resting length and tension in the inactive 
muscle before a contraction occurs. With the left ventricle 
as an example, preload is analogous to left ventricular end-
diastolic volume in vivo which determines muscle fiber 
length which in turn is analogous to end-diastolic pressure. 
Preload determines the degree to which the myocardium is 
stretched before it contracts. 
In the following discussion on preload and afterload it 
is assumed that the state of contractility is held constant. 
The ventricle normally functions along the ascending limb 
of the length-tension curve. The peak of the curve is 
defined as Lmax' the length of muscle that produces 
maximal contraction. s,arcomere length is directly related to 
muscle length. Thi.ii;;, Lmax is that length determined.by a 
preload which produces the optimal average sarcomere length 
to give maximal contraction. A preload of a selected per-
centage of Lmax is a preload which will. give that percentage 
of maximal contraction. When muscle length (sarcomere length) 
is either shortened or increased from Lmax' developed tension 
falls. 
In isolated papillary muscle, peak developed tension 
has been shown ~o occur with a sarcomere length of about 
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2.2µ (Leyton et al.·, 1971; Detweiler, 1973). The sarcomere 
is the fundamental contractile unit. The contractile pro-
teins, actin and myosin, are arranged in an interdigitating 
array within each sarcomere. Contraction involves a move-· 
ment of the actin filaments towards the center of the sarco-
mere, sliding between the myosin filaments. A sarcomere 
length of 2.2µ is an optimal overlap bf thick and thin 
(myosin and actin) fiiaments to produce a maximal contrac-
tion; Further stretching causes withdrawal of actin fila..,. 
_ments from the interaction with inyosin. Lateral projections 
(cross-bridges) from the. thick filaments· attach to thin fila-
ments during activation, and are involved with the generation 
of a force which pulls the thin filaments inward. This is.the. 
qross-bridge theory. Thus, optimal overlap between thick 
and thin filaments allows for potentially more cross-bridge . . 
.attachments· which. has the important·consequence of the 
generation of. more force. 
The length-tension curve is therefore an experimental 
derivation of the Frank-Starling law of ·cardiac tissue •. A·:' 
sarcomere length of 2.2µ, in addition to corresponding to 
~max' occurs at the upper lil!lit of diastolic filling pre'ssure 
'in both the right and ·1eft ventricles. (Leyton ·et al.·, 1971). · 
An increase in diastolic filling changes the length of the . 
individual muscle fibers. This·a1ters the degree of overlap 
Qf the filaments,. which in turn alters the number o"f acti'ITe 
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contractile sites which are capable of generating force. 
After load 
The preload and afterload together make up the total 
load which the muscle contends with when stimulated. In 
vitro, afterload is the additional weight added after a 
stop has been fixed onto the arm of a lever. (The stop pre-
vents further stretching of the resting muscle and thus 
prevents the afterload from acting a:s a preload). It is an 
additional load for the muscle when it begins to contract. 
In vivo, afterload is analogous to the aortic pressure, 
the resistance against which blood is expelled from the heart. 
In summary, the volume of ventricular filling determines 
the initial length of the muscle fibers (preload). At the 
time of systole, the fibers contract isometrically until 
the pressure in the ventricle exceeds that in the arteries 
and blood is ejected. The ventricular fibers then shorten 
as contraction proceeds against the pressure in the aorta 
and pulmonary arteries (afterload). 
Force-velocity relation 
When preload, which determines initial muscle length, 
is kept constant, there is an inverse relationship between 
force and velocity. The initial velocity of shortening 
decreases with increasing afterload as demonstrated by the 
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force-velocity curve (Parmley and Chuck, 1973). 
The inverse force-velocity relationship is considered to 
be associated with the CE and may be expiained by the sliding 
filament and cross-br.idge theory. A certain amount of time' 
is required for a cross-bridge to attach to an active site·on 
·the thin filament and develop force. The muscle has a slow 
shortening velocity, because time is consumed by the forma-
tion of a large number of cross-bridges which result in a 
large generation of force. A rapid velocity occurs when 
less total force is generated by the formation of a fewer 
number.of cross-bridges which require less time to attach 
to the active. sites on actin, .as· w~ll as to react and deveiop 
force (Nayler, 1975). 
P0 The two intercepts of the force-velocity curve 
merit discussion. P
0
, the x..:intercept, is the load which 
just prevents external muscle shortening and represents 
maximum isometric force. P~ is proportional to the frac-
tion of active sites capable· of producing force (actin-
myosin interactions) at zero.contractile element velocity. 
Thus, with a constant or given state of contractility, 
changes in po are produced by alterations in muscle 
length • 
. '~ 
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v , the y-intercept on a force-velocity 
max 
curve, is an extrapolated maximum velocity of shortening 
of the contractile filaments at zero load. Vmax cannot 
be measured directly because the muscle cannot be fully 
unloaded. The true V occurs when the internal load max 
is zero; this is different from the extrapolated Vmax where 
only the external load is zero. 
According to Gulch and Jacob (1975a, 1975b), there are 
unknown "nonvanishing" internal forces which mechanically 
hinder the sliding movement of the filaments and influence 
V measurement. Edman and Nilsson (1972) and Grood et al. max 
(1974) also suggested the presence of a substantial in-
trinsic load acting upon the myofilaments. If muscle fibers 
are prevented from widening during shortening, a pressure 
rises, ultimately producing a longitudinal force at each 
end of the fiber which would act as a load upon the CE. 
There is a controversy concerning the indepen.dence 
of Vmax on muscle length. This debate is significant since 
it questions the value of Vmax as an index of contractility 
in cardiac muscle. A constancy of Vmax over a range of 
muscle length is important for its use as such an index, 
particularly in the intact heart. According to Parmley 
et al. (1972.), Vmax-total independence of preload is an ideal 
requirement for an index of the contractile state. Vmax 
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should only be altered by inotropic influences if it is to 
be used as an index of contractility. Contractility has been 
described as changes in·the mechanical performance of cardiac 
muscle which are· independent of fiber length (Donald et al., 
1972). A change in contractile state relates to the rate 
at which cross-bridges between the myofilaments are formed 
and broken (Parmley and Chuck, 1973). Thus, an index of 
cardiac contractility should serve to distinguish altered 
mechanical responses of muscle' due to changes in length from· 
changes in the. intensity of the active state due to ino-
tropic interventions • 
. Vmax is determined by the rate at which.the actin~ 
.activated myosin cross-bridges hydrolyze ATP (myosin ATPase 
. ' . 
activity), and. is independent of the number of active sites. 
Vma]c is incr:ased by positive inotropic agents such as 
·norepinephrine, digitalis, glycosides, calcium • 
. Vmax. is uncha.nged by changes in preload, but altered 
by changes in contractile state (Parmley et al., 1972; 
Detweiler, 1973). According to Grood et al. (1974), the 
only influence of muscle length was to determine the number 
of participating cross-bridge·s, There was an increase in 
the' force developeq. (P 
0
) when preload was· increased 
(Detweiler, 1973; Parmley et al.; 1969; Kababgi et al.,· 
1974) •. 
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According to Weber and Janicki (1977), shortening velocity was 
independent of initial muscle length, the initial length 
serving only as the starting point of the contraction. It 
has been concluded that the velocity of fiber shortening 
serves as a useful estimate of the contractile state. 
According to Brutsaert et al. (1971, 1973), Vmax re-
mained constant and was thus independent of the initial 
muscle length from L to 87.5% L . This corresponded . max max 
to sarcomere lengths of 2.2µ and 1.9µ indicating that Vmax 
was independent of the degree of myofilament overlap. 
However, when sarcomere lengths of 1.8µ or less were 
reached during shortening, Vmax fell with length. The reason 
for this decline in V at shorter lengths was and is poorly max 
understood. It is possible that at these short sarcomere 
lengths, the thin filaments may pass into the opposite half 
of the sarcomere and interfere with force-generating bonds 
(Brutsaert et al., 1971; Brutsaert et al., 1973). Internal 
forces may also come into play at these short lengths. 
According to Noble (1974), V exhibited only small max 
length-dependence when muscle lengths were studied from 94% 
Lmax to 100% Lmax 
Conflicting results have been reported by other investi-
gators. According to Parmley et al. (1972) and Minelli 
et al. (1975), increasing the muscle length along the 
ascending limb of the Frank-Starling length-tension curve 
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resulted in increases in both Vmax of the CE and P
0
• Thus, 
Vmax was dependent on muscle length. V was significantly max 
dependent on preload (increasing with muscle length) even 
in the physiological range between 85% Lmax and Lmax 
(Gulch and Jacob, 1975a) • 
According to Donald et al. (1972), V was signifi-max 
cantly increased with increasing initial muscle length. A 
linearized form of the Hill equation was used. At the 
shortest muscle length, Vmax was 76% of. its maximum, while 
the isometric force (P
0
) was 43% of its maximum. It was 
conclude.d that Vmax was less sensitive than isometric force 
to' changes in muscle fiber length i.n cardiac muscle. It 
has been proposed that the factors responsible for the 
, . 
drastic fall in isometric force (P ) at muscle lengths below ·o .. 
Lmax' would probably have a similar effect on Vmax to the 
same degree, as is true in skeletal muscle. 
The mechanisms which are responsible for the muscle 
length-dependent change in contractile state have not been 
determined. One cause may be an increase in available 
Ca++ to the myofilaments (Parmley and Chuck, 1973). 
Loeffler and Sagawa (1975) .claimed that use of a 
three~element muscle model might invalidate the once wide-
spread postulate· that Vmax of the CE is indepe_ndent of 
initial muscle length. 
In spite of these discrepancies concerning the value of 
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Vmax as an index of contractile state; it has been used. 
Okada et al. (1977) have expressed the depression of myo-
cardial contractility in terms of Vmax by studying sequential 
changes in Vmax during hemorrhagic shock. 
According to Weber and Janicki (1977), an adequate 
minimum definition of contractile state must include a 
description of instantaneous force, shortening velocity 
and fiber length. The most relevant index of myocardial 
activity may be provided by the force-velocity relation 
(J;;dman, 1977). 
The Hill equation The Hill equation should be 
questioned as to its applicability to cardiac muscle. The 
true shape of the force-velocity curve in cardiac muscle is· 
r- . 
still debated. A. V. Hill, in 1938, identified the mathe-
matical relationship between force and velocity as :fitting 
a hyperbolic curve for tetanically stimulated skeletal 
muscle. The Hill equation is: 
(P+a)v = b(P -P) 
0 
P represents force; v represents velocity; P
0 
is isometric 
force. Vmax is calculated as bP
0
/a. "a" and "b" are mechani-
cal constants; "a" has dimensions of force; "b" has dimensions 
of velocity. When (P
0
-P)/v is plotted against P, a straight 
line with positive slope l/b and y-intercept a/b results 
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(Brady, 1965). 
Since "a" has dimensions of force, (P+a)v = force x 
velocity = energy. The term b(P -P) increases as the force, 
0 
P, decreases. Thus, the energy output of a muscle increases 
as the load, P, decreases as defined in the Hill equation 
(Goll et al., 1977). 
The force-velocity relationship was extended to cardiac. 
muscle and found to be significantly nonhyperbolic by 
many investigators (Loeffler and Sagawa, 1975; Donald et al., 
1972; Nayler, 1975; Gulch and Jacob, 1975a; Brady, 1965). 
It is rare that cardiac muscle force-velocity curves 
can be described.by the Hill equation (Donald et al., 1972; 
Nayler, 1975). Cardiac muscle force-velocity curves obtained 
from afterloaded isotonic contractions are not usually 
hyperbolic in shape over the entire force domain; they 
generally become linear or concave downward at the higher 
forces. 
Edman and Nilsson (1972) were only able to obtain a hy-
.Perbolic force-velocity relation by an instantaneous quick-
release method when they maintained the length of the CE 
constant. However, the quick-release method has been 
questioned by those who have claimed that the technique 
introduces errors (Loeffler and Sagawa, 1975; Noble and Else, 
1972). 
According to Brady (1965), the data from skeletal muscle 
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experiments fit the rectangular hyperbola of Hill due to 
inherent muscle properties which cardiac muscle does not 
share. There are four basic properties: the onset of 
contractility is rapid; twitch tensions can l;>e summated by 
repeated stimulation such that developed tension becomes 
independent of time; maximum tetanic tension development is 
not greatly length dependent over a significant range of 
muscle lengths; and the contribution of resting te11sion to 
total tension is negligible over this range of lengths. 
Data from rabbit papillary muscle experiments did not 
fit hyperbolic force-velocity relations. The curves which 
Brady (1965) developed were not straight lines with positive 
slopes. It was concluded that the Hill equation for skeletal 
muscle cannot be applied to cardiac muscle whose force-
veloci ty relation is nonhyperbolic (Brady, 1965). This.was 
explained by proposing that the excitation-contraction 
coupling in cardiac muscle is different. 
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MATERIALS AND METHODS 
Surgical Procedure for 
Producing MDF 
Pancreatic ischemia was produced by occlusion of the 
superior and inferior pancreaticoduodenal arteries, and the 
.splenic artery in a young male mongrel dog. Rubber bands 
were used to occlude the vessels. 
A ventral midline abdominal incision was made from the 
xiphoid process caudally to.a point along the linea. alba where· 
manipulation of the pancreas would be possible. The superior 
pancreaticoduodenal artery was ligated caudal to the bifurca~ 
tion of the gastroduodenal artery (originating from the 
hepatic artery) into the right gastroepiploic artery and t):J.e 
superior pancreaticoduodenal artery whic}l enters the right 
pancre~tic lobe. The inferior pancreaticoduodenal artery which 
also enters the right pancreatic lobe was ligated caudal ·to 
the superior mesenteric artery bifurcation. The splenic ·artery 
which enters the left. pancreat_ic lobe was ligated caudal to the 
celiac bifurcation. The ~ancreatic branch of the superior 
pancreaticoduodenal artery which enters the left lobe and · 
anastomoses with pancreatic.branches of the splenic artery 
was occluded. Small .branches from the common hepatic artery 
enteri;ig the left. pancreatic lobe were checked for· occlusion. 
The duration of the occlusion was 130 minutes. The rubber 
; . 
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bands were removed over a 15 minute period. Twenty minutes 
after removal of the last rubber band, sixty milliliters of 
blood were withdrawn from the hepatic portal vein for MDF 
isolation. 
Blood Collection Procedure 
Although blood was withdrawn from the shock animal via 
the hepatic portal vein, the jugular vein was used to obtain 
blood from the aged animal. 
Blood was collected in 10-ml heparinized vacutainer 
tubes (Becton-Dickinson) and immediately placed in an ice 
bath. The blood was centrifuged in a GLC-1 Sorvall centri-
fuge at 2500 rpm for 20 minutes at 4C. The plasma was 
removed with a disposable pasteur pipette and placed in 20-
ml scintillation vials, b~bbled with N2 , and stored at OC. 
Dialysis Procedure 
The frozen plasma was thawed, filtered with glass wool 
to remove the cryoprecipitable proteins, and dialyzed 
against double distilled, deionized water under a pressure 
of 200 mm Hg for 48 hours at 4C (Figure 1). 
One end of. Spectra/Per 6 dialysis tubing with a flat 
width of 32 mm, a diameter of 20.4 mm, and a molecular 
weight cutoff of 2000 (Spectrum Medical Industries) was 
· 3.-way 
valv~· 
·250-m1_ 
dialysis 
105 g 
attached to 
.ring stand 
---=-=·~ ~to manometer 
-?!!p!C::lt:i;·of f ~ 
' 
500-ml 
reservoir 
3-way valve 
-Figure ·-1 ;_ 'Apparatus for dialysis under pressure 
to N · tank 
2 
.• 
..... 
U1 I. 
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gently fastened onto the half-bulb end of a 1-ml volumetric 
glass pipette with rubber bands and plastic straps. A 
spectrapor closure was used to seal off the· other end of the 
dialysis tubing. The dialysis tubing suspended from the 
pipette was placed into a 250-ml Erlenmeyer flask filled 
with 250 ml double distilled, deionized water. The membrane 
was kept moist at all times during the attachment procedure. 
Approximately twenty ·ml of filtered plasma was then placed 
into the dialysis tubing via a three-way valve at the distal 
end of the pipette. 
A~ the pressure provided by .a N2 tank was slowly in-
cr.eased to 200 mm Hg, which was monitored continuously 
with a manometer, observations were made for pinhole leaks 
in the men\brane. The dialyzing was periodically checked 
dur.ing the 48 hour period for leaks in the system and a 
ruptured men\brane. 
Lyophilization Procedure 
Ten-milliliter portions of the plasma ultrafiltrate 
were lyophilized for approximately 7 hours (Labconco freeze 
dryer-5). The lyophilized sample was either stored under 
N2 or reconstituted to 2 ml (20% of the original volume) 
with double distilled, deionized water and centrifuged at 
2250 rpm for 10 minutes at 4C. 
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Gel Filtration Chromatography 
The supernatant fluid of the centrifuged 2-mi lyo-· 
philized plasma ultrafiltrate ·sample was then layered o~ a 
glass barrel Econo-column with a 1.5. cm I.D., 120 cm column 
length, 190-ml column volume (Bio Rad Laboratories). The 
column was packed with Bio-Gel P-2, a polyacrylamide gel 
(200-400 wet mesh). Substances with molecular.weights.be-
tween 200-1600 are separated (Lefer, 1970). This is the 
exclusion limit for Bio~Gel P-2. A 500-ml Econo-column . 
reservoir was fitted onto the column. Medical grade vinyl . 
'tubing (0.082 I.D. x 0.142 O.D .• ) (Becton-Dickinson) was 
attached to the Luer outlet of the column and varied in 
length from 260-330 .cm for four columns. The tubing and the· 
·,· 
height of the column were adjuste4 so that the pressure 
he.ad would be· sufficient to establish gravity .flow rates be-· 
tween 9.2 and 11.4 ml/hr. The eluate was collected in 4_.6-. 
5. 7 ·ml fra.ctions (depending on. the flow rate). (Buchler 
.Fractomette 200 a.utomatic fraction, collector, circular ISCO 
fraction collector) .• 
Packing procedure . 
54. 3. g of Bio-.Gel P-2 was dissolved in 570 ml of modi-
fied- Krebs-'Henseleit. buffer without dextrose and bicarbonate 
(pH 7.38) in. a .1000-ml Erlenmeyer flask with sidearm. ·The 
gel was allowed to .swell. at room· temperature for four hours. 
! 
! 
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After warming the resultant slurry in a 60C water bath for 30 
minutes, it was deaerated by vacuum for 15 minutes. The gel 
was then ready for packing the column. 
Deaerated Krebs-Henseleit buffer minus dextrose (pH 
7.38) was first poured into the column to fill up approxi-
mately 20% of the column volume. The entire siurry was 
then poured through the reservoir fitted on top of the 
column. The column settled by gravity flow. After a short 
while, the column was allowed to flow by removal of a 
hemostat which was originally placed on the tubing exiting 
from the column Luer outlet. 
The freshly prepared column was then transferred to 
the cold room (4C) where all additional column work and 
dialysis were conducted. 
Layering a sample 
Before layering a sample on the column, the optical 
density of an eluted buffer fraction was read at 230 nm to 
check for any contamination. A deaerated, modified dextrose-
free Krebs-Henseleit buffer (pH 7.38) was used to elute the 
column. 
With a piece of tubing, the buffer was siphoned out 
of the reservoir and the remainder of the buffer was 
pipetted out of the column to the level of the bed. The 
sample was c'arefully introduced down the sides of the column 
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with a long pipette without disturbing the bed. After the· 
2-ml sample was just absorbed, two 2-ml aliquots of buffer 
wer.e applied in-a similar fashion. to move the sample 
down the column. 
The first fraction was collected as soon as the sample : . · 
-was applied to .the coluI!ln. After the second 2-ml aliquot of 
buffer was :just absorbed into the bed, fresh buffer was 
gently pipetted down the sides of the col1imn to fill that 
portion of the column above the.top of the bed. The reservoir 
was replaced and slowly refilled with fresh buffer. Frac-
:- . . . 
tions were collected until the total elution volume reached 
. ' 
_approximately 300 ml. 
Maintenance of. t;he column 
At the end pf' each. run, the buffer level was drained to·. 
the top of the bed. The upper 1. 0-1. 5 cm layer of the gi:il" ·:. 
bed was st.irred up and removed with pasteur pipettes. The 
entire buffer _volume down to the' -top layer of the bed '· 
was removed and replaced with fresh, deaerated buffer on 
alternate days. Additional fresh buffer was added to the 
re.servoir at all other 'times._ The columns flowed continuousiy •. 
Calibration .of· th-~ column 
The void volumes· of the columns were determined with ·. '· . . ' . 
dextran blue. (molecular weight' 2,000,000) (Sigma). Twenty·· 
llig of. dextran · blue was · dissolved in 1 ml of H;2 o. One drop . 
BO 
· of this solution was then placed in 1 ml of buffer and 
this 1-ml sample was layered on the column. The only modi-
fications were that whenever a 1-ml sample was applied which 
only occurred for molecular weight markers, 1-ml aliquots 
of buffer were used instead of 2-ml aliquots to move the 
sample through the column. 
Molecular weight markers Five mg of angiotensin II 
(l-L-asparaginyl-5-L valyl angiotensin octapeptide) with a 
molecular weight of 1225 (Ciba Pharmaceutical Company) was 
dissolved in 1 ·ml of water (0.0041 M solution) and layered 
·on three columns at separate times. The optical density was 
read at 280 nm. 
· Five mg of 5-isoleucine angiotensin II (L-asparaginyl-
L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-
prolyl-L-phenylalanine·· CH
3
COOH) · with a molecular weight of 
1106.3 (Sigma) was dissolved in 1 ml of water (0.0045 M 
solution) and layered on one column. The optical density 
was read at 280 nm. 
Five mg of angiotensin III inhibitor (des.,.Asp1 , Ile8 
angiotensin II; H-Arg-Val-Tyr-Ile-His-Pro-Ile-OH) with a 
molecular weight of 896 (Beckman) was dissolved in 1 ml of 
0.1 M acetic acid and layered on one column. The optical 
density was read at 280 nm. 
Fifty mg of hexaglycine white crystals with a molecular 
Bl 
weight .of 360.3 (Sigma) was placed in 1 ml of lN HCl, 
warmed.untildissbluti0n, and then layered on one column. 
This was repeated using 30 mg of hexaglycine in 1 ml of 
warm lN HCl. The optical density was read at 280 nm. 
Two ml of a o .• 03 M solution of glycylglycine with a 
·molecular.weight of 132.1 (ICN Nutritional Biochemicals)' 
was layered on four columns. The optical density was read 
at 230 nm. 
Detection of Protein 
Absorption spectrophotometry' 
~lution chromatograms were derived from optical density 
readings at 230 nm using quartz cuvettes and a Beckman 
" ... . ' ' 
DB-GT.spectrophotometer for the .fractions of ·each column 
run •. Most of the moiecular. weight mar.kers were detected 
at 28() nm. 
Ninhydrin procedure 
The presence bf amino nitrogen in the eluate was .. 
confirmed by.the ninhydrin reaction which yields.a violet 
condensation product,. diketohydrindylidene-diketohydrihd-. 
amine. The n.inhydrin reagent was prepared accorqing to . 
the method of Kabat. (1961): 40 mg sncl;2•2H2o d.issolved in 
25 ml of 0.2 M citrate buffer (pH 5) was added to 0,4 g 
ninhydri,n (1,2,3-indantrion:e monohydrate) in 12.5 nil .of 
> "' 
' I 
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methyl cellusolve (ethylene glycol monomethyl ether). 
One tenth-ml samples from each of the peaks eluted 
from the columns were added to either 5- or 10-ml glass 
stoppered volumetric flasks with 100-microliter disposable 
pipettes. One-half·ml of ninhydrin reage~t was added. All 
-·.flasks were heated in a boiling· wa.ter bath for 20 minutes. 
Samples were colorimetrically tested for the presence or 
absence of amino nitrogen. 
Fractions were pooled within peaks according to their 
optical densities and ninhydrin reactions. 
Preparation of Eluted Column Peaks 
for Papillary Muscle Bioassay 
Ten-ml aliquots from peaks that were eluted from the . 
column were lyophilized and reconstituted with double 
distilled, deionized water to 2 ml. 
A modified Krebs-Henseleit buffer was used to elute 
the column and for the papillary muscle bioassay. The 
modified Krebs-Henseleit buffer that was used for the 
papillary muscle bath was modified further for the prepara~ 
tion of the lyophilized test peaks. 
The concentration of each of the constituents of the 
modified Krebs-Henseleit buffer was: NaCl (114.56 rnM), 
KCl (5.00 rnM), MgC1 2 ·6H2o (1.20 rnM), NaH2Po4 -H20 (1.26 
rnM), NaHC03 (25.00 rnM), D-glucose (10.99 rnM), Cac1 2 (2.58 
mM). The concentration of Cac12 was increased from 2.58 rnM 
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to 3.25 mM when the Krebs-Henseleit buffer was used to pre-' 
pare the lyophilized test peaks for bioassay. 
The pH of the Krebs-Henseleit buffer (2.58 mM Cacl2 l 
was adjusted to 7.38 with 0.4N NaOH and lN HCl, and the 
osmolarity which was measured with an osmometer (Advanced 
Instruments) was between 280 and 285 milliosmols/liter. 
The buffer prepared in this manner was used in the papillary 
muscle chamber. The glucose-free buffer used for eluting 
the column was adjusted for pH only. 
· Twenty-three ml of the Krebs-Henseleit buffer (3.25 
mM CaC12 ) was added to the reconstituted lyophilized test 
peak. The pH of this 25-ml test sample was adjusted to 
7.38. The addition of 6 ml of H2o was necessary to adjust 
the osmolarity· .from 349-356 to 282. 
The procedure in brief outline form prior to the 
papillary muscle.bioassay step is diagrammed in Figure 2. 
A stepwise dilution and concentration scheme for the 
sample, which was cc:tlculated by volume, is :indicated. 
This procedure was followed for processing shock 
plasma, and plasma from young and aged dogs. In these 
experiments, the fourth peak (peak D) of the gel filtration 
chromatogram was used. 
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~20-ml plasma sample 
12. 5-fold dilution< dialysis~ 
10-ml aliquot of 250 ml 
plasma ultrafiltrate 
5-fold concentration[ ~ 
lyophilize and reconstitute to 2· ·ml 
7.5-fold dilution< gel filt}ation 
10-ml aliquot of ~15 ml eluted peak 
5-fold concentration[- · J, 
lyophilize and reconstitute to 2 ml 
15.5-fold dilution< ! 
place in 23· ml Krebs-Henseleit 
buffer, adjust pH, adjust osmolarity 
with 6 ml H2o 
Total: 58.8-fold dilution of original starting material 
Figure 2. Procedure prior to the papillary muscle bioassay 
(A stepwise dilution and concentration of the 
sample, which was calculated by volume, is indi-
cated. The end result is a 58. 8-·fold dilution 
of the original starting material.) 
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Experimental Design 
Two initial experiments·were designed to assay for 
MDF activity and to confirm the presence of MDF in shock 
plasma using the papillary inuscle system. 
In the first experiment, the papillary muscle was sub-
jected to thr.ee different muscle baths in the following 
order: Krebs-Henseleit solution, processed plasma peak D 
from a young dog, and processed shock plasma peak D. The 
:term "processed" is used to refer to the steps. outlined in 
Figure 2. · Thus, a bath cons is.ting of processed plasma is 
composeid of a 2-ml ·reconstituted-lyophilized plasma ul~ra­
tiltrate sample of peak D, 23· ·ml Krebs-Henseleit buffer., and 
6. ml, H20. 
In the second experiment, the three muscle baths were: 
Krebs-Henseleit solution, processed shock.plasma peak A, 
anc~-processed shock plasma peak.D. Peaks A and'D, the first 
and .. fourth peaks, reSpE!ctively, were chosen from the same . 
. elution profile. -- . _- - ' 
Ten experimen:!:,S were then designed to detect differences 
betwee.11 .Plasma from young and aged dogs with respect to the 
'presence of _MDF. The three muscle baths in seven of these 
exi;ieriments werE!: Krebs-Heinselei t .solution, .. processed 
plasma peak D from a young dog, and processed plasma peak 
D from· an aged·dog. In the last three experiments, 
! 
• I 
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unprocessed whole plasma was used instead of p:tocess.ed 
plasma peak D, so that the three muscle baths were: Krebs-
Henseleit solution, whole plasma from a young dog, and whole 
plasma from an aged dog. 
The design of all twelve experiments was similar. The 
·first muscle bath was Krebs-Henseleit solution which served 
as a physiological standard;, the second muscle bath was 
either processed plasma peak D, processed shock plasma 
peak A, or whole plasma from a· young dog and served as a 
control; the third muscle bath was either processed shock 
p}.asma peak D, processed plasma peak D from an aged dog, 
or whol~ plasma from an aged dog. 
Six young dogs (less than one year of age) were randomly 
chosen; four dogs were male and two were female. Six old 
doge;, three male and three female, ranging from 13; 5 years. 
to 17 years of age, were selected. Young and. old dogs were 
randomly assigned to an indivi9ual muscle experiment as 
indicated in Table 1. 
Short medical history of two of the dogs 
01: mitral va].ve failure, 'renal failure, treated for 
Cushing's syndrome (hyperadrenalcorticism) 
03: conjunctivitis and vascularization of the cornea 
which was caused by a bacterium, immunological 
deficiency in the eye, longstanding Kl'ebs;iella 
infection and epilepsy 
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Table l. Assignment Of dogs to individual muscle experimentsa· 
shock experiments 
Sex Breed Sex Breed 
l. DYl ~ Mongrel DS 6' Mongrel 
2. AS .! Mongrel DS 6' Mongrel 
A<]e experiments 
Sex Breed Sex Breed Age 
l. DYl 6' Mongrel DOl ~ Dachshund lS 
2.-. DY2 &' Mongrel D02 6' Beagle 13.S 
3 • . DY3 &' Shepperd D03 ! Weimaraner 14 
4 •. DY3 6' Shepherd D04 6' Collie 16 
s. DY4 ~ Shepherd DOS !? Beagle 17 
6. .DYS. J' _Mongrel D06 ~- Dachshund lS 
DY6 '-¥ Mongrel D02 6' Beagle· 13.S 
7. Plasina. YS 6' - Mongrel Plasma 03 6' : Weimaraner 14 
8. Plasma Y4 i Shepherd Plasma 02 6' Beagle 13.S 
9. Plasma YS 6' Mon,grel Plasma OS ¥ Beagle J. 7 
a-
processed plasma peak p; D = 
A = processed plasma peak- A;· 
s = shock d~g.;: 
y = young dog; 
0 = old dog. 
Dogs.were assigned a number from l to 6. "Plasma" precedes a "Y" or an 
!'O" ·.when whole. plasma was used instead of a processed. plasma peak. 
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Papillary Muscle Bioassay 
The canine papillary muscle bioassay was used to assay 
MDF activity. 
Six-week old mongrel dogs (l.5-4.5 kg body weight) 
were anesthetized with sodium pentobarbital (50 mg/kg 
I.V.). The heart was rapidly excised and immersed in a 
continuously oxygenated, modified Krebs-Henseleit solution. 
The right ventricle.was opened along the anterior septal 
margin. Suitable papillary muscles were selected on the 
basis of length, shape, and geometric configuration. The 
first papillary muscle adjacent to the interventricular 
septum was usually the thinnest muscle, and was used if it 
satisfied the criteria established for suitable muscles. 
Criteria for judging validity of papillary .muscle performance 
The ratio of active tension to resting tension in 
Krebs-Henseleit buffer should exceed 4.5:1. If the ratio 
was less, but the papillary muscle had a P
0 
which was 
greater than 2 or if the P steadily' increased with time; 
0 
the papillary muscle was acceptable. 
Papillary muscles that were too short, stubby, with a 
a cross-sectional thick triangular configuration, or with 
area greater than 2.1 mm2 were omitted. If the muscle had 
a cross-sectional area greater than 2.1 mm2 , the P had to 
0 
be large and/or steadily increase with time in order to be 
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included in the study. 
Most importantly, ifthere was the slightest indication 
that a papillary muscle was subjected to mechanical damage 
either by the equipment, a pH or an osmolarity shift, the 
muscle was not used. 
Mounting ·.the papillary muscle 
The preparation of a stainless steel wire with loop· 
for mounting papillary muscles is diagrammed in Figure 3. 
A 15-cm stainless steel wire (32 gauge) was threaded through 
·a 3-mm length of aluminum tubing (1.9875 mm I.D.) so that 
only a very short piece of wire protruded from one end. 
The long end of the wire was then rethreaded through the 
same opening of the tubing as in step 1. The wire was 
pulled taut and then returned through the tubing (indicated 
?Y step 3) to form.a loop approximately 5 mm long. The 
other en.d of the wi:re was then brought around the side of 
the tubing as indicated in step 4, threaded through the· 
tubing once more, and· pulled taut to secure the loop. 
This prepared wire with aluminum tubing and loop at 
the distal end was then encircled around the chorda tendinea 
of a selec~ed papillary muscle. The end of.the wire was 
then threaded once more through the aluminum tubing such 
that the chorda tendinea was also pulled up through the 
tubing. Care was taken not to pull the· muscle up into the. 
I 
. I 
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Figure 3. Preparation of stainless steel wire with loop for 
mounting papillary muscles 
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tubing. The aluminum tubing was then compressed with a 
hemostat to fix the chorda tendinea. 
The papillary.muscle was then dissected free with a 
small piece of the right ventricular wall adjacent to the 
muscle base. A lucite clamp was firmly fitted onto this 
small piece of ventricular wall so that the nontendinous 
end of the muscle was close to the clamp. The long end of 
the wire was cut close so that the only wire visible was 
the loop. This entire.procedure was rapidly performed in 
continuously oxygenated Krebs-Henseleit buffer solution with-
out exposing the muscle to air. 
The papillary muscle was then mounted horizontally in 
a 5-ml inner chamber of a double-chambered constant-
temperature bath .(27C). The loop of the stainless steel 
· wire was hooked onto the distal end of an aluminum lever 
mounted on ·a Brush transducer. The transducer was con-
nected to a 9853 A voltage/pressure input coupler in the 
pressure/force mode on a R-611 dynograph recorder (Beckman). 
An isolation transformer which is part of the isotonic 
muscle transducer (Gould, Inc.) was coupled to the Brush 
transducer. 
I 
I 
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Description of the system 
The Krebs-Henseleit solution was continuously gassed 
with a 95% o2 and 5% co2 mixture. To provide adequate 
oxygenation and a circulating system for approximately 25 
ml of fluid, two additional chanibers were made in a lucite 
·plastic block. One tubelike chamber contained a mini-pH 
probe which took up almost the entire volume of the chamber. 
The pH was continuously monitored and was maintained within 
the range of 7.40-7.56. The second tubelike chamber served 
as a diffusion chamber. A 1.65 m length of silatubing 
(0.889 mm I.D., 0.51 mm wall thickness) (Silatube, Ronthor 
Reiss Corp.) was wound symmetrically around an aluminum 
framework in this 10-ml chamber. 
The gas mixture released from the gas pressure 
tank was directed through a moisturizer to an emergency. 
oxygen roller pump if needed, and the diffusion chamber. 
The silatubing in the diffusion chamber offered a relatively 
large outersurface area for diffusion of gas through the 
wall of the tubing into the circulating chamber fluid. 
From the diffusion chamber, the gas mixture was 
directed to the muscle chamber where silatubing was mounted 
beside the muscle. Finally, the gas inside the lumen of .the 
silatubing was directed to a bubble chamber where it was 
released into room air through a short piece of 22 gauge 
stainless steel tubing. 
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Circulation of the fluid was accomplished by negative 
and positive pressure. The chamber fluid was withdrawn 
by vacuum from the muscle chamber ,via a 20 gauge stainless 
steel tube which was mounted on the end of the inner muscle 
chamber just below the fluid surface. The fluid was 
directed into the.pH-monitoring chamber. A rate controlled 
roller pump (Cole Parmer) propelled the fluid by positive 
pressure from the pH-monitoring chamber into the diffusion. 
chamber. · The oxygenated fluid was then returned to the 
muscle chamber via another 20 gauge stainless steel tube 
' ' ' 
which was mounted at the bottom of the inner muscle chamber 
. directly under the muscle • 
. . The papillary muscle was not directly affected when 
0.1 N HCl or 0.1 N NaOH was added to adjust pH, because the 
addition was made into the system through a three-way valve 
into the tubing and then mixed with the continuously circu-
lating fluid. 
During each experiment, the chamber fluid was changed, 
twice. This was accomplished by quickly draining the solu-
tion froni the pH-monitoring chamber, the diffusion chamber, 
the muscle ch<1mber and all tubing in the system. The muscle 
was kept moist during the exchange. 
A Grass SD9 stimulator was used to stimulate the 
papillary muscle constantly at a frequency of 12 stimula-. 
,' 
tions !?er minute with a ·duration of 5 msec, and 25-30 volts •. 
! 
' "' I 
I 
I 
I 
I 
I 
I 
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The stimulus pulse passed between one silver electrode placed 
through the lucite clamp which held the muscle in place, and. 
one platinum electrode fixed into the sidewall of the muscle 
chamber. 
The papillary muscle was allowed to equilibrate while 
contracting isotonically. After 2 hours of equilibration 
time, a preload curve was generated in order to determine 
L The length-tension curve was run backwards beginning max· 
with 3.6 g. The muscle was allowed to contract isotonically 
with this weight for one minute; and then the weight was 
removed to return the muscle to a zero preload condition 
for one minute. This was repeated for preloads of decreasing 
weight. The amplitude (mm) of contraction was measured for 
each preload. The muscle was prestretched with 3.6 g for 
2 contractions prior to each sequential preload of de-
creasing weight. Care was taken not to overstretch the 
muscle; smaller muscles were prestretched with a lighter 
load. The data were immediately analyzed with a model 600 
Wang computer which was programmed to calculate the L • max 
The selected preload weight was ~92.5% of the preload weight 
that would produce a maximal contraction (L ). Thus, the max 
resting tension was set at a level just below that which 
would yield a maximal contraction for the rest of the 
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experiment. 
After the muscle equilibrated with this new constant 
preload, three afterload curves were generated for each of· 
the three muscle baths with a 30-minute equilibration time 
after each bath solution was replaced. Afterloading.was 
controlled by a stop on the upper side of the arm of· the 
lever which prevented the afterload from acting as a pre-
load. A micro-drive stepping unit with a multistep and 
single step adjustment (David Kopf Instruinents) was used 
for raising and lowering the stop in units of microns. 
Force-velocity curves were generated backwards by 
sequentially adding lighter weights after the determination 
of P
0 
(the load that just prevented muscle contraction). 
Tangents to the contraction ~urves which were recorded at 
25 mm/sec paper Speed on a Beckman R-611 dynog;raph were 
drawn to determine the velocity of shortening at each after-
load. Dupl.icate ·determinations were made to verify accuracy. 
The velocity was calculated by the following equation: 
Velocity (µ/sec) = tan 6 x calibrated difference (µ/cm) 
x l.9J4 x 2.5 cm/sec 
The afterload data were fit to either a 2nd, 3rd, or 4th 
order polynomial by the method of least squares and the 
V · was extrapolated by the model 600 Wang computer. max 
The latency between the beginning of stimulation and 
I 
I 
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the beginning of muscle contraction was determined for each 
afterload. The latency data were also fit to either a 2nd, 
3rd, or 4th order polynomial by the compu,ter and plotted 
against load. 
The muscle contraction, stimulus, and time were re-
·corded on a 4-channel R-611 dynograph recorder (Beckman). 
The osmolarity was monitored every hour throughout the experi-
ment. 
A Bausch and Lomb potentiometric recorder was used to 
measure the length of the papillary muscle. A pinhole 
light was directed on the muscle while it was mounted in 
the muscle chamber. As the light which was attached to a 
rack and pinion device was moved along the length of the 
muscle, a connected Brush transducer and an isolation trans-
former converted the signal to a voltage which the potentio-
metric recorder was able to record. 
The cross-sectional area of the muscle was determined 
from the muscle volume and the muscle length. The muscle 
volume was estimated with a 10-ml picnometer. The weight of 
the muscle in air was subtracted from the weight of the 
muscle and distilled water in the picnometer. This difference 
was then subtracted from the weight of the picnometer filled 
with distilled water to give an estimate of the muscle 
volume. The cross-sectional area was calculated as the 
3 quotient of muscle volume (mm) and muscle length (mm). 
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The resting tension was calculated as the quotient of 
the preload producing L (g) and the cross-sectional area max 
2 (mm ) • 
The active tension of the muscle in each of the three 
baths was calculated as the quotient of the P
0 
(g) and the 
cross-sectional area (mm2 ). The active tension: resting 
tension ratio was determined for each of the muscles in the 
Krebs-Henseleit bath. 
Equations used in the computerized mathematical derivation of 
the preload and af terload curves 
The preload data were fit to the following two equations 
by the method of least squares. 
ascending limb 
descending limb 
Y = a 1 + b1 ln x 
b 2x ~ = a2.t.. 
"a" and "b" are estimators of the intercepts and the slopes 
obtained by the method of least squares; ~is an irrational 
number approximately equal to 2.71828. The data points 
(load, amplitude of contraction) were entered into the Wang 
computer up to and including the experimental ymax to obtain 
the least squares solution for the ascending limb. To obtain 
the least squares solution for the descending limb, the 
experimental ymax was first reentered into the computer 
followed by the rest of the data points. If the experimental 
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ymax appeared to be between two points, then both points 
were used in both the ascending and descending curve calcu-
lation. The preload producing Lmax was the intersection of 
the two least squares solutions. 
The afterload (force-velocity) and latency data were 
each fit to both a polynomial equation and an exponential 
equation by the method of least squares. 
There are m data points of the form (X1 ,Y1
J, CX2 ,Y2J, ..• 
(X ,Y ); m > n+l. The b's are estimators (obtained by the m m 
method of least squares) of the measurements of the model. 
bx ~ =. a.e. 
"a" and "b" are estimators of the intercept and the slope 
obtained by the method of least squares; -e. ~ 2.71828. The 
resultant equations were solved for Y values at chosen x 
points. 
Statistical Analysis 
The first six processed plasma peak D age experiments 
and the three whole plasma age experiments (Table 1) were 
subjected to a 3-way analysis of variance where the third 
factor is nested within the first treatment. The· two shock 
experiments were analyzed separately using a t-test. Five 
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parameters were s.tudied: the slope of the latency c.urve, 
P V Vmax per unit of·cross-sectional area, and active o' max' 
tension. 
The papillary muscle is the primary_ experimental unit 
and, is assigned to a main treatment (method l.or 2). Six 
· ·muscles were sul;>jected to plasma that was prepared according · 
'to method 1. Three muscles were subjected to plasma that 
was prepared according to method 2. Each muscle is a biock 
for t.he subtreatment, age. Each muscle nested within a 
ma~n·treatment received three age treatments. Since each 
muscle served as its own control, muscle to muscle differ-
enoE!s .were removed. Two randomizations were made: the 
assig.nment of muscles to a main treatment, and the assign-
ment of the subtreatment (K-H, plasma from young and old' 
. dogs) ·to the muscle. 
Statistic.al objectives 
1.: To determine if there are main treatment (method) 
effects. 
2. To determiµe if there are subtreatment ·(age) effects. 
3. To determine if ·the age effect, .if present, ~s the. , 
same. for methods 1 !ind 2 ··(age by method interaction) . 
. 4, To study a comparison' of the means: 
To ·determine if· age treatment #2 (youn'g) is ,dif-
ferent from age treatment #3 (old) • 
Tc;> determine if age treatment ill (K-H) is dif-· 
ferent from the mean of age treatments #2 and 
#3 (young and old). 
, .... 
Muscle 
l 
Method 2 
l 3 
4 
s 
6 
Method l 
2 2 
3 
K-H 
#1 
#2 
#3 
#4 
#S 
#6 
#7 
#8 
#9 
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Age 
y 0 
. DYl DOl 
DY2 D02 
DY3 D03 
DY3 D04 
DY4 DOS 
DYS D06 
Plasma YS Plasma 
Plasma Y4 Plasma 
Plasma YS Plasma 
Method l = processed plasma peak D 
Method 2 = unprocessed whole plasma 
03 
02 
OS 
Age = three muscle baths: Krebs-Henseleit (K-H) buffer, 
plasma from young dog, plasma from .old dog 
Source1 
Methods 
Muscles (Methods) 
Age 
Methods x.Age 
Muscles (Methods) x Age 
m-1 
m1 (u-1) m2 Cu·ll 
a-1 
(m-1) (a-1) 
m1 (u-1) (a-1) m (u-1) (a-1) 
2 
d.f. 
l 
~>error (a) , 
2 
2 
1~>error (bl 
TOTAL 26 
1m = Methods, 
u = Muscles, 
a = Age. 
Figure 4. Diagr~m of statistical design 
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If an age effect is present, a comparison of the 
means will determine where the difference lies. 
5. To analyze. individual muscle experiments with the 
pooled variance from the analysis of variance for 
differences between young and old (shock). 
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RESULTS 
Column elution patterns of plasma from all dogs (shock, 
young, old) are first presented, followed by a composite 
elution pattern of molecular weight markers used to calibrate 
the columns. Using peak D from the chromatogram of each 
dog, and whole plasma from five of these dogs, force-velocity' 
and load-latency curves were generated for papillary muscle. 
Various composites of the force-velocity curves for 
Krebs-Henseleit buffer, processed plasma peak D from young 
dogs, processed plasma peak D from old dogs, whole plasma 
from young dogs and whole plasma from old dogs, where 
papiJ,.lary muscles were normalized with respect to force and 
velocity per unit df cross-sectional area, are presented'. 
Tables with ninhydrin tests, estimated molecular weights 
for the six peaks of Bio-Gel ,P-2 chromatograms, characteristics 
of the individual papillary muscles, and numerical responses 
elicited by each of tl;l.e test peaks or plasmas are included 
within the section. A concluding, detailed statistical 
an~lysis is also presented. 
Figure 5. Bio-Gel P-2 column elution pattern of processed 
shock plasma ultrafiltrate obtained from a young 
male mongrel dog with experimental pancreatic 
vessel ischemia 
The peaks are designated A through F in order of 
decreasing molecular weight. Peak D was bio-
assayed and contained significant MDF activity. 
The column flow rate was 10.4 ml/hr (5.2-ml 
fractions). Fractions 1 through 10 had optical 
density readings less than 0.02. 
Peaks Elution volume Location of peak height 
(ml) (ml) 
A 62.0-82.8 67.2 
B 88.0-98.4 93.2 
c 103.6-119.2 108.8 
D 124.4-140.0 129.6 
E 171.2-192.0 176.4 
F 192.0-212.8 197.2 
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Figure 6. Bio-Gel P-2 column elution pattern of processed 
shock plasma ultrafiltrate obtained from a young 
male mongrel dog with experimental pancreatic 
vessel ischemia 
The peaks are designated A through F in order of 
decreasing molecular weight. Peaks A and D were 
bioassayed to differentiate between the two 
large peaks and to confirm the presence of MDF 
in peak D. The column flow rate was 7.6 ml/hr 
(3.8-ml fractions). Fractions 1 through 14 had 
optical density readings less than 0.018. 
Peaks Elution volume Location of peak height 
(ml) (ml) 
A 64.4-83.4 68.2 
B 87.2-102.4 91. 0 
c 106.2-125.2 113.3 
D 129.0-144.2 136.6 
E 163.2-208.8 163.2 
F 216.4-243.0 227.8 
; :. sro 
... 
·~: ~t:;:~~ ;:b:!:~i-:;; ~~~i!i;;; :~\tli{ ~t~~;:'.. ;:!: .. :> ::~~::_~§ ;~~ :~;t~~~! ~~:~ i~~~ ::~:.;:~! :::~:~::'. ::~~~~=J.~1 ~ji~ ~;; ~! ;~~~:;~:~ ~~T~-:;;~::~i .~;; ~m ;f:~~~~~i :; i:m~~ii~;~~ i~ll~:;; .,~ 
.... 
... 
.•. ... ::!: ;: ;:;;: :~~;;;-# :~1;::: ."''''"'""'~""'=""'""''-' 
!0~:"1~~ h:::,,~ii"'~:~l+~'4,,;f."=';+;~EPls'4'-+•i~==~"="-' : f. 
l~) e~~-t < 1 .... t •• w 
. "D_'"'~'\''sI lits,~A -,_1 ... 11u,v»c1 
(s) g•q lf""IS 
"" 
~ 
;~: ~· -:-:.-~ -F · 1 :: ~I· '~i .. :·. '+. ;. ~~~._:Cf ·: ~~-: ~.: . 
I,~:, '.~ ::~}rt r It! ;r11 ~ 
1 
:,i -, , :··' --·' -r~ ~r~· ~~
1
-r ~! ·:: ;F.t·: ~L F · i ~· .. :: 
F:I' ~~~~iJ~T· ir~ :J+J~: 2tt\~
1
·t;t. ~_'..T .,, 
, , .... , ··!· ·::-1····,,·····l·•·hJ·····:·,I·: ··i-·1·, ~ .. ,-
--··. ··~--1-. ..: ..... l,...J.--..... ~·· ... -·-.... :... _ _j __ ._, ··-.. ; ...... -.. 1.-... 
Figure 7. Bio-Gel P-2 column elution pattern of processed 
plasma ultrafiltrate obtained from a young male 
mongrel dog (Yl} 
The peaks are designated A through F in order of 
decreasing molecular weight. The column flow 
rate was 10.4 ml/hr (5.2-ml fractions}. Frac-
tions 1 through 10 had optical density readings 
less than zero. 
Peaks Elution volume 
(ml) 
A 64.4-95.6 
B 116.4-126.8 
c 126.8-147.6 
D 147.6-168.4 
E 178.8-210.0 
F 225.6-236 . 0 
Location of peak height 
(ml} 
74.8 
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137.2 
152.8 
194.4 
230.8 
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Figure 8. Bio-Gel P-2 column elution pattern of processed 
plasma ultrafiltrate obtained from a young male 
mongrel dog (Y2) 
The peaks are designated A through F in order of 
·decreasing molecular weight. The column flow 
rate was 10.8 ml / hr (5 . 4-ml fractions). Fractions 
1 through 10 had optical density readings of 
0.04. 
Peaks Elution volume 
(ml) 
A 63.3-90.3 
B 106.5-122.7 
c 122 . 7-138.9 
D 138.9-155 . 1 
E 165.9-198.3 
F 214.5-263.1 
Location of peak height 
(ml) 
68.7 
117.3 
133.5 
144.3 
165.9 
246.9 
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Figure 9. Bio-Gel P-2 column elution pattern of processed 
plasma ultrafiltrate obtained from a young male 
shepherd (Y3) 
The peaks are designated A through F in order of 
decreasing molecular weight. The column flow 
rate was 10.8 ml / hr (5.4-ml fractions). 
Fractions 1 through 10 had optical density 
readings less than zero. 
Peaks Elution volume 
(ml) 
A 62.0-83.6 
B 94.4-116.0 
c 121.4-132.2 
D 137.6-148.4 
E 153.8-186.2 
F 202.4-240.2 
Location of peak height 
(ml) 
67.4 
105.2 
126.8 
143.0 
159.2 
213.2 
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Figure 10. Bio-Gel P-2 column elution pattern of processed 
plasma ultrafiltrate obtained from a young male 
shepherd (Y3) 
The peaks are designated A through F in order 
of decreasing molecular weight. The column flow 
rate was 10.8 ·ml/hr (5.4-ml fractions). Fractions 
1 through 10 had optical density readings less 
than or equal to 0.01. 
Peaks Elution volume 
(ml) 
A 60.9-82.5 
B 98.7-114.9 
c 114.9-131.1 
D 131.1-141.9 
E 152.7-185.1 
F 195.9-228.3 
Location of peak height 
(ml) 
66.3 
109.5 
120.3 
136.5 
158.1 
222.9 
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Figure 11. Bio-Gel P-2 column elution pattern of processed 
plasma ultrafiltrate obtained from a young 
female shepherd (Y4) 
The peaks are designated A through F in order 
of decreasing molecular weight. The column flow 
rate was 11.2 ·ml/hr (5 . 6-ml fractions). Fraction s 
1 through 10 had opt ical density readings of 
0.039. 
Peaks Elution volume 
(ml) 
A 59.6-93.2 
B 104.4-121.2 
c 126.8-138.0 
D 138.0-154.8 
E 160.4-194.0 
F 205.2-255.6 
Location of peak height 
(ml) 
70.8 
121. 2 
132 . 4 
149.2 
188.4 
222.0 
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Figure 12. Bio-Gel P-2 column elution pattern of processed 
plasma ultrafiltrate obtained from a young male 
mongrel dog (Y5) 
The peaks are designated A through F in order 
of decreasing molecular weight. The column flow 
rate was 9.2 ml/hr (4.6-ml fractions). Fractions 
1 through 14 had optical density readings of 
0.039. 
Peaks Elution volume 
(ml) 
A 67.9-95.5 
B 100.1-118.5 
c 123.1-141.5 
D 141. 5-155. 3 
E 159.9-173.7 
F 178.3-238.1 
Location of peak height 
(ml) 
77.1 
100.1 
136.9 
150.7 
164.5 
178.3 
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Figure 13. Bio-Gel P-2 column elution pattern of processed 
plasma ultrafiltrate obtained from a young fe-
male mongrel dog (Y6) 
The peaks are designated A through F in order 
of decreasing molecular weight. The column 
flow rate was 10.8 ml/hr (5.4-ml fractions). 
Fractions 1 through 8 had optical density 
readings of 0.005. 
Peaks Elution volume 
(ml) 
A 55.4-82.4 
B 104.0-114.8 
c 114. 8-131. 0 
D 131.0-141.8 
E 147.2-168.8 
F 168.8-201.2 
Location of peak height 
(ml) 
66.2 
109.4 
125.6 
136.4 
158.0 
174.0 
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Figure 14. Bio-Gel P-2 column elution pattern of processed 
plasma ultrafiltrate obtained from an aged 
female dachshund (15 years) (01) 
The peaks are designated A through F in order 
of decreasing molecular weight. The column 
flow rate was 11.2 ml/hr (5.6-ml fractions). 
Fractions 1 through 10 had optical density 
readings of zero . 
Peaks Elution volume 
(ml) 
A 65.2-87.6 
B 104.4-121.2 
c 126.8-143.6 
D 143.6-160.4 
E 166.0-194.0 
F 216.4-255.6 
Location of peak height 
(ml) 
70.8 
110.0 
138.0 
149.2 
177.2 
250.0 
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Figure 15. Bio-Gel P-2 column elution pattern of processed 
plasma ultrafiltrate obtained from an aged 
male beagle (13.5 years) (02) 
The peaks are designated A through F in order of 
decreasing molecular weight. The column flow 
rate was 11.2 ml/hr (5.6-ml fractions). Frac-
tions 1 through 9 had optical density readings 
less than or equal to 0.02. 
Peaks Elution volume 
(ml) 
A 64.7-87.1 
B 98.3-120.7 
c 126.3-137.5 
D 143.1-154.3 
E 165.5-199.1 
F 210.3-249.5 
Location of peak height 
(ml) 
70.3 
109.5 
131.9 
148.7 
171.1 
221.5 
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Figure 16. Bio-Gel P-2 column elution pattern of processed 
plasma ultrafiltrate obtained from an aged male 
Weimaraner (14 years) (03) 
The peaks are designated A through F in order of 
decreasing molecular weight. The column flow 
rate was 11 ml /hr ( 5. 5-ml fractions) . Fractions 
1 through 10 had optical density readings less 
than or equal to 0.02. 
Peaks Elution volume 
(ml) 
A 64.4-86.4 
B 91. 9-113. 9 
c 119.4-135.9 
D 135.9-152.4 
E 157.9-185.4 
F 196.4-267.9 
Location of peak height 
(ml) 
69.9 
91. 9 
130.4 
141.4 
163.4 
245.9 
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Figure 17. Bio-Gel P-2 column elution pattern of processed 
plasma ultrafiltrate obtained from an aged male 
collie (16 years) (04) 
The peaks are designated A through F in order of 
decreasing molecular weight. The column flow 
rate was 9.2 ·ml/ hr (4.6-ml fractions). Fractions 
1 through 13 had optical density readings of zero. 
Peaks Elution volume 
(ml) 
A 73.1-96.1 
B 100.7-114.5 
c 119.1-142.1 
D 142.1-160.5 
E 160.5-174.3 
F 188.1-215.7 
Location of peak height 
(ml) 
77.7 
100.7 
132.9 
155.9 
165.l 
192.7 
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Figure 18. Bio-Gel P-2 colwnn elution pattern of processed plasma ultrafiltrate 
obtained from an aged female beagle (17 y ears) (OS) 
The peaks are designated A through F in order of decreasing molecular 
weight. The colwnn flow rate was 11.4 ml/hr (5.7-ml fractions). 
Fractions 1 through 10 had optical density readings less than or equal 
to 0.03. 
Peaks Elution volume 
(ml) 
A 60.2-83.0 
B 105.8-122.9 
c 128.6-140.0 
D 140.0-157.1 
E 162.8-197.0 
F 208 . 4-265.4 
Location of peak height 
(ml) 
65.9 
117.2 
134.3 
145.7 
168.5 
219.8 
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Figure 19. Bio-Gel P-2 column elution pattern of processed 
plasma ultrafiltrate obtained from an aged 
female dachshund (15 years) (06) 
The peaks are designated A through F in o rder 
of decreasing molecular weight. The column 
flow rate was 11.2 ·ml/hr (5.6-ml fractions). 
Fractions 1 through 10 had optical density 
readings less than or equal to 0.039. 
Peaks Elution volume 
(ml) 
A 65.0-93.0 
B 98.6-115.4 
c 121.0-137.8 
D 137.8-154.6 
E 160.2-199.4 
F 216.2-255.4 
Location of peak height 
(ml) 
70.6 
104.2 
132.2 
149.0 
171.4 
221. 8 
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Fraction number - Elution volume (ml) 
Average void volume was.51 ml • 
. Figure 20... Bio-:Gel P-2 column elution pattern of dextran 
blue (molecular weight 2,000,000) 
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Figure 21. Composite Bio-Gel P-2 column elution pattern of molecular weight markers 
El E3 EB 
' . ' 
Angiotensin II (1225 daltons) 11 . 2 ml/ hr flow rate 
99.8-122 . 2 ml l ocation of peak heigh t 111 ml 
Angiotensin II (1225 daltons) 9.2 ml / hr flow rate 
108 . 2-135.8 ml location of peak height 122 ml 
Angiot ens i n II (1225 daltons) 9 . 2 ml / hr flow rate 
110 . 2-137.8 ml l ocation of peak height 124 ml 
Angiotensin II (1106 . 3 daltons) 10.6 ml/ hr flow rate 
100.9-127.4 ml location of peak height 111.5 ml 
Angiotensin III Inhibitor (896 daltons) 11.2 ml / hr flow rate 
92.0-117 . 8 ml location of peak height 101 ml 
MDF- peak D shock (?) 10 . 4 ml/ hr flow rate 
122- 140 ml location of peak height 129.6 ml 
MDF-peak D shock (?) 7 . 6 ml/ hr flow rate 
129.0- 144 . 2 ml locati on of peak height 136 . 6 ml 
Hexaglycine (360 . 3 daltons) 10 . 8 ml / hr flow r ate (50 mg) 
1 55.4- 214. 8 ml locati on of peak height 177 ml 
Hexaglycine (360.3 daltons) 9 . 2 ml/ hr flow rate (30 mg) 
168.9-187 . 3 ml location of peak height 173.5 ml 
The aver age elution vol umes o f peak D from young dogs and old 
dogs were 138 . 0-152.2 ml and 140 . 4-156 . 6 ml , respectively . 
Elution •olUllll (Ill) 
:·1 ~ :: !:· ~J.;·· ··:.1 ~·: l :-=.: .·. ··: ·.· ~~ ~r."~·=:*'°*'''~' 
I 
hak 0 - J'GWlg 
a s 
I 
Peak D - o1d 
Ar.giotensin II (1225) 
Angiotensin II (1~25) 
Angiotensin II 
Angiotensin II 
(1225) 
(1106.J) 
,; 
u.~ ml/hr !low rate 
9•2 ml/hr rlow ;ate 
9.2 ml/hr flaw riite 
10.6 ml/hr flow rate 
Angiotensin III Inhibitor (890) 11.2 i:U/hr flow rato 
MD_F - peat D 'shock (?) 10.4 ml/hr flow raw 
MDF ; ~ak D shock (?) 7.6 mi/hr tlow n.te 
Hexaglycine ()60.)) lo.a· mi/hr now rate 
(J60.J) 9.2 ml/hr now rat• 
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::::: .1 
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Table 2. Ninhydrin test and average elution volumes of the 
six peaks of Bio-Gel P-2 chromatograms with an 
estimate of molecular weighta 
Ninhydrin Average Elution 
Estimated 
Molecular 
Test Volume (ml) Wei ht 
Peak A - young (n=7) + 061.93-089.01 >1225 
old (n=6) + 065.43-088.87 
Peak B - young (n=7) + 103.50-119.27 "'1100 old (n=6) + 099.95-118.10 
Peak c - young (n=7) + 121.50-137.19 700-850 old (n=6) + 123.53-139.48 
Peak D - shock (n=2) + 126.70-142.10 700-850 
young (n=7) + 137.96-152.24 600-700 old (n=6) + 140.42-156.55 
Peak E.- young (n=7) + 159.81-188.01 "'360 old (n=6) + 162.15-191.53 
Peak F - young (n=7) + 198.67-237.50 <350 old (n=6) + 205.97-251.58 
aNote that the column separation of plasma from young 
and old dogs is virtually identical, and. that the elution 
volume for MDF (found in peak D of shock plasma) is similar 
to the elution volume for peak C of plasma from young and 
old dogs. 
' • I 
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Length (amplitude) is plotted agaii::J.st tension .(load) 
Note that the experimental Lmax is at a· preload · 
of 0. 8 g. The L . computed from the ascending max · ·. 
and descending limbs of the preload curve was 
at a pre1oad o·f o. 761 g. 
Figure 22. Typical preload curve 
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Table 3. Cross-s~ctional area, muscle length, Lmax preload, 
resting tension, and active tension to resting 
tension ratio values for papillary muscles in 
the shock and age experiments.a 
Shock experiments 
Cross~sectional 
area 
(mm2) 
l. l. 263 
2. 0~571 
Age experiments 
l. 3.289 
2. 5.206 
3. 3.077 
4. 0.437 
5. o. 347 
6. o. 969 
7. 2.063 
8. 1.048 
9. o. 955 
X (n=ll): 
1.748 
Muscle 
length 
(irun) 
2.93 
4.73 
2.25 
1.94 
3.64 
4. 35 
4.61 
3.20 
2.71 
2.10 
3.77 
3.29 
Lmax 
pre load 
(g) 
0.620 
0.675 
0.761 
1.076 
1.383 
1.006 
0.582 
0.773 
0.485 
0.818 
l. 001 
0.835 
Resting. 
tension 
(g/mm2) 
0.491 
l.181 
0.231 
0.207 
0.449 
2.302 
1.677 
0.798 
0.235 
0.781 
1.048 
0.855 
Active tension: 
resting tension 
ratio 
7.90 
2.15 
2.15 
1.15 
2.90 
4.79 
7.11 
6.74 
4.78 
3.26 
7.39 
4.51 
aNote that the papillary muscle subjected to DY6 and 
D02 treatments (Table l) was omitted. 
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Table 4. Latency (slope), P
0
, vmax' Vmax per unit of cross-
sectional area, and active tension values for·all 
·muscle experimentsa 
Shock 
l. KH 
DYl 
DS 
2. KH 
AS 
DS 
L KH 
DYl 
DOl 
2. KH 
DY2 
D02 
3. KH 
DY3 
D03 
4. KH 
DY3 
D04 
5. KH 
·oy4 
DOS 
Latency 
slope 
(msec/g) 
062.398 
045.905 
094.039 
228.192 
157.963 
218.570 
#1 214.600 
126.200 
088.510 
#2 403.460 
306 .115 
327.090 
#3 337.445 
347.255 
294.915 
#4 095.071 
091. 521 
104.109 
#5 .. 051. 084 
0.45. 984 
068.~63 
4.902 
5.274 
3.247 
1.448 
l. 51.0 
1.055 
l. 634 
1.903 
l. 903 
1.241 
1.282 
l. 324 
4.012 
4.095 
4.137 
4.819 
4. 984 . 
4.716 
·4 .137 
4. 054 . 
3.557 
V vmax/cross-
( ma1
x ) sectional area 
mm sec . · . _1 
6.647 
6. 3.69 
4.590 
2.792 
2.818 
2.861 
5.057 
5.852 
7.156 
2.060 
2.344 
3.036 
2.583 
2.824 
2.572 
6.028 
5.399 
5.602 
8.467 
7.123 
6.415 
(mm· sec) 
01. 554 
01.781 
02.177 
00.396 
00.451 
00.581 
00.839 
00 •. 917 
00.835 
13.823 
12.393 
12.826 
24.401 
20:539 
.18 •. 353 
Active 
tension· 
• 2 
(g/mm ) 
03.881 
04.176 
02.571 
02.534 
02.643 
01.84.6 
00.497 
00.579 
00.579 
00.238 
00.246 
00.254 
01,304 
Ol.'331. · 
01.3"44 
11.027 
11.405 
10;792 
11.922 
. 11. 6.83 
10. 25.l 
aThe linear portion of· the load-latency curve (2nd, 3rd, 
or 4th o.rder polynomial.) was fit by linear regression to a 
stra:i,.ght line from which the slope was calculated. Po val\leS 
are·experimental. Vmax/c::ross-sectional area values were. 
extrapolated from force-velocity curves where velocity per 
unit. of cross-sectiqnal area was plotted against P/P0 • • . 
Explanation of symbols (DYl, DOl, AS, DS, Plasma YS, etc.) :is .. 
found. in Table 1. 
I 
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Table 4 (Continued) 
Latency P Vmax Vmax/cross- Active 
slope ( ) · (mm/sec): sectional area tension (msec/g) g (mm·sec)-1 (g/mm2) 
Age 6. KH Jl6 048.591 5.212 6.482 06.687 05.379 
DYS 060.461 4.633 5.959 06.147 04.781 
DOG 094.554 3.909 6.248 06.445 04.034 
KH 251.116 1. 324 2.966 00.197 
DY6 420.799 0.724 2.114 00.108 
D02 364.943 0.786 2.106 00.117 
7. KH JI 7 121.166 2.316 3.221 01.559 01.123 
Plasma YS 154.814 1.923 2.763 01.343 00.932 
Plasma 03 259.384 1.324 1.166 00.565 00.642 
8. KH JIB 136.175 2.668 1. 924 01.836 02 .. 546 
Plasma Y4 153.740 2.627 1.752 01.672 02.507 
Plasma 02 130.970 2.523 1.725 01.646 02.407 
9. KH Jl9 047.759 7.394 6.853 07.171 07.742 
Plasma YS 155 .• 6 70 5.440 6.144. 06.433 05.696 
Plasma 05 130.425 5 • .584 5.900 06.181 05.847 
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Load ve Veloclty 
- KH : Kreb• - Heneal&lt aolutlon 
--·OY1 : Peak D YoW!g dog •1 
- OS : Peak D Shock dog 
O.li 
·KH: 
DYl: 
DS: 
Effective load 1111 
Krebs-Henseleit solution 
Peak D, Young dog #1, mongrel (M) 
Peak D, Shock dog, mongrel (M) 
Fourth power equation curve. 
Significant MDF activity was present in peak D of 
shock plasma indicated by the depressed P0 and 
Vmax values. P
0
, Vmax' and active tension were 
significantly different . (Cl = O. 0025, 0. 05, . 0. 025, 
respectively) for papillary muscle subjected to· 
peak b of shock plasma a.rid peak D of plasma from 
a young dog. 
Figure 23. Force-velocity curve 
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Load vs Velocity 
0.5 
-- KH : Krebs - Heriseleit 
solution 
--- AS : Peak A 1 
·Shock dog 
········· DS : Peak D j 
1.0 1.5 2.0 
Effective load ( g) 
-. _ KH: Krebs-Henseleit solution 
--- AS: 
··--·-· DS: 
:::~ ~ } Shock dog, mongrel (M) 
Second power equation curve. 
MDF activity was present in peak D of shock 
plasma indicated by the depressed P0 value. 
Peak A of shock plasma caused the initial 
increase in P0 beyond the K-H P0 value. 
Figure 24. Force-velocity curve 
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Figure 25. Force-velocity curve 
KH: 
DYl: 
001: 
Krebs-Henseleit solution 
Peak D, Young dog #1, mongrel 
Peak D, Old dog #1, dachshund 
15 years 
Third power equation curve. 
(M) 
(F) ' 
Note that the P value of the muscle was the same 
for peak D of p~asma from both the young and old 
dog. The V value of the muscle when sub-max 
jected to peak D of plasma from the old dog was 
greater than the value when the muscle was 
subjected to peak D of plasma from the young dog 
or K-H . The difference between peak D of plasma 
from the young dog and peak D of plasma from the 
old dog was not significant. 
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Load vs Velocity 
8 
7 i 
"'-"-- KH : Krebs - Henseleit .solution 
--- DY1 : Peak D Young dog #1 
········· 001 : Peak D Old dog #1 ., 
6 \ 
\ .\ 
\\ 
\ i 5 ,, 
\\ 
\\ 
\i 
"i. 
\ 
··~ 
...... 3 ·· .. ', 
··~:--.... . .. ' 
·--.... " 
~· .... 
"'-" '· 
2 
1 . '··. '~·. 
'\ 
0.4 1.6 
Effective load (g) 
2.0 
...... 
0 
Q) 
ui ...... 
E 
E 
0 
0 
4 
3 
2 
.145 
Load vs Velocity 
__:_ KH : Krebs-- Henseleit solution· 
--~DY 2 : Peak D Young dog #2 
. ········· DO 2 : Peak D Old dog #2 
~ 1 
KH: 
--- .DY2 i 
D02: 
O+--.----...-...... ~~~ .............. ~ 
0 0.4 0.8 1.2 1.6 
Effective load (g) 
Krebs-Henseleit solution 
Peak D, Young dog #2, mongrel (M) 
Pea.k D, Old dog #2, beagle. (M), 13.5 
Second power.equation curve. 
yea.rs 
Note that there was.an improvement in muscle P4:!r-
formance wi.th peak D from the old dog. The dif-
ferenc::e between peak, D of plasma . from the .Young.· 
dog and peak D of plasma from the old dog was . 
not.significant. 
Figure 26. Force-velocity curve 
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Load vs Velocfty 
--~ - KH : Krebs ~ Henselelt solutlon .......... ·--DY 3 : Peale- D Young dog 13 -... 
KH: 
DY3: 
003: 
-,_ -- 003: Peak D Old dog 13 ----... .. -
Krebs-'Henseleit solution 
Peak D, Young dog #3, shepherd 
Peak D, Old dog #3, Weimaraner 
Second power equation curve. 
(M) 
(M) , 14 years 
Note that all thr.ee curves are very similar. The P0 value of the 
muscle subjected to peak D of plasma from the old dog was greatest, and 
the Vmax value of the muscle subjected to peak D of plasma from the old 
dog was identical to the V value of the muscle subjected to K-H. The max 
difference between peak D of plasma from the young dog and peak D of 
plasma from the old dog was not significant. 
Figure 27. Force-velocity curve 
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Load ve Velocity 
\\, 
'-' \' 
'' \' 
\ ' 
- KH : Krebs - Henselelt solution 
--· DY 3 : Peak D Young dog 13 
......... 004 :Peak. D Old dog 14 
\," . .... ,_ ' ............ .............. 
. ...... ' ........ ...... ..._ 
........ 4"9-
............... ::.:.::.::-.:---
········::"·1:-·····I::-
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Ellectlve load (g) 
KH: 
DY3: 
D04: 
Krebs-Henseleit solution 
Peak D, Young dog #.3, . shepherd (Ml 
Peak D, Old dog #4, collie (M), 16 
Fourth power equation curve. 
years 
Note that the P0 value of the muscle subjected to 
peak D of plasma from the old dog was close to 
the value for K-H, and that the Vmax value of the 
muscle subjected to peak D of plasma from the old 
dog was actually higher than the value when the 
muscle was subjected to peak D of plasma from the 
young dog. The difference between peak D of 
plasma from the young dog and peak D of plasma 
from the old dog was not significant. 
Figure 28. Force-velocity curve 
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Load va Valoclly 
8 
148 
- _KH : Kreb• .:. .HenMlell aolutlOR 
a --:·DY4:PeakDYoungdogt4 
-Dos.: Pe•k.D Old dog•& 
e 
3 
2 
.. 00±'--~"."""'~-r-~...-.--,.-.--.-.,.-.,....,-o"-.......-.+.-~~o.... ~ ~· u ~- ~ u u u u ~ « 
Efleotlva load (g) . 
. . 
___ . KH: Krebs-Heiiseleit solution . 
___ DY4: Peak o, .Young dog 114, shepherd (F) 
~-----··-- DOS : Peak. D, Old dog' il.5, beagle (F) , 1 7 years 
I · Fourth power equ(ition curve; Although there. was · 
a decrease .. in P and V x. values of "the muscle. . o . ma 
when subjected to peak D of plasma from the old 
dog, the difference between peak D of plasma 
from the .young dog and peak D of plasma from the· 
old dog was not signific(int. 
Figu're 29. Force...,velocity curve 
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Load vs Velocity 
\ ., 
- KH : Krebs - Henselelt solution 
·--DY5 : Peak D Young dog 15 
......... 006 : Peak D Old dog 16 
\~ 
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0.f-..-..-.,...,--.--.--.--.--.--.--.--.--.-........ -.--.--.--.--.--.-,,,_-.--.--."'-r--.--?--.-~· 
0 . 0.4 '0.8 
KH: 
DYS: 
DOG: 
1.2 1.6 2.0 2.4 2.8 3.2 3.8 4.0 
Effective load (g) 
Krebs-Henseleit solution 
Peak D, Young dog #5, mongrel 
Peak D, Old dog #6, dachshund 
Third power equation curve. 
4.4 4.8 5.2 5.6 
(M) 
(F), 15 years 
Although there was a decrease in the P0 value, 
the difference between peak D of plasma from the 
young dog and peak D of plasma from the old dog 
was not significant. Note that the velocity of 
the muscle subjected to peak D of plasma from 
the old dog approaches and exceeds the velocity 
of the muscle when subjected to peak D of plasma 
from the young dog. 
Figure 30. Force-velocity curve 
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Load vs Velocity· 
0 
---- KH: Krebs - Henseleit solution 
;..._.·ova: Peak D Young dog 16 
········· 002 : Peak D Old dog 12 
0.4. 0.8 1.2 .1.6 
Effective load (g) . 
.......__ KH: · Krebs.;.Henseleit solution 
.-'-"-- DY6 :. Peak D, Young. dog 116, mongrel (F) 
............ 002: · Peak D, Old dog 112, beagle (M) , · 13. 5 years 
. . ,, ' ' 
Linear equation curve. 
Note. that the curves for peak D of· plasma from 
the young· dog and peak D of plasma from the·old 
dog are virtually identical. The P
0 
vci.lue W<i,S 
only, slightly larger when the muscle was sub-" 
j'ected to peak .D of plasma from the old dog. 
Because of the unexpected large depression in · 
muscle performance after the buffer·was replaced 
. with peak D from young .dog 116, this muscle was 
omitted.and D02 was. repeated (Figure 26). 
Figure 31. ·Force-ve.locity curve 
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Load vs Velocity 
-· KH : Krebs - Henseleit solution 
---Plasma Y5: Plasma Young dog#5 
......... Plasma 03 : Plasma Old dog #3 
' ..... ' 
" 
0.4 0.8 1.2 1.6 2.0 2.4 
Effective load (g). 
___ KH: Krebs-Henseleit solution 
___ Plasma Y5: Plasma, Young dog 115, mongrel (M) 
~ ......... Plasma03: Plasma, Old dog ·113, Weimaraner (M), 
14 years 
Fourth power equation curve: KH, Plasma Y5. 
Linear equation curve: Plasma o3. 
Although there was a depression in P
0 
and Vm~x 
values of the muscle when subjected to whole 
plasma from the old dog, the difference in P0 
between whole plasma from the young dog and whole 
plasma from the old dog was not significant and 
only approached significance for V . Note that max 
the response elicited by peak D03 was very 
different (Figure 27). 
Figure 32. Force-velocity curve 
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Figure 33. Force-velocity curve 
KH: Krebs-Henseleit solution 
___ Plasma Y4: Plasma, Young dog Jl4, shepherd (F) 
--------·.Plasma 02: Plasma, Old dog Jl2, beagle (M) , 13, 5 years 
Second·power equation curve. 
Note that the three curves are very similar. There was no sig-
nificant difference between whole plasma from the young dog and 
whole plasma from the old dog. Note that there was a slight 
improvement in inuscle performance when peak D02 was used (Figures 
26, 3l)·instead of whole plasma. 
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Figure 34. Force-velocity curve 
KH: Krebs-Henseleit solution 
Plasma YS: Plasma, Young dog #5, mongrel (M) 
Plasma 05: Plasma, Old dog #5, beagle (F), 17 years 
Third power equation curve. 
Note that the P0 value of the muscle when subjected to whole plasma 
from the old dog was slightly greater than the value when whole plasma 
from the young dog was used. The difference between whole plasma from 
the young dog and whole plasma from the old dog was not significant. 
The curves for peak D from a young dog and peak DOS (Figure 29) are 
similar to the curves for whole plasma except that there was a decrease 
in P0 when peak D from the old dog was used. 
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Figure 35. Composite of Krebs-Henseleit force-velocity curves where velocity 
is plotted against P/P
0 
KH il -& -13 -19- KH #6 
• .. • KH #2 _._ S _. KH #7 
8 IB l!I KH #3 
____ ....,_.. KH #8 
- -- - KH #4 _ -f- f-+ KH #9 ..... + ..,_ KH ts 
The number following KH indicates the buffer that preceded a certain 
peak DY (peak D of plasma from a young dog) or plasma Y (whole plasma 
from a young dog) bath and thus refers to a certain muscle experiment 
(Table 4). 
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Figure 36. Composite of processed plasma peak D-young force-velocity curves where 
velocity is plotted against P/P
0 
DYl #1: Peak D, Young dog #1 
t: ' Ai 
DY2 #2: Peak D, Young dog #2 
e 8 8 DY3 #3: Peak D, Young dog #3 - - -- DY3 #4: Peak D, Young dog #3 
""* -+ + 
DY4 #5: Peak D, Young dog #4 
-e- -3 -& DYS #6: Peak D, Young dog #5 
DY3 f 3 and DY3 #4 were preceded by KH #3 and KH #4, respectively 
(Table 4). 

Figure 37 . Composite of processed p l a sma peak 0 - old force-veloc i ty curves 
where velocity is plot ted agains t P/P
0 
001 #1: Peak O, Old dog #1 
• • l 002 #2: Peak O, Old dog #2 8 e 8 003 #3 : Peak O, Old dog #3 - 004 #4: Peak D, Old dog #4 
-6-- -+ ...._ DOS #5 : Peak D, Ol d dog #5 
-er ~ -a- 006 #6: Peak D, Ol d dog #6 
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Figure 38. 
Plasma Y5 #7 arid Plasma Y5 #9 were preceded by 
KH #7 and KH #9, respectively (Table 4). 
Composite of whole plasma-young force-velocity 
curves where velocity is plotted against P/P
0 
Figure 39. Composite of whole plasma-old force-velocity curves where velocity 
is plotted against P/P
0 
Plasma 03 #7: Whole plasma, Old dog #3 
Plasma 02 #8: Whole plasma, Old dog #2 
Plasma 05 #9: Whole plasma, Old dog #5 
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Figure 40. Composite Krebs-Henseleit, peak D-young and peak D-old force-velocity 
curves from age muscle experiments where mean velocity is plotted 
against P/P 
0 
KH n=9: Krebs-Henseleit solution 
_... _,,._-..,._ DY n=6: Peak D of plasma from young dogs 
~ 8 -a- DO n=6: Peak D of plasma from old dogs 
The velocities for the Krebs-Henseleit curve are the means of the 
velocities for the nine K-H curves (Figure 35) from the nine age 
muscle experiments. The velocities for the peak D-young and -old 
curves are the means of the velocities for the six DY and DO 
curves (Figures 36, 37) from the corresponding six age muscle 
experiments. The three points along the x-axis (zero velocity) 
are means of similar points from the composites of K-H, DY, and 
DO. Note that the curves for DY and DO are very similar, and 
that the V value for DO is greater than that for DY or K-H. max 
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KH n=9: Krebs-Henseleit solution 
Plasma Yoi.ing n=3: Whole plasma from young : . 
dogs , 
Plasma old .n=3: whole plasma. from old dogs 
.. 
The velocities 'for.the I<-H curve are the means 
of the velocities for the nine K;.H curves 
(Figure 35) •. The.velocities for plasma-young 
and plasma-old are the means of the velocities 
for the three piasma:..young and plasma-old curVeS 
(Figur,es 38, 39) • The three points, along the ·, 
x-axis (zero velocity) are means of similar 
point's· from the composites of K..;H, plasma-young, 
Figure 41. composite I<rebs:.Henseleit, plasma-young and 
plasma-ol,d force-velocity curves from age muscle 
experiments where mean velocity is plotted 
and plasma-old. · 
against P/P0 
Figure 42 . Composite Krebs-Henseleit , peak D- young and peak D-old force - velocity 
curves from age muscle experiments where the mean of velocity per 
unit of cross- sectional area is plotted against P/ P
0 
KH n=9: Krebs-Henseleit solution 
DY n=6: Peak D of plasma from young dogs 
DO n=6: Peak D of plasma from old dogs 
Note the similarity in the curves for DY and DO. 
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KH n=9: Krebs-Henseleit solution 
Plasma Young n=3: Whole plasma from young dogs 
Plasma Old n=3: Whole plasma from old dogs 
Note the similarity in the curves for whole 
plasma from young dogs and whole plasma from old 
dogs. 
Figure 43 •. Composite Krebs-,Henseleit, plasma-young .and. 
plasma-old force-velocity curves from age muscle 
experiments where the mean of velocity per unit 
of cross-sectional area is plotted against P/P0 
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EHect1'v,. LoaA (5) · 
KH: 
.,-&- -e- -a-
...,. ---A _._ .. ,,__ 
DYl: 
DS: 
Krebs~Henseleit solution 
Peak D, Young dog #1 
Peak ·D, . Shock dog 
Figure 44. 
Third power equation curve. . 
Aithough the slope of the shock curve was 
greater than that of the K-H or young curve, 
it was not significantly different. 
Lo~d~latency curve 
Figure 45. Load-latency curve 
KH: Krebs-Henseleit solution 
AS· Peak A} ~ -&r- -er · Peak 0 Shock dog --& ~ -j- DS: 
Second power equation curve. 
Note that the slope decreased with shock plasma 
peak A and then increased with shock plasma 
peak D. The difference in slope was not 
significant. 
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Figure 46. Load-latency curve 
KH: Krebs-Henseleit solution 
-il- -a- -Q- DYl: Peak D, Young dog #1 
__. ~A ~&~ 001: Peak D, Old dog #1 
Third power equation curve. 
The slope continually decreased as Krebs-Henseleit 
was replaced with peak D of plasma from a young 
dog and then with peak D of plasma from an old 
dog . There was no significant difference between 
peak D of plasma from the young dog and peak D 
of plasma from the old dog. 
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Loo.d vs Lo.+en.c.y 
KH 
DY I 
[>O I 
-G -8-Eil--•-•-A-.. 
0 0.2. OJI O,(, o.s 1.0 /,7. I.~ ,,, 1;g z.o z.t. 
E~-9 Qc:fr've. Loa.cl (9) 
Figure 47 . Load-latency curve 
KH: Krebs-Henseleit solution 
~ -e- -s- DY2: Peak D, Young dog #2 
_.. --A ~A~ D02: Peak D, Old dog #2 
Second power equation curve. 
There was no significant difference between 
peak D of plasma from a young dog and peak D 
of plasma from an old dog . 
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Figure 48. Load-latency curve 
KH: Krebs-Henseleit solution 
-e- --e- -a- DY3: Peak D, Young dog #3 
-+ __... _ It-- D03 : Peak D, Old dog # 3 
Fourth power equation curve. 
The slope of the curve for peak D of plasma 
from an old dog was less than the slopes of the 
K-H curve and the curve for peak D of plasma 
from a young dog, but was not significantly 
different. 
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Loa.~ vs Lo.+e11cy 
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-A- ~ -A-·-. D04: 
Krebs-Henseleit solution 
Peak D, Young dog #3 
Peak D, Old dog #4 
Fourth power equation curve. 
The slope of the K-H curve decreased with peak 
D of plasma from the young dog, and then increased 
and exceeded the slope of the K-H curve with peak 
D of plasma from the old dog. There was no 
significant difference between peak D of plasma 
from the young dog and peak D of plasma from · 
the old dog. 
Figure 49. Load-latency curve 
Figure 50. Load-latency curve 
KH: Krebs-Henseleit solution 
-i!r -a- -a- DY4: Peak D, Young dog #4 
_.,.___.~A~ DOS: Peak D, Old dog #5 
Fourth power equation curve. 
The slope of the K-H curve decreased with peak 
D of plasma from the young dog, and then increased 
and exceeded the K-H curve slope with peak D of 
plasma from the old dog. The difference between 
peak D of plasma from the young dog and peak D 
of plasma from the old dog was not significant. 
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Loo.J vs La.+el\cy ·. 
KH 
-e -s-13'- l>Y 5 
DO/o -.A-A-.A-
Krebs-Henseleit solution 
Peak o, Young dog #5 
Peak D, 01d.dog·#6 
Third power equation curve. 
The slope continually increased as Kre.bs-
Henselei t was replaced with peak D of plasma from 
the young dog and tqen witq peak D ·of plasma 
from the old dog. The difference between peak 
D of plasma from the young dog and peak D of 
plasma from the old dog was not significant: 
Figure 51 •. · Load-latency curve 
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Load VS La.+el\c.y 
KH 
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E-f1e.c:tive. Lo .. A (9) 
-ii- -&- -e-
~ --·- KH: Krebs-Henseleit solution Plasma Y5: Plasma, Young dog #5 Plasma 03: Plasma, Old dog #3 Fourth power equation curve. 
The slope continually increased as Krebs-Henseleit 
was replaced with whole plasma from the young dog 
and then with whole plasma from the old dog. There 
was a significant difference between whole plasma 
from the young dog and whole plasma from the old 
dog (~=0.05). · 
Figure 52. Load-latency curve 
Figure 53. Load-latency curve 
KH: Krebs-Henseleit solution 
-&- ~ -e- Plasma Y4: Plasma, Young dog #4 
__.. __. _ ,..._ Plasma 02: Plasma, Old dog #2 
Fourth power equation curve. 
The slope for whole plasma from the old dog 
was less than the slope for K-H and whole plasma 
from the young dog. There was no significant 
difference between whole plasma from the young 
dog and whole plasma from the old dog. 
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Figure 54. Load-latency curve 
KH: Krebs-Henseleit solution 
-&- s----e -e- Plasma Y5: Plasma, Young dog #5 
_.... '-A--A~ Plasma 05: Plasma, Old dog #5 
Third power equation curve. 
There was no significant difference between whole plasma from the 
young dog and whole plasma from the old dog. 
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Table 5. F-values to test· -for method and age effects and age by method interaction 
Method effects Age effects A9:e by Method Interaction - -
Fl 2 . 2 
7 Pr>F Fl4 Pr>F Fl4 Pr>F 
Latency 0.14 0.723 0.06 0 •. 940 3.63* 0.054 
p 0.01 0.930 3.60* 0.055 2.47 0.120 
0 
v 1.07 0:334 0.61 0.557 1.58 0.240 max 
v~ax/cross-
sectional 
area 0.66 o_. 442 1.93 0.182 0.13 0.881 
I-' 
Active co "' tension 0.24 0.639 3.84** 0.047 1.08 0.367 
* Approaching significance at.10% level (a=0.10). 
** Significance at 5% level (a=0.05). 
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The critical F~ value (cx=0.05) = 5.59. The H
0
: method l = 
method 2 was not rejected at cx=0.05, nor at cx=0.25. There 
were no significant method differences or effects on any 
of the five parameters: latency, P
0
, Vmax' Vmax·per unit of 
cross-sectional area, active tension. 
The critical Fi4 value (cx=0.05) = 3.74. The H0: age 
1 = age 2 =age 3 was not rejected at cx=0.05, nor at cx=0.25, 
and no significant age effects on latency or Vmax were claimed 
to exist. The H
0
: age 1 = age 2 = age 3 was not rejected 
at cx=0.05, nor at cx=0.10; there were no significant age 
differences on Vmax per unit of cross-sectional area. The 
H : age 1 =age 2 =age 3 was not rejected at cx=0.05; 
0 
there were no significant age effects on P
0
• However, the 
H
0
: age 1 = age 2 = age 3 was rejected at cx=0.10, and an 
age effect on P was claimed to approach significance. The 
0 . . 
H
0
: age 1 ·=age 2 =-age 3 was rejected at cx=0.05 and a 
significant age effect on active tension was claimed to be 
present. 
Overal'l, age effects were significant for active tension 
and approached significance for P • The H : age 1 = age 2 = 
0 0 ' 
age 3 was not rejected at cx=0.05, nor at cx=0.10 for latency, 
Vmax' or Vmax per unit of cross-sectional area. 
The H
0
: all B's (slopes) are equal was not rejected 
at cx=0.05, nor at cx=0.25; there was no significant age by 
method interaction for active tension. The H
0
: all B's are 
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equal was not rejected at a=O. 05, nor ·at a=O .10, and no 
age by method interaction was claimed to be significant or to 
approach significance for P
0
• This indicated that the age 
effect on active tension and P
0 
was the same for methods 1 
and 2. 
There were no age effects ··on latency, Vmax' or Vmax 
per unit of cross-sectional area, so it was not necessary 
to assess any age by method interaction. 
The critical value fort, 14 d.f., a=0.05 is 1.761. 
The H
0
: µ2 = µ 3 was not rejected at a=0.05. There was no 
significant difference in P
0 
or active tension (n=9) be-
tween young age treatment #2 and old_ age treatment #3. 
The LSD· also indicated that there was no significant dif-
ference between_young and old. 
1 = 2(µ2 + µ 3) was rejected at a=0.05, and_ The H : µ1 ' 0 
the standard, K-H treatment #1,was claimed to be different 
from the mean of young and old age_ treatments for P 
0 
and 
active-tension (n=9). 
An age effec_t ·approached significance for P · and was 
' '0 
sign_ificant for active tension. This . age effect, however, 
was determined over three treatments: K-H, Y, O. It is 
necessary to determine wher~· this age effect is occurringi 
thus two appropriate comparisons were made •.. There was no. 
signif-icant differen.ce in P 
0 
or active tension. between young 
an~ old demonstrated by comparison 1 and the LSD. The 
Table 6. Means 
Analysis of Variance Procedure a 
Means 
Mb N Yi Y2 Y3 Y4 Y5 
1 18 172.529333 3.41955556 5.06705556 7.28577778 4.86922222 
2 9 143.344778 3.53322222 3.49422222 3.15622222 3.27133333 
Ac N Yl Y2 Y3 Y4 Y5 
1 9 161.705667 3.71477778 4.74166667 6.47400000 4.64200000 
2 9 160.195556 3.43788889 4.46222222 5~74166667 4.35111111 
3 9 166.502222 3.21966667 4.42444444 5.51211111 4.01666667 
M A N Yl Y2 Y3 Y4 Y5 
1 1 6 191.708500 3.50916667 5.11283333 7.95000000 5.06116667 
1 2 6 162.922667 3.49183333 4.91683333 7.03783333 5.00416667 
1 3 6 162.956833 3.25766667 5.17150000 6.86950000 4.54233333 
2 1 3 101.700000 4.12600000 3.99933333 . 3.52200000 3.80366666 
2 2 3 154.741333 3.330.00000 3.55300000 3.14933333 3.04500000 
2 3 3 173.593000 3 .1.4366667 2 •. 93033333 2.79733333 2.96533333 
aYl refers to latency; Y2 refers to P ; Y3 refers to V ; Y4 refers to V I 
cross-sectional area; Y5 refers to active 'Eension; M = methl:l}~l{ A = age sub- max 
treatment (1 = K-H (Krebs-Henseleit solution), 2 = Y (plasma from young dogs), 
3 = 0 (plasma from old dogs)); N =number of observations in a mean. 
bThe first set of means Ml,2 consists of method means. 
cThe sec.end set of means Al, 2, 3 (n'=9:) consists of age means over both 
methods. The third set consists of age means for each method. 
f-' 
"" N 
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Table 7. Comparison of the meansa 
comparison l = comparison 2 = 
(Y2 .-Y3.l (2Y1. -¥2. -Y3. l LS Db ·n t-value t-value 
latency 9 0.337 0.101 32.966 ++ 
6 0.001 l. 449* 40.375 ++ 
3 0,581 2.225** 57.099 + .. 
p 9 1.178 2.405** 0.326 +. 
0 6 1.032 0.683 0.399 ++ 
3 0.58 3.203** 0.564 + 
Vmax 9 0.121 1 •. 099 0.553 ++ 
6 0.663 0.206 0.677 ++ 
3 1.146 1.609* 0.957 + 
V /cross-' . 9 0.45 1.914** 0.90 + max t. 1 6 0.268 1.8·3'7** 1.102 ++ ·· · . · sec iona 
area 3 0.398 0.716 1.559 ++ 
Active 9 1.478* 2.343** 0.398 + 
tension 6 1.671* 1.203 0.487 + 
3 0.205 2.360** 0.689 + 
a .. . . - . -
Comparison.! =.y2 .-y3 ~; comparison .2 = 2y1 .-y2 .-y3 •• 
¥1 • ,¥2 • ,y3 • refer to the means of all the observations in the· 
K,..H, young age,· an(i old .age i;reatments, respectively. LSD 
· refer.s to the Least Significant Difference·. Note 'that when · 
n=9, we are studying the age means over both -methods which · 
is ,valid since f.here are no significant method di'fferences·.; 
b+ LSD' is greater than. the difference between the young 
and old· age treatme~t means. ++LSD is greater than the dif-
fer~nce between any two of the three age treatment·means: K-H, 
y,' o. 
* Approaching si~nifidance at 10% level (a=0.10). 
'** Significance at 5% level (a=O. 05) • · 
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standard, K-H treatment, was significantly different from 
the mean of the young and old age treatments (comparison 
2). It can be concluded that it was the first treatment 
(K-H) that was separate from the young and old age treat-
ments which, as a pair, were not significantly different 
from each other. Thus, the age effect exhibited for P
0 
and 
active tension could be attributed to the standard (K-H 
treatment) differing significantly from both the young and 
old age treatments which did not differ from each other. 
The H
0
: µ
2
=µ
3
was not rejected.at a=0.05; there was no 
significant difference in latency, Vmax' or Vmax per unit 
of cross-sectional area (n=9) between young age treatment 
#2 and old age treatment #3. This was in agreement with the 
LSD. 
1 
The H
0
: µ1 = zCµ2 + µ3 ) was not rejected at a=0.05; 
the standard was not significantly different from the mean 
of the young and old age treatments for latency and V (n=9). max 
The H 1 + µ3) rejected at : µl = 2<µ2 was a=0.05, and K-H was 0 
claimed to be significantly different from the mean of young· 
and old for Vmax per unit of cross-sectional area (n=9). An 
age effect on Vmax per unit of cross-sectional area was not 
significant when all three treatments were considered. How-
ever, when treatment #1 (K-H) was separated out and compared 
with the mean of treatments #2 (Y) and #3 (0), there was a 
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significant difference which was masked when all three treat-
ments were considered together in determining age effects. 
This masking was probably due to the closeness of the values 
for Y and O age treatments (Table 6). 
Although no significant method differences were present, 
comparisons of the young with the old age treatment, and the 
standard with the mean of the young and old age treatments 
were made for each method (n=6, n=3). 
The H
0
: µ2 = µ3 was not rejected at a=0.05; there was 
no significant difference in latency, P0 , Vmax' Vmax per 
unit of cross-sectional area or active tension between yourig 
and old age treatments for methods l or 2. 
l· Tlie H
0
: µl = z(µ.2 + µ3) was_ not rejecteq at a=0.05; 
there was no significant difference between the standard_ 
(K~H) and the inean of the young and old age treatments for·· 
latency, P , V , or active tension (n=6). ,The H
0
: _. --,o max 
µ1 = ~(µ2 + µ3) was· rejected at a=O. 05, ,and a significant 
difference between K-H and the mean of Y and O was claimed 
to.be present· for Vinax per unit of cross-sectional area 
(n=6). Again, this difference was probably masked by the 
closeness of the values for Y and .0 (Table 6), since no sig-
ni'ficant age effects were presen_t for this parameter. 
l The H0 :. µl = zCµ2 + µ3) was not. rejected at a=O. 05; 
there was no significant difference between the standard 
a~d.-the Il\ean'of Y and o for vrnax or vmax per unit c:if cross-
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sectional area (n=3). 
a=0.05, and a significant difference between the standard 
(K-H) and the mean of the young and old age treatments was 
claimed to be present for latency, P
0
, and active tension 
(n=3). These significant differences in P
0 
and active tension· 
were expected since age effects were demonstrated for these 
parameters, and were actually due to the K-H treatment dif-. 
fering from the young and old age treatments which did not 
differ from each other. The significant difference between 
K-H and the mean of Y and O for latency became apparent when 
the means over both methods 1 and 2 (n=9) were subdivided 
into individual method means (n=6 and n=3). K-H was then 
seen to differ from Y and O which did not differ at all from 
each other for method 1, and differed only slightly from 
each other relative to the K-H value for method 2 (Table 6) . 
. To conclude, there was no significant difference be-
tween plasma from young and old dogs. Any significant age 
effect could be attributed to the first age treatment (K-H) 
differing from both the young and old age treatments which, 
as a pair, did not significantly differ from each other. 
Table 8. Correlation coefficients 
age 
latency 
Po 
Vmax 
Vmax/cros~-
sectional 
area 
latency 
0.019 
p 
0. 
-0.126 .-0.062 
"'-0.487. -0. 719 
0.566 
V /cross-
max sectional 
area 
-0.059 
-0.628 
0.488 
0.729 
active tension 
-0.061 
·-o.656 
0.674 
0.679 
0.938 
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Latency values are in msec/g. 
Age treatments 1, 2, 3 correspond to Krebs-
Henseleit (K-H) solution, Young (Y) (plasma, 
processed or unprocessed, from young dogs), and 
Old (0) (plasma, processed or unprocessed, from 
old dogs), respectively. 
Figure 55. Latency (slope) and age 
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Figure 57. Vmax and age 
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processed or unprocessed, from young dogs), and 
Old (0) (plasma, processed or unprocessed, from 
old dogs), respectively. Note that the scatter 
of observations is similar for the young and 
old age treatments. 
Figure 59. Active tension and age 
203 
Table 9. t-values for latency, Po' vmax' vmax1 cross-
sectional area, and active tension for individual 
muscle experimentsa 
V /cross- active 
latency Po Vmax max sectional tension area 
DYi-DS -0.857 3.652**** 1.890** 2.370*** 
AS-DS -1.079 0.820 -0.046 1.177 
DYl-DOl 0.671 0.0 -1.385* -0.258 0.0 
DY2-D02 -0.373 -0.076 -0.735 -0.085 -0.012 
DY3-D03 0.932 -0.076 0.268 0.053 -0.019 
DY3-D04 -0.224 0.483 -0.216 -0.282 0.905 
DY4-D05 -0.402 0.895 0.752 1.425* 2.115** 
DYS"'."D06 -0.607 1.305 -0.307 -0.194 1.103 
DY6-D02 0.995 -0.112 0.008 -0 .. 013. 
Plasma Y5- -1.862** 1.079 1.696* 0.507 0.428 
Plasma 03 
Plasma Y4- 0; 405 ' 0.187 0.029 0.017 0.148 
·Plasma 02 
Plasma Y5- 0.450 -0.259 0.259 0.164 -0.223' 
Plasma 05 
aNote that the pooled variance for each of the five 
parameters determined by the analysis of variance was used in 
· calculating t-values. There was a significant difference iri 
po' vmax' and active tension between processed shock plasma 
. peak D. and processed plasma peak D' from young dog #1. 
* Approaching significance at 10% level (a=0.10)· 
·**Significance at 5% level (a=0.05) • 
. ***Significance at 2.5% level (a=0.025). 
*'*** 
Significance at 0.25% level (a=0.0025). 
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DISCUSSION 
Discussion of Methods 
Dialysis and gel filtration were the most significant 
steps in the preparation of purified depressant factor 
(MDF) activity, separating MDF from protein and salt in 
plasma. 
Dialysis 
The reason for freezing and thawing plasma prior to 
dialysis was to remove the cryoprecipitable proteins which, 
if not removed, would collect on the dialysis membrane and 
interfere with the filtration process. Pressure dialysis 
was chosen in lieu of other deproteinization techniques. 
Filtration gels and membranes for ultrafiltration tend to 
bind polypeptides and proteins. Higher yields of MDF 
activity are obtained with pressure dialysis than with tri-
chloroacetic acid-ether treatment (Yamada and Pettit, 1977). 
Column chromatography 
It was necessary to remove the upper 1.0-1.5 cm layer 
of the gel bed between column separations. When a column 
is repeatedly used, the flow rate may decrease. The upper 
part of the gel bed may become clogged with fine particles 
from the buffer solution or sample. The removal of this un-
wanted debris helps to maintain the flow rate and resolution 
' 
' 
I 
I 
I 
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of the column, and to diminish the tendency of the gel bed 
to become compressed .during elution. 
Papillary muscle sensitivity 
Several variables can influence _isolated papillary muscle 
performance: osmolarity, pH, temperature, oxygenation, 
sodium ion concentration and calcium ion concentration. 
According to Goldfarb et al. (1978), an osmolarity range 
of 270-310 milliosmols/liter did not induce any cardio-
depressant activity. This is not consistent with what I 
have found to occur. An osmolarity of 288 and above will 
damage the papillary muscle. The base line resting tension 
will. rise upwar9' and eventually, the amplitude of contrac-
tion will decrease until the muscle dies. An osmolarity 
change_ may be due-either to salts and ion buildup in the 
tubing_ of the.system or water removal from the bath solution •. 
Tens:i:on develop~ent undergoes sigmoidal depression W,ith . ' . :i 
acidosis. Developed tension was depressed by a sol.'ution pH 
outside the range of 7.25-7._60 (Goldfarb and Weber, 1977b;. 
. . . 
Lefer•arid :Blattberg, 1968). Any pH.changes that occurred 
may -be.due to a drift in pH of the buffer, air entering the 
syst~m throµgh leaks in the tubing or valves, or muscle . 
activity_. · If the muscle is dying, cellular contents are 
rel_\l!ased into the bath solution which lowers pH. 
All.muscle experiments were run at 27C. It has been 
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shown that the velocity of shortening of preloaded isotonic 
contractions was not dependent on temperature (Parmley and 
Chuck, 1973). In another study, temperature was found to 
have an effect on peak active tension. The peak active 
tension was reduced fivefold as temperature was incre·ased 
from 20C to 38C (Johnson et al., 1974). Although physio-
logical temperature is approximately 38C, papillary muscle is 
studied at lower temperatures to slow the contractile 
processes. Since equipment has a slow reaction time, it 
would be best if the muscle contracted as slowly as possible 
during mechanical measurements. 
A high sodium ion concentration depresses and calcium 
ion concentration stimulates tension development in a linear . 
fashion. An adequate calcium ion concentration in the 
muscle bath solution is important for contraction. When 
mammalian myocardium was exposed to calcium-free perfusion 
fluid, contractile tension declined with a half-time of 15-60 
seconds (Langer, 1971; Langer, 1977). The necessity of 
having the correct concentration of ionized calcium is un-
questioned. Calcium at concentrations of 7.5 mM effectively 
' 
counteracted thelnegative inotropic effect of MDF in iso-
lated feline papillary muscle preparations (Lefer, 1978). 
The activation of the mechanical response of papillary 
' muscle is dependent pn the influx of ionized calcium from 
the extracellular phase with depolarization of the cell 
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membrane. The source of the Ca++ for excitation-contraction 
coupling is the cellular surface. Acidic mucopolysaccharides 
in the basement membrane are capable of binding ionized 
calcium. The Ca++ which moves into the cell either directly 
activates the mechanical response or triggers the release 
of additional Ca++ from intracellular storage sites. 
An increased intracellular Ca++ concentration results 
in the increased binding of Ca++ to troponin C which neu-
tralizes the inhibitory action of troponin I on myosin ATP-ase. 
These changes in the regulatory protein system permit the 
interaction of actin and myosin. Ca++ is essential for 
-2 MgATP hydro·lysis and contraction. The hydrolysis of ATP 
provides the· energy for the.activation of cross-bridges. 
Calcium governs both the number of active cross-bridges 
between the actin and myosin filaments during tension de-
velopment and the rate of turnover of cross-bridge formation 
(Brutsaert et al., 1971, 1973; Edman, 1977). P and shortening 
0 
velocity were greatly enhanced when pa'pillary muscle was 
subjected to high calcium ioh concentrations (Brutsaert 
et al .. , 1973). 
It was therefo:i:e imperative to know the calcium ion. con-
centration in the solution bathing the papillary muscle!·and 
to monitor the variables which affect isolated papillary 
muscle. 
T~e cacl2 concentration in the Krebs-Henseleit buffer was 
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increased from 2.58 mM to 3.25 mM when the buffer was to be 
used with the lyophilized test peak. The osmolarity of the 
lyophilized test peak in 23 ml of K-H buffer was much higher 
than 282, and required the addition of 6 ml of water. The 
addition of water, whi.le adjusting the osmolarity to physio-
logical range, would concomitantly alter the concentration 
of the important ion, calcium. This was avoided by starting 
with an initial concentration of 3.25 mM Cacl2 • 
Papillary muscle selection 
The young age of the dogs from which papillary muscles 
were taken had no negative effect on this study. These 
muscles served as effective experimental units. Papillary 
muscles from 4-6 week old dogs have been shown to be func-
tional with respect to receptor development (Hembrough 
et al., 1978). Since papillary muscles of young dogs are 
thinner they are easier to oxygenate in solution. Since the 
effect of old age was studied, it was desirable to use 
muscles from young dogs. 
The geometric shape of the papillary muscle is impo:r:tant 
in determining the usefulness of the muscle and in esti-
mating the capability of the muscle to function for an ex-
tended period of time (8 hours). The ideal morphology of a 
papillary muscle is length and thinness. 
It is speculated that more tubular invaginations of the 
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'.' . 
plasma membrane may extend into the cytoplasm of long muscle. 
cel·ls. The lumen of the tubules from the ·transverse-tubular . . . 
system is continu.ous with the extracellular space. These· 
tubular invaginations usually are o~served at the leve.l of 
the z band. Thus, with longer muscle ceils, more tubules ~ay 
come·in. contact with the contractile component area, and a 
rapid distribution of excitatory stimulus is facilitated 
·throughout the cell. A recruitment of more myofibrils from 
the depth of the ·fiber is a result of .the spread of de-
polarization along the transverse-tubular system. 
The sarcoplasmic reticulum lies close to the plasma 
membrane, Electron-dense·· feet protrude from the wall of 
the sarcoplasmic reticulum and may facilitate the direct 
transfer of information from the plasma membrane to the 
sarcioplasmic retic.ulum. It would be advantageous to decrease 
the diffusion d.i,st,ance for calcium ions to the myofibrils. 
The inner core of thick, tria11gular shaped papillary muscles 
becomes hypoxic in a few hours in the muscle chamber .since 
the diffusion distance for oxygen and ions is large·. The 
spread of depola.rization alon,g the T-system would, most 
' - . ' - ' 
likely, not reach the inner core of very thick muscles. . . ,'. 
There are more p'lasma membrane tubular. invaginations which 
contact the inner core of long, thin muscles; 
If only ·the outer core of the, muscle is functional., 
tflen a thick, trian,gular .shaped muscle has a wasted inner 
. l 
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core with a minimal outer functional area. A long, thin 
muscle has an extended outer core with larger functional 
area, and a smaller inner core. A long muscle is advan-
tageous, since the total functional range of papillary muscle 
is approximately 25% of the muscle length (Ford and Forman, 
1974). As muscle length is increased and cross-sectional 
area is decreased, oxygen diffuses more effectively into the 
central hypoxic core. The life of the muscle is extended. 
According to Brutsaert et al. (1971), developed force 
should exceed resting force by a ratio of 5 or 6 to l in 
adequately functioning feline papillary muscle preparations. 
smaller ratios usually reflect mechanical damage to the muscle 
preparation. Feline papillary muscle is usually longer and 
thinner than canine papillary muscle. A long, thin muscle 
develops more force since the outer core of the muscle is 
functional. The P
0 
is higher in feline papillary muscle. 
Thus, the ratio of active tension to resting tension in 
feline papillary muscle is larger than the ratio in canine 
papillary muscle. 
Based on Brutsaert's guideline ratio, a ratio of 4.5:1 
was used as the primary criterion for canine papillary muscle. 
The mean ratio for eleven canine papillary muscles was 4.57 
(Table 3). Caution should be exerted when interpreting the 
results of papillary muscles from other species, since species 
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differences do exist. 
F.ive papillary muscles did not satisfy this initial 
criterion but did satisfy other criteria. Papillary muscles 
with ratios smaller than 4.5, but with P 's larger than 2 
0 
were used in age experiments: 3 a:nd 8. The P
0 
steadily in-
. creased with time in age experiments 1, 2, 3, a:nd in shock 
experiment 2. The only exception was the expected decrease 
in P with .shock plasma peak D. Three papillary muscles 
0 
had a cross-sectional.area larger than the criterion value 
2· 
of 2.1 mm • The P0 was large and/or steadily increased 
with time for thesi:i muscles in age .experiments: 1, 2, 3. 
Based on these criteria (active tension to resting tension 
ratio, P , cross-se'ctiortal area), i;ileven out of twelve 
' ... 0 
muscle,s were acceptable. 
The five muscles whose active to resting tension ratios 
were·smaller than 4.S'were not omitted. The secondary cri-
teria, large P
0 
ahd/or a steadily increasing P
0
, are indi-
cators of an adequately and continuously functioning muscle 
preparation. Mechanical damage to the muscle would not be 
reflected by a steadily increasing P
0
, A muscle with a 
large P was usually indicative of a muscle with.the po-. 0 
~ential .to exhibit_ true· clear.cut. differences between test 
sample.a, if differences .existed •. A s~all P
0 
indicated less 
developed: force, and ·possibly a weak ·muscle which was very 
sensitive to minor 'differences between test samples. There 
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is the uncertainty, however, with small P -muscles, that any 
0 
depression exhibited may very well be due to the deterioration 
of the weak muscle and not due to the presence of a depressant 
factor in the test sample. 
The papillary muscle which was subjected to peak DY6 
and peak D02 was not used. The cross-sectional area was too 
large (6. 73 ·mm2 ), the muscle length was too short, and the 
P
0 
was greatly depressed after the buffer solution was re-
placed with peak D of plasma from young dog #6 (Figure 31, 
Table 4). Mechanical damage to the muscle was assumed to be 
responsible for this depression; the papillary muscle system 
was initially not circulating well. This was indicated 
by an improvement in amplitude of muscle contraction with the 
addition of oxygen directly to the muscle, and difficulty 
in stabilizing pH. This muscle experiment did serve to 
reconfirm the lack of difference between peak D of plasma 
from young and old dogs, despite the difference of peak D of 
plasma from both young and old dogs from the standard (K-H 
buffer solution). Peak D of plasma from the same old dog 
(02) was repeated in age experiment 2 (Figure 26). 
One final justification for the inclusion of three 
muscles with cross-sectional areas larger than the criterion 
value is the evidence in an experiment performed by Lundgren 
et al. (1976). There were no statistically significant 
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differences in the responses of thin and thick rabbit 
papillary muscles to plasma. He concluded that cross-
sectional area was of. no sign.ificance in relation to muscle 
responses. Again, it should be remembered that. a different 
species was used, and also that the hypoxic core effect with 
thick muscles is only a hypothesis. The value of establishing. 
criteria for muscle selection is an attempt to include only 
select stable muscle preparations with high potential for 
contractility. 
Prestretching· the· mus·c1e 
The papillary muscle was prestretched with a heavy load 
for two contractions prior to each preload during the genera-
tion of a preload curve. Cardia.c muscle contracts more 
vigorously .when. stretched. At an optimal length., the degree 
of overlap of thick ~nd thin filaments will permit the 
generation of a· large'. force. According to .Noble and Else 
... 
(1972), stretching the muscle during contraction overcomes 
the.inhomogeneity of muscle and maintains. the central 
sarcomeres at· the· desired lergth. , . 
Prestretching the muscle with the same hea'li'y weight 
prior to each preload weight places the muscle in the same 
condition with respect to thick and thin filament overlap 
for each test preload weight. This reduces the variability· 
.of tJ::!.e muscle during :the generation of the curve. 
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Prestretching the muscle increases the length and per-
mits a transient decrease in cross-sectional area of the 
muscle which subsequently increases oxygenation of the inner 
core. As the muscle is prestretched, the increased oxygena-
tion aids the muscle to contract maximally for each preload 
weight. Any decline in amplitude of contraction during 
the generation of a preload curve cannot be due to a 
hypoxic inner core, since the muscle core continuously 
receives a "burst"' of. increased oxygen with each prestretch. 
Basis for selecting the preload weight 
The selected preload weight was ~92.5% of the preload 
weight that would produce a maximal contraction (Lmaxl· 
The selected preload thus produced a percentage of Lmax 
between 90 and 100. 
A preload producing a high percentage of Lmax was used 
for a specific reason. When muscle length was increased from 
90% Lmax up to Lrnax' there was an immediate increase in 
isometric force due to the Starling mechanism. This was 
followed by a gradual secondary increase in force which 
occurred during the subsequent ten minutes (Parmley and Chuck, 
1973). Parmley and Chuck (1973) conducted their study with 
99% L max 
The question as to whether the heart functions at the 
top of the length-tension curve or at 10% below Lmax has been 
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a point of contention. According to Sonnenblick (1974), the 
heart functions between 2.0 and 2.2 µm. At sarcomere lengths. 
shorter than Lmax' the resting tension declines exponentially" 
to zero at ~85% Lmax" A positive filling pressure distends 
the heart, and therefore, the heart must work at sarcomere 
lengths greater than 85% Lmax" 
In all cases, Vm~x increased with increasing'musdle 
extension even in the range of physiological muscle length 
from 85% Lmax to Lmax (Gulch and Jacob, 1975a; Minelli et al., 
1975; Donald et al., 1972). Brutsaert et al. (1971), how-
ever, claimed th~t Vmax remained constant between Lmax 
and 87.5% L · max The inhomogeneity and variation in sarcomere 
length was reduced by using a high preload, a resting tension 
close to Lmax (Brutsaert et al., 1973). 
By using a preload which produced a high percentage of 
Lmax' the resting.tension was set .at a level just below that 
whic;h would yield a·maximal contraction. This places the 
muscle in an optimum state with respect to sarcomere length, 
' 
and permits the muscle to respond with its full potential. 
Any change in contractility which may be induced by MDF 
signifies the sensitivity of the muscle to this depressant 
factor, ·since the muscle was functioning at an optimum point 
along the' ascending liinb of the length-tension curve. 
I 
·1 
I 
I 
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Generating preload and afterload curves backwards 
Preload and afterload curves were generated backwards, 
beginning with the heaviest load and serially replacing it 
with lighter loads. This was done to avoid overstretching 
and fatiguing the muscle with time. Maximum velocity of 
shortening (Vmax> is determined only by the total load, and 
not by the sequence of length changes or the mode of un-
loading to zero load (Brutsaert et al., 1971). 
Composite fo·rce·-veloci'ty curves 
Velocity was plotted against P/P
0 
where P = load and 
P
0 
= maximum isometric force at zero velocity in the composite 
force-velocity curves (Figures 35-41). Dividing P by P
0 
normaliz.ed ·the force of all muscles, thereby eliminating dif-
ferences in the size of the papillary muscles. The total 
number of activated myosin cross-bridges for each muscle 
was standardized. 
Velocity per unit of cross-sectional area was plotted 
against P/P
0 
in the composite force-velocity curves (Figures 
42, 43) to eliminate differences in cross-sectional area. 
Thus, all muscles were normal;ized with respect to both force 
and velocity per unit of cross-sectional area. 
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Discussion of Results 
Although I have confirmed the presence of MDF in the 
plasma of a canine with experimental pancreatic vessel 
ischemia, and.have resolved the controversy between Lefer 
and Wangensteen, many questions concerning the nature of 
MDF still remain. 
MDF is undoubtedly a.peptide, since it is ninhydrin-
positive and absorbs ultraviolet light at a wavelength of 
230 nm, which is the optimum wavelength for peptide bonds. 
Based on calibration of the columns with molecular weight 
marke:i;-s, MDF is estimated to have a molecular weight between 
700 and 850 (Table 2). This small range has not been reported. 
Canine MDF exerted a negative inotropic effect on canine 
papillary muscle. Vmax' P
0
, and active tension values were 
depressed significantly (Figure 23, Table 9). There was no 
significant effect on latency which was determined as the 
time from the beginning of stimulation to the beginning of 
· contraction. This is consistent with other reports; MDF (two-
hour shock) exerted' no significant effect on latency which 
was.determined as the.time to peak tension • 
. seiveral investigators have reported the presence of 
Mi:>F in shock plas111a at concentrations in the nanomolar and 
picomolar range. Since MDF could not be completely isolated, 
and no calculations or descriptions on the de.termination of 
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these concentrations were provided, these concentrations 
should be considered only as estimates. There was no way 
to precisely measure the concentration of MDF in the eluate 
or lyophilized samples.. However, it was possible to demon-
strate the potential of MDF activity and the sensitivity of 
the papillary muscle bioassay to a 58.8-fold dilution of 
MDF from the original starting material (Figure 2). 
The dilution of plasma during gel filtration should be 
considered when determining MDF bioassay parameters. A 
direct linear relationship between the concentration of the 
sample and the percentage inhibition of papillary muscle 
contraction was reported. Thus, the sensitivity of the 
papillary muscle bioassay was demonstrated for MDF, since a 
significant depression in contractility was observed with a 
58.8-fold dilution of the original shock plasma. Thus, in 
actuality, the depressed values for Vmax' P
0
, and active 
tension for MDF-treated muscles represent a higher depressant 
capability of MDF, since the MDF was diluted 58.8-fold from 
the original shock plasma sample. This is consistent with the 
high absorbance readings for peak D of shock plasma which, 
while in the eluate, was diluted 18.8-fold from the.original 
starting material. Low absorbance readings for peak D of 
plasma from young and aged dogs were matched with expected 
contractility responses which indicated insignificant MDF 
activity in comparison to shock MDF activity. 
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It is impressive that the elution volume for MDF, which 
was found in peak D of shock plasma, was very similar to the 
elution volume for peak c of plasma from both young and old 
dogs. Peak D of plasma from both young and old dogs was 
found at a later elution volume than that for ,peak D of shock 
plasma. Peak C contains a normal·. component of plasma which 
has moderate negative inotropic activity (Lefer and Martin, 
1970a). However, the negative inotropic effect of peak C was 
not seen in shock plasma when both peaks 'C and. D were present·~ 
Only the effect of peak D (MDF) was observed. It is hy-_ 
pothesized that the active component(s) of peak C and pi;ak 
D (MDF) may act on the same receptor site. Peak C would then 
have a weaker affinity for the receptor since the negative 
inotropic effect of peak C was not observed in shock plasma 
when MDF (peak D) was present. MDF probably saturated the 
available receptors and prevented the effect of the peptide 
in peak C from being expres.sed. 
It is possible that peaks C and D-peptides compete· for. 
the same receptor site, since ·myocardial depressant activity 
was_ demonstrated. with peak C of normal plasma, _but not of 
shock plasma. Depressant a.ctivity was demonstrated in shock 
plasma with peak D. Similar elution volumes for peak C of 
plasma.from young and old dogs and peak D of shock plasma 
imply that MDF has the same molecular weight as the peptide 
in peak c of normal control plasma from young and:old dogs. 
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Peak D of normal control plasma from young and old dogs ap-
peared at a later elution volume than MDF and did not have a 
large absorbance peak like MDF. No depression of papillary 
muscle in any fashion which was quantitatively similar to 
MDF was demonstrated. 
The combination of isolated canine papillary muscle with 
canine processed and unprocessed plasma eliminated muscle-
plasma interactions due to species differences and per-
mitted the study of a species-specific (canine) MDF. The 
effects of MDF on.isolated canine papillary muscle have not 
been reported. In the past, canine MDF was assayed on -feline 
and rabbit papillary muscle, and the possible effect of 
i>pecies differences had to be considered with the effect of 
MDF. 
Experiments were designed in such a manner that each 
muscle would serve .as its own control. This removed the 
effect of muscle differences and eliminated the inconsisten-
cies between muscles that arise from differences in muscle 
length, cross-sectional area, or in the state of contractility. 
Two very large and similar peaks, peak A and peak D are 
depicted in each of the column elution patterns for a dog 
with experimental pancreatic vessel ischemia (Figures 5, 6). 
Significant MDF activity was present in peak D of the 
chromatogram in Figure 5 (Figure 23). Peaks A and D of the 
chromatogram in Figure 6 were then tested with another 
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papillary muscle to differentiate between the two large 
peaks and to confirm the presence of MDF in peak o (Figure 
24). 
Al~hough there was a depression in P
0 
with peak o of 
shock plasma in the AS-OS muscle experiment (Figure 24), 
it was not significant. The response of the muscle in terms''·· 
of Vmax ·was_unexpectedly different from the response of the 
lllUscle in Figure 23, There are several possible explanations 
as to why the' expected significant differences between shock 
plasma peaks A and D did not occur. 
When the muscle was subjected to shock plasma peak A! 
the immediate response was an increase in the amplitude of 
contraction. .Although this initial increase in amplitude 
was observed for every test peak, the increase for shock 
plas)lla peak A was definitely much larger;·so large, that the 
sensitivity on thedynograph recorder had to be 'reduced. 
It was therefore unusual that the P
0 
value for peak A was 
not larger than .it was. 
In reevaluating t.he·situation, peak A from shock 
P,lasma should not be considered to be equivalent to eith~r 
peak A.or peak D of control plasma from a young dog not in 
shock;. Although MDF was reported to be c:inly in peak D 
of.shock plasma, the possibility that. a negative depressant 
factor may be aggregated to a large peptide or protein in 
, peak· A of shock plasma cannot be. ruled c;iut, especially since . · 
I 
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the formation of MDF is only hypothesized. There may be 
large molecules in peak A which have combined temporarily 
with some residual MDF. 
Peak A contains large peptides and protein which are 
beneficial to the muscle. This has been shown by a very 
large increase in amplitude of contraction. However, there 
may have been a competitive action between the large peptide·s 
in peak A which exert a positive effect on the papillary 
muscle and the hypothesized aggregated depressant factor which 
would prevent the expected significant increase in P
0
• The 
effects of shock _in plasma peak A should have been ascertained 
by testing an individual muscle with peak A of plasma from 
normal and shock-induced dogs. 
The absence of a significant depression of P
0 
with shock 
plasma peak D following shock plasma peak A must be explained, 
since shock plasma peak D (Figure 23) contained significant 
MDF activity. It is possible that the beneficial supple-
mentary protein found in peak A stabilized the muscle such 
that the reaction time for MDF (peak D) was slowed past the 
thirty-minute period for induction of a response.. Thus, the 
exhibition of the negative effects of MDF were only delayed 
because the papillary muscle was stabilized with peak A. 
Another point is that this one muscle experiment consti-
tutes a small sample size, even though a pooled variance 
determined by the analysis of variance was used to test this 
223 
particular experiment for significance. 
That the Vmax value for DS (Figure 24) was greater than 
the Vmax values for both AS and K-H is not consistent with 
the DS response in Figure 23. The· incongruity of the V .max 
value with P
0 
is also demonstrated in Figures 25 and 30. 
The P
0 
values of the papillary muscle subjected to peak 
D of plasma from a young and old dog were identical (Figure 
25) • .However, the V x· value was larger for peak D of plasma ma . · 
from the old dog. In Figure 30, the P
0 
of the muscle sub~ 
jected to peak. D of plasma from an old dog was depressed, 
but the Vmax value was larger than the vmax value for the 
ceding bath, peak D of plasma ·from a young dog. 
Four explanations for this biological incongruity are 
presented. First, the validity of Vmax was questioned by 
several researchers. The possibility of an intrinsic loa(i 
pre-
is not considered when v is extrapolated from the force-max · 
v~locity curve to ze.ro load. There is no. way of knowing· 
whether unidentif~ed internal forces.are negligible or not, 
or whether they are consistent or changing in a muscle. 
It is possible that· the Vmax·values do not represent the 
maximum velocity of m.uscle shortening at· zero load. un-
expected values for Vmax for particular muscle baths m~y be 
attributed to the presence of changing internal forces which 
would increase or decrease Vmax as they decreased or increased, 
:i;-espectively. 
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Second, there is some subjectivity in the selection of 
a particular polynomial to fit the experimental data points 
of a force-velocity curve by the method of least squares. 
The data points of all force-velocity curves were fit to 
2nd, 3rd, and 4th order polynomials by the method of least 
squares and correlation coefficients were compared. The pre-
dieted y values (velocity) for chosen x values (load) were 
compared with experimental y values. The polynomial which 
gave y values as close as possible to experimental values was 
selected. The polynomial chosen for fitting the data points 
was the same for all three muscle baths within one muscle 
experiment. The polynomial which was used could vary from 
one muscle experiment to another. 
Extrapolated Vmax values differed for all three poly-
nomials, and therefore the polynomial had to be carefully 
selected. 
Third, the incongruity lies within the extrapolation 
itself. When the P
0 
of a muscle is large and the afterload 
curve is generated backwards, the velocity changes gradually 
along a semi-plateau similar to a sigmoidal curve (K-H 
curve, Figure 30J . A large number of data points may be 
entered into the computer, programmed to extrapolate Vmax' 
when the P value is large. The points along the plateau 
0 
part of the curve influence the Vmax value. However, when. 
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the P
0 
value bf a muscle is small, the velocity changes 
more rapidly as the load is decreased. There is usually 
no plateau. The Vmax value is extrapolated from a smaller 
number of data polnts which can only force the V value max 
to a much higher value than is biologically possible. This 
occurs because the velocity points are changing faster over 
a smaller range of loads than in the sigmoidal curve where 
t_he P 
0 
is large. 
Fourth, since a high percentage of L was produced max 
by the selected preload, it is possible that the muscles 
were potentiated by a high resting tension and were closer 
to t_heir ceiling of contractility. This may partially, 
expl_ain why some Vmax values remained high and were not 
easily depressed, assuming that Vmax is length-dependent. 
The use of particular molecular weight markers for 
Bio:...Gel P-2. should be discussed. Glycylglycine (molecular 
weight 132.1) was consistently found in the eluate at a mean 
elution volume of 110-131 ml (n=4) which does not correlate 
with the molecular weight. There are two possible reasons. 
First, the exclusion limit for Bio-Gel P-2 is 200-1600 
(Lefer, 1970). The elution volume for a substance will not 
be linear beyond the exclusion limits of the beads. Gly-
cylglycine is below the cutoff point of the fractionation 
range. The other possible explanation is that the . 
. •. 
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glycylglycine stock material was not really the dimer, and 
therefore came off the column at a position which correspond-
ed to a larger molecular weight substance. 
Glycylglycine was used as a molecular weight marker for 
Bio-Gel P-2 by one research group (Lefer and Martin, 1970a), 
which prompted me to include it with the other molecular 
weight markers. Although Lefer (1970) acknowledged that the 
lower end of the exclusion range for Bio~Gel P-2 was 200, 
glycylglycine was still used as a marker. Glycylglycine in 
my separations consistently appeared in the eluate at a 
position which corresponded to a molecular weight of about 
1200. It is believed that the molecular weight of gly-
cylglycine is too low to satisfactorily calibrate Bio-Gel 
P-2 columns with this peptide. 
Hexaglycine was used instead of glycylglycine, since 
the molecular weight (360.3) was larger than the low cutoff 
point for separation by Bio-Gel P-2. However, hexaglycine 
introduced a different problem, that of dissolution. This 
peptide would not dissolve unless it was heated in lN HCl. 
A precipitate formed when the solution cooled to room tempera-
ture. Although hexaglycine was absorbed into the top layer 
of the gel bed, there was no assurance that hexaglycine was 
not precipitating within the column. This was substantiated 
by the poor resolution of the hexaglycine peak in the composite 
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chromatogram for molecular weight markers (Figure 21). 
Thirty milligrams of hexaglycine instead of fifty mg was 
dissolved in the same amount of acid and was reapplied to a 
column. Although the warm solution of 30 mg of hexaglycine 
in lN HCl would still precipitate when cooled to 25C, it 
was layered on the colllilin. The 30-mg hexaglycine peak was 
not as broad as the 50-mg hexaglycine peak, but the existence 
of a shoulder on the high molecular weight side of the 30-mg 
hexaglycine peak may indicate poor resolution. This probably 
means that hexaglycine was still precipitating as it passed 
through the column. The elution volumes at the peak h~ight 
of both 50-mg and 30-mg hexaglycine peaks were similar (177.0 
and.173.5 ml). Hexaglycine was not an ideal marker and may 
only serve as a rough estimate for the position of a 360.3 
molecular weight substance. 
Angiotensi~ III inhibitor (molecular weight 896) was 
found at an elution volume corresponding to a molecular 
weight of ab,ou:t 1375 (Figure 21). This peptide may have · 
aggregated and passed through the column as a heavier 
particle. If this peptide combined as a dimer, it would 
aJ?pear i'n the eluate at an elution volume corresponding to 
twice, the molecular weight. It would then be found in the 
void volume. A possible explanation for the position of 
angiotensin III inhibitor in the eluate is that there was 
some nonspecific "sticking" which altered the molecular 
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weight properties of the peptide. Angiotensin III inhibitor 
did not seem to have a monomeric weight when applied to 
Bio-Gel P-2. 
The faster the flow rate, the sooner is the appearance 
of the peak in the eluate. This was evident with angiotensin 
II (molecular weight 1225). When the column flow rates were 
identical (9.2 ml/hr), two of the peaks were found in 
similar elution volumes. When the flow rate was increased to 
11.2 ml/hr, the peak appeared sooner in the elution volume, 
but overlapped with two later peaks at the slower flow rate 
(Figure 21). 
The column flow rate was constant throughout an entire 
run and varied only slightly, if at all, between runs for any 
one of the four columns. Differences in flow rates occurred 
when columns were repacked. 
The different elution volumes for MDF (peak D of shock 
plasma) that are reported by different researchers may b.e 
explained by altering characteristics of the column. Any 
variance in column size, length, eluant or flow rate may 
shift the elution volume of peak D. 
According to Lefer and Martin (1970a), all eluted peaks 
of shock plasma were ninhydrin-positive except peak B. My 
ninhydrin test results agree with those of Okuda and Fukui 
(1974); all eluted peaks including peak B were ninhydrin~ 
positive (Table 2). The results of the ninhydrin assay, 
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which is indicative of total proteolysis, were consistent 
with absorbance readings at 230 nm for each of the peaks. 
Several trends and consistencies may be suggested from 
the· column elution patterns for young and old dogs (Figures 
7-19), 
In the chromatograms for young dogs, peak D was con-
sistently smaller than peak C except for young dogs #2 and 
#4. In the chromatograms for old dogs, peak D was con-
sistently larger than peak C except for old dogs #2 and #4 
where peaks C and D were· similar. A tradeoff in activity 
b_etween peaks C and D was observed when shock plasma was 
compared with control plasma. The activity of peak C of 
control plasma diminished in shock plasma where peak D would 
be v.ery active • 
.. Although peak.DY! was smaller than peak CYl, and peak 
DOl was larger than peak COl, no depression of the papillary 
muscle resulted (Fi_gure 25). There was even a continual 
increase in Vmax and a continual decrease in the slope of 
the latency curve (Figure 46) as Krebs-Henseleit buffer was 
replaced first with peak D of plasma from the young dog and 
then wi t_h· peak D of plasma from. the old dog. 
The medical history of old dog #1 (01) made this dog an 
inte_resting subject. The· 15-year old dog had mitral valve 
failure, renal failure and was being treated for Cushing's 
syndrome. An increased concentration of glucocorticoids 
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would be present which would stabilize lysosomal membranes. 
This would counteract the production of MDF if MDF was 
associated with old age. If large peak D's were found in 
the plasma of the other aged dogs, but not old dog #1, then 
the hypothesis that lysosomal enzymes are important in MDF 
formation would be valid. 
Peak D02 was not larger than peak C02 and a continual 
increase in muscle performance resulted (Figure 26). 
Although peak DY3 was smaller than peak CY3, and peak 
D03 was larger than peak C03, the P
0 
value of the muscle 
steadily increased as buffer was replaced with peak D of 
plasma from the young dog and then with peak D of plasma 
from the old dog (Figure 27). The slope of the latency 
curve for peak D of plasma from the old dog was the smallest 
(Figure 48). 
Although peak DY3 of the second column elution pattern 
for young dog #3 was not much different than peak CY3, just 
as peak D04 was similar to peak C04, the P
0 
and slope of the 
latency curve improved with peak D of plasma from the young 
dog and worsened with peak D of plasma from the old dog. The. 
changes, however, were only slight (Figure 28). 
The depression of the papillary muscle subjected to 
peak DY4 and peak DOS (Figure 29) should be considered. 
Peak DY4 was larger than peak CY4, and there was a slight 
initial depression in P and V when K-H was replaced with o max 
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peak D of plasma from the young dog. The column elution 
pattern for old dog #5 (Figure 18), the oldest dog in the 
study, was different from the chromatograms of the other 
dogs (young, old, and shock dogs) with respect to the size 
of peak A. 
The possibility that the large peptides or protein con-
tained in peak A were lost was considered at each step in 
the procedure (Figure 2). Freshly obtained blood from the 17-
year old dog was completely processed again and a similar 
elution profile was produced (Figure 60, Appendix). This 
was repeated a third time, but peak A remained small (Figure 
61, Appendix), unlike the peak A's from every other dog. 
There is a similarity of the peaks and the relationship be-
tween peaks C, D, and E for all three column elution 
patterns (Figures 18, 60, 61). 
A decrease in sensitivity of the spectrophotometer 
was even considered, since peaks A and D were of the same 
size in shock plasma. If peak A was reduced by a decrease 
in sensitivity of the spectrophotometer, then peak D would 
also be reduced . However, peaks B, C, E, and F were no 
smaller than those for other dogs, so this step of the pro-
cedure was ruled out. The dialysis procedure was suspect 
because fibrin might adhere to the membrane if it was not 
completely removed from the plasma. This might prevent large 
proteins from passing into the ultrafiltrate. However, it is 
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extremely unlikely that the large peptides in peak A were 
lost during the procedure at three separate times for one 
particular dog. No explanation for small peak A for old 
dog #S can be offered at present, unless some deficiency in 
the blood is exhibited by this small peak. 
It should be noted that peak DOS was larger than peak COS, 
and a depression of P , V and an increase in the slope o max 
of the latency curve resulted (Figures 29, SO). 
Peak DYS was smaller than peak CYS and peak DOG was 
larger than peak COG. A continual depression in P
0 
and a 
continual increase in the slope of the latency curve resulted 
(Figures 30, Sl). 
Whole plasma was used instead of processed plasma peak 
D for three muscle experiments (Figures 32, 33, 34). Plasma 
YS caused a depression of P
0
, Vmax' and an increase in the 
slope of the latency curve (Figures 32, 34, S2, S4). This is 
consistent with peak DYS (Figure 30) which also caused a 
depression of P
0
, Vmax and an increase in slope of the 
latency curve. This suggests that some common factor in 
peak D might also be present in the whole plasma of young 
dog #S. The elution pattern of the plasma from this dog 
does not differ from the others with the exception that peak 
E is larger than usual. However, this would not affect the 
response elicited by peak D. The depression elicited by 
young dog #S may be traced to the anesthetic which was 
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administered to the dog in order to obtain a sufficient amount 
of blood. 
According to Lundgren et al. (1976), the depression in 
developed tension elicited by whole plasma from control cats 
was due to the presence of pentobarbital in the plasma. 
Plasma 03 (Figure 32) depressed P
0
, Vmax' and increased 
the slope of the latency curve; however, these responses 
were not due to any anesthetic. Note that the response 
elicited by peak 003 (Figure 27) was different from whole 
plasma. The medical history of this 14-year old Weimaraner 
may be considered when explaining the depression in con-
tractili ty. Although there was no history of a heart 
condition, there may very well have been some component in 
the blood which-would cause the-observed depression. This 
component could not be of the same molecular weight as the 
substance which is found in peak D. 
P
0
and Vmax were depressed with plasma Y4 (Figure 33) 
and peak DY4 (Figure 29) in a similar manner. No anesthetic 
was administered to young dog #4. However, there was a 
discrepancy in the effect on the slope of the latency curve. 
The slope increased with plasma Y4 (Figure 53), while the 
slope decreased slightly from the· K-H slope value with 
peak .DY4 (Figure SO). _There is no explanation for the 
biological inconsistency concerning the slope of the latency 
curve.· 
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The relationship of the plasma 02 force-velocity curve 
(Figure 33) to the plasma-young force-velocity curve was very 
similar to the relationship of the peak D02 curve to the 
peak D-young curves (Figures 26, 31). 
The P
0 
value of. the muscle subjected to plasma OS 
(Figure 34) was slightly larger than the P value for plasma 
0 
from the young dog. This is in contrast to peak DOS which 
depressed the P
0 
value from the value for peak D from the 
young dog (Figure 29). The curves for peak D from a young 
dog and peak DOS were similar to the curves for whole plasma, 
except for a decrease in P when peak D from the old dog 
0 
was used. 
The probable reason why plasma OS decreased the slope 
of the latency curve from the value for the plasma-young 
curve while peak DOS increased the slope of the latency 
curve from the value for the peak D-young curve is that the 
large increase in slope which was caused by plasma from the 
young dog was due to the presence of the anesthetic in the 
whole plasma. Although both plasma OS and peak DOS increased 
the slope of the latency curve from the Krebs-Henseleit 
value, the effect of plasma OS was not as detrimental as 
the effect of the anesthetic present in plasma YS (Table 4). 
The P0 value increased when whole plasma from old dog 
llS was used, but decreased when peak DOS was used. There 
may be components of whole plasma which are beneficial and 
235 
absent in peak D which may be responsible for the improve-
ment in P
0 
value. 
There is a possible contributing factor .for the de-
pression of the force-velocity curves from processed plasma 
peak D samples when compared with the K-H force-velocity 
curves. The activity of the column eluate (Krebs-Henseleit 
minus glucose after passing through the column) was reported 
to be slightly myocardial depressant (Lefer, 1970; Lefer and 
Martin, 1970b). This may account .for some of the depression 
which was observed with the peak D samples (Figures 28, 29, 
30, 31). 
However, the peak D samples used in Figures 25, 26, 27 
improved muscle performance beyond the performance of the 
muscle with K-H buffer solution. 
Another possible explanation for the depression with 
whole plasma when compared with the Krebs-Henseleit buffer . 
is the lower free calcium ion concentration in .the plasma 
relative to the Krebs-Henseleit solution. Protein-bound 
calcium which is nondiffusable represents about 30-55% of 
the total serum calcium (Moore, 1971). 
One point should be clarified in interpreting the 
composite force-velocity ci;irves (Figures 35-43). The.total 
number of activated myosin cross-bridges for each muscle is 
corrected for with P/P • The force of all muscles is 
0 
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normalized and differences in the size of the papillary 
muscle are eliminated. The force measurements along the 
x-axis should then range from 0 to 1 since P
0
/P
0 
for each 
muscle is 1. 
The points along the x-axes larger than 1 are the 
points extrapolated by the computer which is programmed to 
calculate the force where velocity is zero. 
From the composite Krebs-Henseleit,·peak D-young and 
peak D-old force-velocity curves (Figure 40) where veloci-
ties are the means of the velocities for the nine K-H curves, 
six DY curves and six DO curves, the overall effect may be 
demonstrated. The curves for DY and DO are very similar, 
and the peak D-old curve has a larger Vmax value than that 
for peak D-young or K-H curves. A general trend of improved 
muscle performance as K-H was replaced with peak D of plasma 
from young dogs and then with peak D of plasma from old 
dogs is depicted. 
A different trend is depicted in the'composite with 
whole ·plasma from young dogs and.whole plasma from old dogs 
(Figure 41). There was a general depression as buffer was 
replaced with plasma from young dogs and then with plasma 
from old dogs. However, two points must be considered. 
First, the sample size .for whole plasma experiments was 3. 
Second, plasma from the same young dog was used in two of 
these experiments. The muscle depression which occurred 
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was probably due to the presence of anesthetic in the plasma. 
The difference between the plasma-young curve and the 
plasma-old curve may be attributed to one muscle experiment 
(Figure 32) where the difference in Vmax between plasma Y5 
and plasma 03 approached· significance (a=O .10) (Table 9) . 
Thus, this compo$ite is representative of only three experi-
ments in which it is very easy for just one experiment to 
shift a curve either toward or away from the K-H curve. 
The composites in Figures 42 and 43 include a further 
normalization of the papillary muscles with respect to force 
and velocity per unit of cross-sectional area. The close 
similarity between peak DY and peak DO, and the improvement 
in muscle performance above the performance of the muscle 
with K-H buffer is again present. 
The only difference between Figures 40 and 42 is that 
in Figure 42, it appears that peak DY was more beneficial 
to the muscle than peak DO in.terms of Vmax per unit of 
cross-sectional area. 
The effect of normalizing the three muscles subjected to 
whole plasma with respect to velocity per unit of cross-
sectional area (Figure 43) was to approximate the plasma-
young and plasma-old curves which indicates a similarity 
between whole plasma from .young and old dogs. 
A comparison should always be made with a constant 
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standard, such as modified Krebs-Henseleit solution, because 
of the components and unknown variables present in plasma. 
As it was concluded in the statistical analysis section of 
the RESULTS, there.was no significant difference between 
plasma (processed or unprocessed) from young and old dogs. 
Any significant age effect could be attributed to the first 
age treatment (K-H) which differed from both the young and 
old age treatments. As a pair, the young and old age treat-
ments did not significantly differ from each other. 
Conclusions 
The question still remains: Is MDF present in the 
plasma from aged dogs? Blood containing MDF was collected 
directly from the pancreas via the hepatic portal vein from 
a shock dog (pancreatic vessel ischemia). The blood from 
aged dogs was obtained via the jugular vein. If MDF was 
present in the aged animal, this peptide would not accumu-
late in concentrations which are present during shock or 
the aged animal would die. However, a low-grade concentra-
tion of MDF circulating within the aged animal is possible, 
since depressed reticuloendothelial and kidney systems 
are not uncommonly found in aged animals. Two possibilities 
should be considered when coinparing the chromatograms from 
shock plasma with plasma from aged dogs. Peak D of shock 
plasma·, which unquestionably contained MDF, was larger than 
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peak D of plasma from old dogs. The first hypothesis is that 
MDF could not be present at the same concentration in an 
aged dog as in a shock dog for survival reasons alone. Thus, 
the optical density readings for this peptide, which was 
found in the eluate at peak D, could not be similar for age 
and shock. The second possibility, which is only a mere 
thought, is that in. an aged dog with poor circulation, .if 
blood is not collected directly from the source of MDF, how 
certain can we be that MDF is present in detectable and 
undiluted concentrations in the peripheral circulation at 
any given time. 
Basal amounts of MDF may always be present in the pa~creas 
of .a normal animal, young or old. Relatively low MDF 
activity was indicated in a chromatogram of sham-shock cat 
pancreas. Low MDF concentrations could be present in the 
normal animal and be continuously eliminated from the body .. 
Only when the systems are depressed during shock does MDF 
accumulate and exert its actions in a vicious positive feed~ 
back cycle. 
Thus, if MDF were to be detected in t.he pla·sma 'of an 
aged animal, the systems of the aged .animal would have to 
malfunction to the same degree of severe depression as in the 
·shock state. 
A major problem. inherent in the study of aging animals 
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should be realized. As a population ages, a continual selec-
tion occur.s as members are removed by death. If MDF accumu-
lates with age, but .the animals die before the plasma MDF 
concentration is detectable, the study of surviving aged dogs 
will yield misleading results. 
There is a possibility that MDF is present in the aged 
animal. MDF was not present in the six aged animals selected 
for the study at a detectable concentration with the pro-
cedures used. MDF, if present in these aged dogs, was 
certainly not present at th~ same concentration as MDF of 
shock plasma. There is a good possibility that the concen-
tration of MDF may be increased by performing a series of 
lyophilizations of the initial 10-ml aliquot of peak D. 
Physiological osmolarity would have to be maintained without 
altering calcium and other ion concentrations. Low levels 
of MDF could then be detected in the aged animal with the 
bioassay. The other option would be to develop a more sensi-
tive bioassay, although significant sensitivity has been 
demonstrated with the papillary muscle system. 
Another alternative to the procedure of concentrating 
MDF would entail twelve or thirteen repeated column separa-
tions of plasma from the same aged dog to yield twelve or 
thirteen peak D's. These would then be pooled, lyophilized 
together and reconstituted to 24 or 26 ml. 
Osmolarity would have to be adjusted without altering 
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the calcium ion concentration. No K-H buffer would be used 
since the muscle chamber holds 25 ml, or varied proportions 
of pooled peak D's and K-H could be used for the mus.cle 
batl).. 
A third alternative is to further purify peak D with a 
Dowex-50 ion exchange column. 
Although the effects of each young dog can be explained, 
the value of using d,ifferent young dogs as controls might 
.be reevaluated. It was informative to study as many column 
elution patterns from young dogs as from old dogs. However, 
with the papillary muscle bioassay, each sample from a dif-
ferent aged dog was being tested against a sample from a 
different young dog. If this additional variable (young dog 
differences) was eliminated by repetitively using plasma 
samples from the same young dog on every papillary muscle, 
only .muscle differences and differences between aged dogs 
would be present. The advantage of using samples from dif-
ferent young dogs was to observe the effects of plasma from 
young dogs compared with K-H buffer, in addition to using 
the young dogs as controls for aged dogs. The disadvantage 
of using one young dog for all aged dogs is that a young 
dog may be randomly chosen which has an unusual plasma 
component wh~ch may influence the papillary muscle to respond 
to plasma from all aged dogs in a particular way. The only 
way to fairly represent a population is to randomly sample 
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young dogs. If plasma samples from several young dogs are 
pooled, there may be interactions between different dog 
plasma which might also influence the papillary muscle to 
respond to plasma from all aged dogs in a certain way. It 
is possible to test a concentrated test solution of peak D 
of an aged dog (pooled from 12-13 identical column separa-
tions) against a series of different young dogs whose peak D 
solutions would be equally concentrated (12-13 column sepa-
rations of plasma ultrafiltrate from each young dog). 
Variabilities are high in mechanical studies of isolated 
muscles (Heller and Whitehorn, 1972). The bioassay technique 
has limitations. The number of samples which can be assayed 
at one time is limited by the viability of the papillary 
muscle utilized. The papillary muscle is extremely sensitive 
to pH and osmolarity changes, and a stable system must first 
be established. A noteworthy consideration is that it is 
very difficult to obtain large quantities of blood from 
aged dogs which makes it difficult to replicate steps in the 
procedure. 
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APPENDIX 
Figure 60. Bio-Gel P-2 column elution pattern of processed 
plasma ultrafiltrate obtained from an aged 
female beagle (17 years) (05) 
The peaks are designated A through F in order of 
decreasing molecular weight. The column flow 
rate was 11.2 ml/hr (5.6-ml fractions). Fractions 
1 through 9 had optical density readings of 0.02. 
Peaks Elution volume Location of peak height 
(ml) (ml) 
A 61. 7-84.1 72.9 
B 100.9-123.3 123.3 
c 128.9-145.7 134.5 
D 145.7-156.9 151.3 
E 168.1-179.3 173.7 
F 218.5-257.7 252.1 
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Figure 61. Bio-Gel P-2 column elution pattern of processed plasma 
ultrafiltrate obtained from an aged female beagle (17 years) 
(OS) 
The peaks are designated A through F in order of decreasing 
molecular weight. The column flow rate was 11.2 ·ml/hr (5 . 6-ml 
fractions). Fractions 1 through 10 had optical density 
readings of 0.02. 
Peaks Elution volume Location of peak height 
(ml) (ml) 
A 65.8-88.2 71.4 
B 105.0-121.8 121.8 
c 127.4-144.2 138.6 
D 144.2-161.0 149.8 
E 177.8-200.2 194.6 
F 217.0-261.8 250.6 
Old dog #5 (05) 
Beagle (F) 17 years· 
Jio,• 11'1 
Fraction number - Elution volume (ml) 
